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1 Introduction and research objectives 
Peptides and proteins are important components for living organisms. They fulfil a various 
number of tasks ranging from structure-giving functions up to transporting and catalysing 
processes.
[1]
 Membrane proteins represent an important class of proteins as they are 
encoded in up to 30 % of the open reading frame. More than 50 % of currently available 
drugs target membrane proteins, emphasising the importance of membrane protein 
research.
[2,3]
 Membrane proteins usually feature a complex structure, and due to their 
hydrophobic properties, the isolation and purification of membrane proteins can be 
challenging. Nevertheless, a large number of complex membrane proteins consist of the 
well-known -helices.
[4,5]
 Therefore, different peptidomimetics, like the WALP and KALP 
model peptides, have been developed to imitate the behaviour and function of -helical 
transmembrane proteins in a less complex environment.
[6–8]
 Such peptidomimetic model 
systems help to investigate the structure and dynamics of transmembrane peptides within 
lipid bilayers. Thus, they offer the possibility to understand protein-protein binding, signal 
transduction, protein stability and enzyme catalysis in a variety of cellular processes 
better.
[1,6–8]
 Besides the use of transmembrane -peptides, the design and synthesis of 
further transmembrane model systems based on artificial β-peptides consisting of β-amino 
acids has become of great interest.
[9]
 β-Amino acids differ from the natural -amino acids 
by an additional methylene group in the amino acid backbone, and due to this 
modification, β-peptides are able to form more stable secondary structures than 
-peptides.
[9,10]
 Peptidomimetics based on β-amino acids are still widely unexplored. The 
development of model transmembrane β-peptides, however, can help to understand the 
orientation or the peptide aggregation of helical transmembrane peptides and proteins.
[11–15]
  
The first part of this thesis focuses on the synthesis, characterisation and investigation of 
transmembrane β-peptides which were inspired by prior studies.
[12]
 These novel 
transmembrane β-peptides differ in the N-terminal modification and partially in the peptide 
length, which extend range of transmembrane β-peptides.
[7,14]
 Their secondary structure 
was analysed in organic solvents as well as in large unilamellar vesicles by means of 








was inserted either peripherally or centrally into the hydrophobic peptide sequence to 
observe the tryptophan fluorescence which is influenced by the surrounding polarity.
[16–21]
 
Furthermore, the determination of the exact position of the D-β
3
-hTrp in the membrane was 





examined by tryptophan fluorescence quenching experiments based on DOXYL-labelled 
lipids.
[22–25]
 In order to perform surface-enhanced infrared absorption (SEIRA) 
spectroscopy to obtain information about orientation, association and localisation of the 
β-peptides within the membrane, the novel β-amino acid Fmoc-D-β
3
-Ala(CN)-OH (1) was 
synthesised and incorporated into the transmembrane β-peptide sequence.
[26–28]
 These 
experiments were performed in collaboration with STAFFA from the HILDEBRANDT research 
group. 
The second part of this thesis deals with the question whether β-peptides can function as 
membrane-anchored molecular rulers to investigate processes at the membrane interface. 
Already known sensors were anchored by acyl chains or lipid molecules into the 
membrane.
[29–37]
 These kinds of molecules limit the exact determination of the sensor 
distance to the membrane surface as they have no fixed rigid anchoring structure. Hence, 
the advantages of β-peptides like conformationally well-defined and stable secondary helix 
structures seem to be interesting for the development of new transmembrane anchoring 
peptides.
[10]
 A recently published transmembrane β-peptide consists of a hydrophobic inner 
membrane part that is flanked by two D-β
3
-hTrp residues at each side of the peptide.
[38]
 
These residues anchor the peptide in the membrane and stabilise the vertical insertion of 
the β-peptide. Based on this basic structure, transmembrane β-peptides were equipped 
either with a pH-sensor (carboxyfluorescein) or with a newly designed Ca
2+
-sensor. To 
analyse near-membrane pH values, two carboxyfluorescein-labelled transmembrane 
β-peptides were synthesised with different sensor distances to the membrane surface and 
pH titration was employed. The different distances were achieved by attaching the sensor 
to peptides with varying lengths of the peptide sequence outside the membrane. To analyse 
near-membrane Ca
2+
 concentration, two Ca
2+
-sensors were developed based on literature 
known models.
[37]
 Titration series with the sensors attached to hydrophilic peptides and 
Ca
2+
 were performed and analysed with UV/Vis and fluorescence spectroscopy to 





 concentration differences were applied to study one of the sensors 
attached to transmembrane β-peptides.  
 
 





2 Artificial transmembrane β-peptides  
The peptide synthesis is based on the stepwise linking of monomers in a solution phase or 
on a solid phase. During the last decades a peptidomimetic with an increasing potential is 
the -peptide. In the following the synthesis of D-
3
-homoamino acids as SPPS building 
blocks and the -peptide synthesis are shown.  
2.1 β-Amino acids  
Native peptides and proteins consist of -amino acids. These -amino acids exhibit a 
common structure, which includes an amine functionality, a carboxylic acid functionality 




 a) b)  c)  d) 
 
Figure 2.1 a) General structure of -amino acids. Based on the incorporation of an additional methylene group in 
the -amino acid backbone different substitutions in - amino acids are possible: b) -amino acid, c) -amino 
acid, d) 2,3-amino acid.[10] Adapted with permission from R. P. Cheng et al., Chem. Rev. 2001, 101, 3219–3232. 
Copyright (2001) American Chemical Society. 
The -amino acids can be classified into homoamino and isoamino acids. The -isoamino 
acids are based on the structure of the -amino acids, except for the amino group, which is 
moved without another change to the -carbon atom of the side chain.
[40]
 Due to this, the 
side chain is reduced by one methylene group and the backbone is increased by one. The 
-alanine, found in the coenzyme A, follows this nomenclature.
[41]
 The -homoamino 
acids differ from the natural -amino acids by the incorporation of an additional methylene 
group in the backbone. This results in an additional torsional angle (see Figure 2.4 a) as 
well as a second position for a side chain linkage (see Figure 2.1) without any functional 
reduction on the side chain group.
[9,10,40,42]
 In the following, -homoamino acids are 
referred to as -hXxx (Xxx = three letter code), a designation that is based on the 
nomenclature of the -amino acids. The numbering of the C-atoms begins with the C-atom 
of the carboxylic acid and ends at the C-atom next to the amine group (see Figure 2.1). The 
designation with Greek letters starts at C-2.
[9,10,40,43]
 Furthermore, the side chain can be 







acids (see Figure 2.1). A multiple substitution at C-2 and C-3 with side chain groups is also 














Despite the great potential for modifying -amino acids, the occurrence of -amino acids 
in nature is low. They are found, for example, as free amino acids or as special building 
blocks in peptides and alkaloids.
[9,44]
 The low abundance of -peptides might be because of 
a limited availability in the origins of life, structurally disadvantages compared to 
-peptides and differences in reactivity of the monomers. Due to the additional methylene 
group in -amino acids, the reactivity of - and -amino acids are different. 
Phosphorylation reactions, which are important for the regulation of biological processes, 
provide a method to examine different reaction behaviours.
[45]
 Studies of N-phosphoryl 
-aspartic acid showed that the -carboxylic acid displays a different behaviour compared 
to the -carboxylic acid.
[46,47]
 For example, dipeptides are only formed between -amino 




Figure 2.2 Possible intermediates for the formation of - or -dipeptides by N-phosphorylamino acid.[47] Adapted 
with permission from Z.-Z. Chen et al., J. Org. Chem. 2003, 68, 4052–4058. Copyright (2003) American Chemical 
Society. 
Thus, it is presumed that the -carboxylic acid has a higher activity after 
N-phosphorylation then the -carboxylic acid. Comparable results were found in a 
nitrosation reaction with amino acids, a reaction that was observed in preserved food 
within the stomach.
[48,49]
 Here, a similar reactivity of amino acid types was found (-amino 
acids < -amino acids < -amino acids). Besides other explanations, these different 
reactivities are an indication why -amino acids are preferred in natural systems.
[46,47]
  
However, during the last decades the research on -amino acids has become more 
important. Especially SEEBACH et al. and GELLMAN et al. published ground-breaking work 
in this research field.
[9,10,40,50–54]
 The incorporation of -amino acids in -peptides and the 
synthesis of pure -peptides lead to interesting compounds. Properties in connection with 
biological systems, structure and thermal stability have been described extensively.
[9,55–59]
 
SEEBACH et al. pointed out that the enzymatic proteolysis of mixed and pure -peptides is 
slower than the proteolysis of native amino acid bonds or it is totally blocked.
[60]
 





Due to the widespread use as peptidomimetics, the synthesis of the monomeric building 
blocks and the optimisation of the SPPS based peptide synthesis represent important 
research fields.  
2.2 -Peptides  
A lot of basic research on the secondary structure was performed with regard to the 
behaviour of -amino acids and the resulting -peptides. In general, -peptides can mimic 
the native -helices, the sheet structure as well as the hairpin structures.
[9]
 Furthermore, 
-peptides can form different helices and the type of helix can be anticipated by the type of 
amino acid side chain and the substitution of the -amino acid.
[9]
 The helix is defined by 
the number of atoms between the hydrogen bond, formed by the backbone NH and O (see 
Figure 2.3).
[9,10,43,61]
 The best studies helices are the 8-, 10-, 12-, 10/12- and 14-helix. 
 
Figure 2.3 Hydrogen bond-based nomenclature of -peptides. The atoms involved in hydrogen bonding are 
coloured.[10] Adapted with permission from R. P. Cheng et al., Chem. Rev. 2001, 101, 3219–3232. Copyright (2001) 
American Chemical Society. 
Due to the easier accessibility of the 
3
-amino acid monomers, compared with other 
-amino acids, the secondary structure formed by 
3
-peptides is well known.
[9]
 The 
conformation variation in the C-C bond of these peptides prefers the formation of helices 
or turns. Possible conformations are the trans conformation ( = ), gauche 
conformation ( = ± ), skew conformation ( = ± ) and syn-clinal conformation 
( = ± ). The gauche conformation is the favourable conformation for 3-peptides 
because of steric effects which result from repulsive forces (see Figure 2.4 b).
[9]
 The most 
common secondary structures are the 12- and 14-helix. Other helix conformations, for 












 a) b)  
 
Figure 2.4 a) Torsion angles in -peptides. b) Different conformations of 3-peptides. The favoured conformation 
is the gauche conformation and it results in the formation of a helix or a turn.[9,10,43] Adapted with permission from 
R. P. Cheng et al., Chem. Rev. 2001, 101, 3219–3232. Copyright (2001) American Chemical Society. 
The helices differ in their characteristics such as radius, residue per turn or rise per 
residue.
[43]





 and X-ray crystallography.
[63]
 For similar types of helices, these 
different methods lead to virtually the same results. There can be small variations in the 
structure based on the measured differences for example in probe preparation or in the used 
model peptides. In Table 2.1, characteristic structure properties of the 12- and 14-helix 
based on simulation and X-ray measurements are given. In general, the thinner 12-helix 
differs with 2.5 residue per turn from the 14-helix, which exhibits 3.0 residue per turn.
[10]
 
These averaged residue per turn of the 12-helix and 14-helix allow a simpler design of the 
peptide motifs as compared to the -peptides (3.6 residue per turn).
[71–73]
 Consequently, the 
12-helix has a higher rise per residue (2.1 Å) than the 14-helix with 1.56 Å.
[10]
 As with the 
-peptides, it is possible to control the handedness of the presented helix by selecting the 
chirality of the amino acids used. -Amino acids with a natural chirality (L-amino acids) 
induce a right-handed -helix.
[1]
 The right-handed 14-helix can be achieved by the use of 




Table 2.1 The characteristic structural properties of 12-helices and 14-helices based on NMR, CD and X-ray 
crystallography of model peptides. There are small variations in the structure values based on different 
literatures.  













































The helix formation can be predicted by the chosen amino acid sequence and the choice of 
amino acids. Cyclic amino acids, for example, stabilise different helices due to the ring 




Figure 2.5 Cyclic amino acids that support different helix conformations.[10,43,51] 
The non-cyclic amino acids can influence the secondary structure as well. Here, the type of 
branching is important.
[83]
 In contrast to molecular-dynamics (MD) simulations of GLÄTTLI 
et al.,
[84]
 the CD measurements of RAGUSE et al.
[83]
 indicate that a high amount of 
3
-hVal 
forces the helix in a 14-helix conformation whereas a high amount of 
3
-hLeu forces a 
12-helix conformation. It is assumed that branching next to the -C-atom is favourable for 
a 14-helix, like in the case of 
3
-hVal. Studies of unbranched amino acids implied 
controversially discussed results. ABELE et al. proved that model peptides with a high 
amount of 
3
-hLys in MeOH show the typical CD spectrum of a 14-helix.
[85]
 In contrast, 
the same peptides in H2O or buffer have no typical pattern, due to a possible disruption of 
the H-bond network by 
3
-hLys. The same peptides with 
3
-hSer instead of 
3
-hLys show 
a pattern specific for a 14-helix. For this reason, ABELE et al. assumed a stabilising effect 
of 
3
-hSer in aqueous solutions.
[85]
 KRITZER et al. concluded that in a model peptide the 




-hGlu has a stabilising or 
destabilising effect.
[74]
 Near the N-terminus a stabilising effect of 
3
-hLys and a 
destabilising effect of 
3
-hGlu was found, whereas at the C-terminus a reversed effect was 
observed.  
2.3 Transmembrane -peptides as model structures 
Biological membranes are the place of essential reactions, transmembrane signalling as 
well as anchor point of cell structure units.
[1,86,87]
 Therefore, a lot of peptides are localised 
in or on the lipid membrane. Hydrophobic α-helices are a ubiquitous structure motif. This 
is verified by the fact that 20 – 25 % of open reading frames in the genome sequence 
encode these α-helices.
[4,5]
 In order to understand how peptides are anchored in the 





membrane, a vast amount of synthetic peptides based on transmembrane α-helices has been 
studied.
[7,8]
 Generally, the model peptides feature a hydrophobic core, which interacts with 
the lipid acyl chains. This hydrophobic core commonly consists of amino acids with 
hydrophobic side chains, such as leucine or alanine. The amino acids are either arranged 
alternatingly or the core features one type of amino acid that is repeated several times. The 
hydrophobic core is usually flanked by polar amino acids, for example lysine or 
tryptophan. Lysine increases the solubility of the model peptide
[88]
 and tryptophan ensures 
that the peptide is anchored in the membrane.
[7,89]
 It has been shown that tryptophan is 
more efficient in anchoring the peptide than lysine. In Table 2.2, examples of model 
transmembrane peptides are given.  
Table 2.2 Examples of model peptides designed for studying lipid-peptide interactions.[7] 
Model peptide Amino acid sequence 
WALP Ac-GWW(LA)mLnWWA-CONH2 (m = 3, 5, 6, 7, 8, 10, 12, n = 0, 1) 




The length of the hydrophobic core especially influences how peptides interact with the 
lipid membrane. If the hydrophobic core of the peptide is longer than the lipid bilayer, a 
positive hydrophobic mismatch is generated. A negative hydrophobic mismatch, on the 
contrary, results if the hydrophobic core of the peptide is shorter than the length of the lipid 



























Figure 2.6 Possible lipid-peptide interactions to prevent mismatch situations.[8] Adapted with permission from M. 










Depending on the kind of mismatch, the lipid-peptide interaction is different. It can lead to 
a deformation of the membrane, deformation of the peptide or other interactions to prevent 
the peptide lipid mismatch (see Figure 2.6).
[8]
  
The development of alternative approaches for transmembrane peptides can help to 
increase the number of membrane study tools. In various studies transmembrane 
-peptides were developed, which are based on the already mentioned KALP and L24 
model peptides.
[7,11–15]
 Among others, with these transmembrane -peptides incorporation 
and aggregation studies were performed. 
2.4 Synthesis of D-3-homoamino acids 
As starting material for the synthesis of D-
3
-homo amino acids, the respective Fmoc 
protected -amino acids were used. The free carboxylic acid was treated with isobutyl 
chloroformate (1.10 eq) and triethylamine (1.10 eq) in THF. This resulted in an activated 
mixed organic acid anhydride that reacted with diazomethane (2.00 eq) to a diazo ketone 
(see Figure 2.7). This intermediate can be used without any purification. In the case of a 
discolouration (red instead of yellow) purification by flash chromatography (pentane/ethyl 
acetate) is also possible and advisable.  
 
Figure 2.7 Reaction schema of the ARNDT-EISTERT homologation to obtain 3-homoamino acids (PG = protection 
group).[11]  
The second step of the ARNDT-EISTERT homologation was a silver(I) catalysed WOLFF 
rearrangement. Therefore, two reaction conditions were established.
[9,11,90,91]
 For the first 
reaction condition, the educt was solved in THF/H2O (9:1) and silver(I) benzoate (0.10 eq) 
was added to the solution. This mixture was sonicated for 2 h at RT. For the second 
reaction condition, the educt was solved in dioxane/H2O (2:1) and after the addition of 
silver(I) benzoate (0.10 eq) the mixture was irradiated in a domestic microwave (480 W, 
60 s). Here, a partly incomplete conversion was observed, which is likely due to the used 
glassware. The thinnest possible wall thickness is probably more beneficial than a thick 
one. In the following, the reaction was worked up and the product was purified by 
precipitation in cold pentane or by flash chromatography. Small amounts of impurities 
remained in the product after purification by precipitation, but they did not affect the 
following peptide synthesis.  





2.5 Synthesis of -peptides 
2.5.1 Manual peptide synthesis 
The -peptides were synthesised by solid phase peptide synthesis based on the Fmoc 
strategy.
[92,93]
 The used method is well established.
[14,38,94]
 As an insoluble solid phase a 
MBHA rink amide or a Nova PEG LL rink amide resin was used. The substrates differ in 
their swelling properties and loading density. The MBHA rink amide resin is based on 
polystyrene and was used with a resin loading of 0.3 – 0.5 mmol/g. Due to the 
polyethylene glycol (PEG) substrate of the Nova PEG LL rink amide resin, the swelling 
properties are higher and a smaller resin loading (0.18 mmol/g) was used, so that this resin 
was chosen in challenging syntheses. Both resins form a carboxamide group at the 
C-terminal end on account of the rink amide functionalisation.
[95]
 This prevention of 
charge at the C- and N-terminus of transmembrane peptides is very common.
[7,8,96,97]
 The 
resin was washed during the synthesis with MeOH, (DCM) and DMF. All synthesis steps 
were supported by microwave radiation which increases the effectiveness of the coupling 
reaction (see Chapter 6.4).
[98–102]
 
The N-terminal resin-bound Fmoc group was cleaved twice by using a solution of 
NMP/piperidine/DBU (v/v/v; 79:20:1). The free N-terminus was treated with a mixture 
consisting of amino acid (5.00 eq), which was solved in a solution of 0.49 M/0.50 M 
HATU/HOAt in DMF (5.00 eq) followed by adding 2.0 M DIPEA in NMP (10.00 eq). 
Depending on the efficiency of the coupling, this step was performed once, twice or thrice. 
(see Figure 2.8).  
 
Figure 2.8 Schematic overview of solid phase peptide synthesis. 





The peptides based on D-
3
-hLeu showed an inadequate coupling efficiency, which led, 
despite a high number of coupling to a small amount of target peptide. Subsequently, the 
free amino groups were capped with acetic anhydride in NMP (v/v; 20:80) to prevent 
undesirable peptide elongation (see Figure 2.8). The entire resin-bound peptide was dried, 
cleaved by TFA/H2O/TIS (v/v/v; 95:2.5:2.5) and purified by HPLC. A modification of the 
N-terminus with acetylation or fluorophores was performed on resin before cleaving. In the 
mass spectrometric examination of the synthesised peptides, the tryptophan containing 
peptides showed temporary mass differences. The Boc protected 
3
-hTrp showed a 

































































Figure 2.9 a) Reaction schema of the deprotection of 3-hTrp with TFA. In a TFA solution, the side chain may be 
incompletely deprotected. By an acidic aqueous workup, the complete decarboxylation takes place. 
b) Deconvoluted ESI mass spectra of a peptide with incomplete Trp deprotection (left) and mass spectra of the 
same sample after lyophilisation with a mixture of dioxane and dilute HCl (right).  
This leads to an increase of the measured mass by the number of 
3
-hTrp (n × 44 m/z). The 




2.5.2 Automatic microwave-supported peptide synthesis 
The development of automatic peptide synthesis is a relevant working method and is 
recently gaining importance. During the last decades, methods were developed to reduce 
expenditure of time and chemical consumption considerably in comparison to the standard 
manual method.
[98,100,104–106]
 The complex automatic peptide synthesis of -peptides was 
among others, examined by GELLMAN et al. with the synthesis of an established 6-mer 
peptide that formed a 12-helix without any results.
[9]
 In contrast, with similar reaction 
conditions it was possible to synthesis several 9-mer peptides that formed 14-helices. This 





peptide synthesis was performed with HBTU/HOBt at RT.
[53]
 A much longer mixed 
17-mer (16 × 
3
- and 1 × 
2
-homoamino acids) -peptide was successfully synthesised by 
LELAIS from the SEEBACH group.
[107]
 However, most of the synthesis conditions for 
-peptides show long reaction times and coupling steps at RT.  
An increase in efficiency of -peptides synthesis was achieved by heating during the 
elongation step with conventional oil bath or microwave irradiation.
[101,102]
 The beneficial 
effect of the temperature increase was already successfully used for the manual synthesis 
of -peptide (see Chapter 2.5.1).
[98,100]
 As a result of this, it could be advantageous to 
combine the established benefits of microwave synthesis with an automatic system for 
-peptides.
[38,94]
 In order to develop a synthesis that is more time-efficient, two different 
syntheses have been developed. These methods differ in the choice of coupling reagents, 
the number of couplings and the coupling time. The first method (Method 1) is a 
combination of the established manual microwave-assisted SPPS (see Chapter 2.5.1) and a 
modified method based on the work of CAPORALE et al.
[108]
 CAPORALE et al. found an 
improvement of the synthesis of aggregating peptide sequences by using a double coupling 
strategy with DIC/Oxyma and HATU/Sym-collidine. Due to this work, the first coupling 
step was performed in Method 1 with DIC/Oxyma at 90 °C with a reaction time of 7.0 min 
(60 s preactivation at RT, 300 s ramp at 90 °C, 60 s cool down to RT) what constitutes an 
adapted method of the HE-SPPS method developed by CEM.
[98]
 The second coupling step 
of Method 1 was performed with HATU/HOAt/DIPEA at 75 °C with a reaction time of 
20 min (60 s preactivation at RT, 1140 s at 75 °C). The second method (Method 2) was 
based on the CarboMAX
TM
 method by CEM.
[104,105]
 Here, the coupling takes place with 
DIC/Oxyma at 105 °C for 2.6 min (155 s ramp at 105 °C). In contrast to the DIC/Oxyma 
coupling step used in Method 1, the CarboMAX
TM
 method is based on the double amount 
of DIC in relation to the amino acid. In Table 2.3 an overview of the reaction conditions of 
the methods and in Appendix A the detailed settings, synthesis scale and quantities for the 
automatic peptide synthesis are given. Both methods were tested at a LibertyBlue
TM
 
peptide synthesiser. The uncoupled peptide was capped with Ac2O during the synthesis to 
increase the efficiency of the coupling, especially for longer peptide sequences. In 
addition, an easier purification of uncoupled subsequences is possible. For this, an adapted 
capping solution was used. This was developed by EMD MILLIPORE (Burlington, 
Massachusetts, United States) and based on Ac2O/Oxyma Pure/DIPEA. This mixture 
allows the use of a more diluted solution of acetic anhydride and shows better results 





compared with the standard capping solution (MERCK information brochure “Applications 
of Oxyma Pure and K-Oxyma Pure in Fmoc SPPS”). The deprotection of the N-terminal 
Fmoc group was performed with a standard deprotection solution of 20 % piperidine in 
DMF at 90 °C.  
Table 2.3 Overview of the reaction conditions of the automatic microwave-supported SPPS for Method 1 and 
Method 2. 
 Method 1 Method 2 













Coupling temperature 90 °C 75 °C 105 °C 
 
HPLC measurements and mass spectrometric examinations were carried out to determine 
the success of both methods. For this purpose, the peptide was cleaved from the resin, 
lyophilised, dissolved in HFIP and measured with HPLC. The main signals of the HPLC 
were collected and examined by ESI-MS.  
To test the efficiency of the methods, two different peptides were used. Method 1 was 
used for a peptide shown in Figure 2.10 Pep Met 1, which was developed by KLOOS 
(unpublished results). The C-terminal amino acid D-
3
-hLys was protected on the side 
chain with Mtt. In contrast, the remaining D-
3
-hLys was protected with Boc at the side 
chain group. 
 
Pep Met 1 [3718.6 g/mol] 
                               
Pep Met 2 [3534.4 g/mol] 
Figure 2.10 Structure of the used test peptides to determine the synthesis efficiency of automatic 
microwave-assisted SPPS.  
Compared to Method 1, Method 2 works at higher temperatures and the thermal stability 
of the Mtt protecting group is unknown. Though, it is known that the highly acid-labile 





2-chlorotrityl resin, which has as linker a similar basic structure as Mtt, is instable at higher 
temperatures. This peptide Pep Met 2 shown in Figure 2.10, was used as -peptide based 
transmembrane regions and was synthesised in the presented work using Method 2.
[11]
 The 
quality of the synthesised peptides was determined by HPLC. For this purpose, the crude 
peptide was lyophilised with dilute HCl solution and then dissolved in 
hexafluoro-2-propanol (HFIP). HARA et al. was able to show that the use of fluorinated 
alcohols, such as trifluoroethanol, facilitates the purification of hydrophobic and 
aggregation-prone transmembrane peptides. For this purpose, TFE was added up to 10 –
 16 % to the mobile phase.
[109]
 In cooperation with SCHIRMACHER, it could be shown that a 
combination of solving the sample in HFIP and the addition of 0.1 % HFIP into the mobile 
phase leads to an improved splitting of the peaks in the HPLC chromatogram (unpublished 
results). Figure 2.11 shows the HPLC chromatogram of Pep Met 1 and Figure 2.12 
displays the MS analysis data of the main peaks. The HPLC chromatogram of the 
Pep Met 1 (see Figure 2.11) shows two main signals at tR = 14.7 and 17.3 min. MS 
analysis of the two peaks revealed in the peak at tR = 14.7 min the desired product with a 
mass of 3718.6 mol/g. The peak at tR = 17.3 min has a mass greater by 96 m/z (see Figure 
2.12).  



















































Figure 2.11 HPLC chromatogram of the crude peptide Pep Met 1. Absorption was recorded at 215 nm. Analytical 
HPLC was performed using a gradient 80→100 % B (A: H2O + 0.1 % TFA + 0.1 % HFIP and B: MeOH + 
0.1 % TFA + 0.1 % HFIP) in 30 min, flow 1.0 mL/min and 50 °C. The sample was dissolved in 100 % HFIP. 
This mass difference can be explained, inter alia, by the addition of a TFA molecule, 
which is bound to one of the lysine side chains via an amide bond. RIZO et al. found that 
contamination in TFE can cause trifluoroacetylation at the lysine side chain.
[110]
Whether 
this reaction is caused by impurities in the HFIP is unclear. Pep Met 2 was also treated 
under the same conditions with the same HFIP batch. Perhaps the residues of Mtt 





deprotection associated with HFIP leaded to a trifluoroacetylation. Another possibility is 
the selective deprotection of Mtt which was performed with a mixture of 
DCM/HFIP/TFE/TIS (v/v 65:20:10:5) at the resin-bound peptide. The Mtt deprotected 
resin-bound peptide was then split in two fractions. One part was used for further 
investigations by KLOOS and the other part was cleaved from the resin and analysed 
(Pep Met 2). However, these hypotheses require further research. All in all, it can be 
assumed that Method 1 leads to a successful automated SPPS. 
a) b) 
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M = 3814.6 m/z
 
Figure 2.12 ESI mass spectra of Pep Met 1 at a) tR = 14.7 min and b) tR = 17.3 min. 
In the HPLC chromatogram of the Pep Met 2 (see Figure 2.13) is a signal increasing in the 
range from 12 min to 20 min with an maximum peak at tR = 15.8 min. MS analysis of the 
this main peak showed the desired product with a Mass of 3534.4 mol/g (see Figure 2.14 
a).  

























































Figure 2.13 HPLC chromatogram of the crude peptide Pep Met 2. Absorption was recorded at 215 nm. Analytical 
HPLC was performed using a gradient 80→100 % B (A: H2O + 0.1 % TFA + 0.1 % HFIP and B: MeOH + 0.1 % 
TFA + 0.1 % HFIP) in 30 min, flow 1.0 mL/min and 50 °C. The sample was dissolved in 100 % HFIP. 
The less resolved chromatogram of Pep Met 2 compared to Pep Met 1 can be explained 
by a higher concentration of raw product as well as the different structure. In comparison 





to Pep Met 1, Pep Met 2 has one D-
3
-hLys less. This lower number of charged amino 
acids is a main reason for the water solubility of the used peptides and leads to a poorer 
resolution of the chromatograms.
[88,89]
 In Figure 2.14 b) the enlarged mass spectrum of 
Pep Met 2 in a range of 706 – 720 m/z is given. In addition to the signal of the desired 
target peptide [M + 5H]
5+
, two further signals with a mass difference of 14 m/z 
respectively 28 m/z are shown. These signals may be due to methylation of the target 
peptide on the D-
3
-hLys side chains. Whether this side reaction occurs during peptide 
synthesis or through the MS analysis is still unclear. However, this side reaction requires 
further research. All in all, it can be assumed that Method 2 leads to a successful 
automated SPPS. 
a) b) 
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M = 3534.4 m/z
 
Figure 2.14 ESI mass spectra of Pep Met 2 tR = 15.8 min from a) 500 – 1500 m/z and from b) 706 – 720 m/z. 
In summary, in the context of this work, two methods have been developed which make it 
possible to carry out an automatic SPPS of -peptides. These methods allow the reduction 
of the above-mentioned peptides from 4 – 5 d to less than 1 d. The analysis of both 
methods with HPLC chromatograms and subsequent MS analysis show the desired target 
peptide. However, both reactions showed peptides with undesired masses, which may be 
due to side reactions. These side reactions require further analysis to completely exclude a 
connection with the peptide synthesis or to adapt the automatic SPPS by e.g. the reduction 
of the coupling time. Furthermore, the isomerisation of the individual amino acids was not 
investigated and the degree of isomerisation per coupling is unclear. Nevertheless, methods 
have been introduced to significantly reduce the time spent on laboratory and to allow an 
efficient synthesis of -peptides which can significantly accelerate the understanding of 
-peptides.





3 Transmembrane β-peptides functionalised with 
fluorescence and IR-sensors  
Due to the hydrophobicity of transmembrane peptides and the membrane environment, 
both the synthesis and investigation are a difficult task. Sensor molecules and 
peptidomimetics are often used to clarify precise scientific research questions, like protein 
properties, protein localisation or protein interaction.
[6,42]
 In the following, transmembrane 
-peptides, with two different secondary structures, which function as peptidomimetics are 
shown. Additionally, these transmembrane -peptides have either indole or nitrile based 
sensors incorporated in their primary structures. 
3.1 Fluorescence-based sensors 
Biological systems are sensitive towards changes in their environment which might lead to 
biological responses.
[1]
 As an example, the transmembrane ATP synthase can transport 
protons across the membrane as well synthesis ATP by a proton gradient. To study these 
biological responses, different methods were developed such as spectroscopic-based 
methods like fluorescence or electron spin resonance spectroscopy.
[111]
 Especially in the 
last 30 years the biochemical research has benefited from the improvement of the 
fluorescent techniques.
[112]
 Fluorescence spectroscopy offers high sensitivity, fast response 
time, selectivity, experimental simplicity and flexibility.
[112]
 Fluorescence is the 
spontaneous emission of light by a substance that has absorbed light of an appropriate 
wavelength.
[113]
 Irradiation with light causes the electrons to be excited to an energetically 
higher state, from which they can follow different nonradiative or radiative relaxation 
processes to return to the ground state. Fluorescence is a radiative process, which means 
that energy is released by emitting photons.
[113]
 Since internal crossing to lower vibrational 
states usually precedes fluorescence, the emitted light has a higher wavelength than the 
light that was used for excitation, a phenomenon that is called STOKES shift. 
Phosphorescence is another radiative process which follows after intersystem crossing to a 
triplet state. The JABLONSKI diagram is a common method to illustrate the processes that 
may happen after excitation (see Figure 3.1).
[112,114,115]
 
Labelling proteins with fluorescent molecules is a common method to study biological 
processes.
[112,116–119]
 For example fluorescence-labelled antibodies or cell proteins reveal 
the localisation in the cell by fluorescence microscopy is used.
[1]
 However, the synthesis of 
these proteins is often tedious because of their complex structure.
[118,120]
 Here, peptides 
represent a useful alternative, as they have been widely studied over the past years.
[121]
 Due 





to the fact that they exhibit a less complex structure they are easier to synthesise which 
allows fast and easy modifications of the structure.
[98,122]
 Compared to small molecules, 
peptides feature similar structures as proteins and thus allow mimicking functional areas or 




Figure 3.1 JABLONSKI diagram with absorption (A), internal conversion (IC), intersystem crossing (ISC), 
fluorescence (F), light emission (h), thermal deactivation (Q), chemical reaction (Chem) and phosphorescence 
(P).[112,114,115] 
In addition to fluorescence-based markers, fluorophores with controllable fluorescent 
properties enable the use as fluorescence-based sensors and can be classified into three 
groups. The first group comprises sensors that are environment-sensitive and change their 
fluorescence for example upon increasing the hydrophobicity. The second group consists 
of sensors that react to concentration changes of anions, cations or neutral molecules. The 
third group of sensors allows studying the location or movement of biomolecules by 
undergoing "through-the-space" effects like FRET.
[112]
 A fluorescence change caused by 
the environment is mostly based on a large excited-state dipole moment of the fluorophore. 
Due to this, the fluorophore usually shows a low quantum yield in an aqueous solution, 
resulting in a weak fluorescence emission. In organic solvents or hydrophobic 
surroundings a high fluorescence emission is expected, which is blue-shifted.
[112]
 Some 
well-known examples for fluorescence-based sensors are NBD, Dansyl and the natural 
aromatic amino acids. The change of fluorescence caused by the coordination of an ion is 
usually based on a chelation-enhanced fluorescence mechanism, which involves a change 
in the electronic structure of the system by the addition of an ion (see Chapter 4.2). A 
variety of fluorescence-based sensors has been developed for a multitude of ions and 
molecules.
[123–126]
 Through-the-space effects are based on interactions of one or more types 
of fluorophores, which lead to quenching by intermolecular energy transfer.
[38,89,127,128]
  





In order to study peptides and proteins by fluorescence spectroscopy, a fluorophore is 
necessary. Beside unnatural fluorophores, natural amino acids can be exploited for 
fluorescence spectroscopic measurements.
[112,116–119]
 For this, the aromatic amino acids 
tryptophan, tyrosine and phenylalanine can be used.
[129]
 The most common 




3.2 Design of tryptophan incorporated model -peptides 
The complexity of the most natural transmembrane helical peptides made it necessary to 
develop model systems which can be easily modified and characterised. For the natural 
-peptides a broad spectrum of -model peptides were developed and tested for their 
properties.
[7,128,130–132]
 All of these peptides have a hydrophobic core which can be flanked 





 developed transmembrane -model peptides. The synthesised -peptides in 
the following chapter were adapted and modified from PETERSEN
[12] 
and inspired by KALP 
and L24 model peptides.
[7]
 
The design of the following -model peptides is based on a hydrophobic core which is 




-hLys). Lysine is known to increase the 







-hTrp) was used as environment sensor and 
placed central or close to terminal position of the hydrophobic core. Tryptophan is built up 
from an -amino group, -carboxylic acid group as well as an indole as side chain 
functionality and it shows characteristic fluorescence behaviour due to the large aromatic 
indole system.
[133,134]
 Additionally, the uncharged indole ring has the highest 
hydrophobicity of the 20 different amino acids side chain groups.
[135]
 Together with the 
polar NH group, tryptophan generates an amphiphilic character which allows to form 
hydrogen bonds.
[136]
 This amphiphilic character leads to the good anchoring properties of 
the amino acid tryptophan in lipid bilayers. However, the fluorescence properties of the 
tryptophan are sensitive to the environment. This effect can be used to analyse the 
hydrophobicity of the surrounding of peptide-bound tryptophan.
[11,16–20]
 It has been shown 
that tryptophan in a hydrophobic surrounding, like the inner membrane part, has a 
fluorescence maximum of λmax < 330 nm.
[16–19]
 In a more hydrophilic part, like the 
headgroup region, tryptophan shows a red-shift with a fluorescence maximum of 





λmax > 330 nm.
[18,20]
 Tryptophan in aqueous solution shows a fluorescence emission 
maximum of approximately 350 nm.
[21]
  
The length of the hydrophobic core was adjusted according to span the entire lipid bilayer. 
As calculation basis, 3.0 amino acids per turn (1.56 Å rise/residue) were considered for the 
14-helix and 2.5 residues per turn (2.1 Å rise/residue) for the 12-helix (see chapter 2.1).
[10]
 
Based on the different structure properties of the helices, the number of amino acids in the 
hydrophobic core of the 12-helix formed peptide was modified, unlike the work of 
PETERSEN.
[12]
 The length of the hydrophobic region (2Dc) in the lipid bilayer varies 
depending on the length of the acyl chains, the lipid composition of the membrane and the 
lipid phase (see Table 3.1). The used model membranes were built by one species of 
phosphatidylcholine lipids, which varied in the length and saturation grade. The following 
lipids with the corresponding hydrophobic region length were provided: 1,2-dimyristoyl-
sn-glycero-3-phosphocholine (DMPC, 19 – 26 Å),
[137–141]
 1,2-dipalmitoyl-sn-glycero-3-
phosphocholine (DPPC, 26 – 29 Å)
[137,139,140]
 and 1,2-dioleoyl-sn-glycero-3-phospho-
choline (DOPC, 27 – 30 Å).
[137,139,142]
  








2Dc (Å) 19.0 – 26.2 26.0 – 28.5 27.0 – 30.0 
 
The large variance in the listed values is due to the complexity of lipid systems. In a 
monolipid system, environmental factors, such as the degree of hydration or the ambient 
temperature play a significant role and influence, inter alia, the lipid phase.
[139]
 Based on 
these data, the hydrophobic sequence of the right-handed 14-helices was assembled with 
19 
3
-amino acids, which leads to a length of about 30 Å. For the thinner and stretched 
12-helical β
3
-peptide, 15 amino acids were placed in the hydrophobic core which leads to a 
length of about 31 Å (see Table 3.2).  
Table 3.2 Length of the hydrophobic peptide region of the different used helices based on the number of 
hydrophobic amino acids (AA). 
12-helix 14-helix 
31.5 Å (15 AA) 29.6 Å (19 AA) 
 
Based on these considerations ten different peptides were synthesised (see Figure 3.2 & 
Figure 3.3). However, to receive the desired secondary structures, the primer sequences of 
the hydrophobic core have to be considered. To obtain a right-handed 14-helices based on 



























 m n 
Pep 1 H Val 9 9 
Pep 2 H Val 1 17 
Pep 3 H Ile 9 9 
Pep 4 H Ile 1 17 
Pep 5 H Leu 7 7 
Pep 6 H Leu 1 13 
Pep 7 Ac Leu 7 7 
Pep 8 Ac Leu 1 13 
 
Figure 3.2 Schematic structure of the designed β3-peptides Pep 1 – Pep 8 for checking the influence of branching 
on the secondary structure of transmembrane β3-peptides. 
The possibility to force a left-handed transmembrane 12-helix into a right-handed 
transmembrane 14-helix was examined by the steric ring structure (1R,2R)-trans-2-
aminocyclohexane carboxylic acid (ACHC).
[10,74,83]
 Therefore, a peptide sequence based 
on D-β
3
-hLeu was chosen, which is interrupted at every third amino acid with ACHC (see 
Figure 3.3).  
 
 Pep 9  
 
 Pep 10  
Figure 3.3 Chemical structure of the synthesised β-peptides Pep 9 and Pep 10. 
The carboxylic acid of the C-terminus was transferred in a carboxylic acid amide during 
the peptide synthesis. Studies showed that carboxyl groups like aspartic acid or glutamic 
acid influence the incorporation of transmembrane peptides and the pH stability.
[143]
 The 
influence of a free N-terminus was tested for left-handed 12-helices formed peptides. 
Therefore, the N-terminus was free and able to build up a positive charge or it was 
eliminated by acetylation with acetic anhydride what resulted in an N-terminal amide bond. 
The acetylated right-handed 14-helices were synthesised and characterised by 







In particular, the β
3
-hVal containing peptides showed stable formation of a 
secondary structure in organic solvents and model lipid systems. These results are in 
contrast to PETERSEN hypotheses of the destabilisation of the peptide structure by 
N-terminal modification.
[12]
 However, the results obtained are supported by studies of 
Seebach et al. which were unable to detect a significant difference from N-terminal 
protected β-peptides to N-terminal unprotected β-peptides.
[144]
 The synthesis of the 
peptides was carried out in accordance with the manual SPPS of β-peptides.
[11–13,15,145]
 As 





-hIle (Pep 1 – Pep 4), showed a high efficiency. Because of this, a 
single coupling step was sufficient for these hydrophobic amino acids.
[11–13]
 The 12-helix 
formed peptides (Pep 5 – Pep 8), consisting predominantly of hydrophobic D-β
3
-hLeu 
showed less coupling success, what is known from other studies.
[12,13]
 In contrast to 
ZANBOT,
[13]
 this study shows that it was possible to obtain a sufficient amount of the 
full-length peptide by triple coupling, with 5.00 eq amino acid for each coupling step. 
These synthesis problems did not appear by the ACHC containing leucine peptides 
(Pep 9 – Pep 10). This may be due to interactions during the synthesis with the resin, the 
growing peptides or a poorer accessibility of the 12-helix N-terminus during the synthesis. 
In all peptides (Pep 1 – Pep 10) tryptophan was double coupled. The same procedure was 
done in Pep 9 – Pep 10 regarding the coupling of ACHC. This was done in order to obtain 
a higher yield for these coupling steps.  
The formed secondary structure and the verification of the incorporation in phospholipid 
membranes are in focus of the following analysis. To confirm the structure of the peptides, 
the results of recorded CD spectroscopy were compared with literature known spectra. The 
incorporation was verified by the maximum tryptophan fluorescence (λmax,). Therefore, the 
peptides were measured in organic solvents like MeOH and TFE as well as in DMPC, 
DPPC, DOPC. The use of different lipid ensured the structure analysis by decreasing the 
negative mismatch.  
3.2.1 Measurements and results 
Conformation studies  
The secondary structure of the synthesised β-peptides Pep 1 – Pep 10 was analysed by CD 
spectroscopy and compared with the literature.
[62,64,70,74,75,77,78,83,146–150]
 The CD spectra 
were measured in organic solvents (MeOH, TFE) and in LUVs with different lipid 
composition (DMPC, DPPC, DOPC) varying in the length of the hydrophobic 







 From different peptides, like Gramicidin A or 14-helical β
3
-peptides, it is 
known that TFE can stabilise the secondary structure.
[81,153,154]
  
The CD spectra of Pep 1 in TFE (~50 µM, T = 25 °C) and in model lipid vesicle DMPC 
(LUVs, P/L-ratio = 6:100, T = 30 °C) are shown in Figure 3.4 a) with a minimum between 
185 nm and 195 nm and a maximum between 200 nm and 220 nm. The CD spectra of 
Pep 5 in TFE (~50 µM, T = 25 °C) and in model lipid vesicle DMPC (LUVs, 
P/L-ratio = 5:100, T = 30 °C) are presented in Figure 3.4 b) with a minimum between 
190 nm and 200 nm, a maximum between 200 nm and 210 nm and a second minimum 
between 210 nm and 230 nm. The CD spectra of the β-peptides in organic solvent as well 
as in lipid model systems showed a similar and characteristic pattern. This indicates a 

































 Pep 1 in TFE
 Pep 1 in DMPC (LUV)
Wavelength  [nm]










 Pep 5 in TFE


















Wavelength  [nm]  
Figure 3.4 CD spectra of Pep 1 (a) and Pep 5 (b) in TFE (black, ~ 50 µM, T = 25 °C) and incorporated in DMPC 
LUVs (red, Pep 1: P/L ratio = 6:100, Pep 5: P/L ratio = 5:100, T = 30 °C). 
The maxima and minima of the CD spectra in organic solvent (TFE, MeOH) of the Pep 1 –
 Pep 4 and Pep 9 – Pep 10 are slightly shifted compared to those spectra in lipid systems 
(DMPC, DPPC, DOPC). On the one hand, it is known from -peptides that a different 
dielectric constants of the surrounding solvents or lipids might be a reason for a shift in a 
CD spectrum.
[155]
 On the other hand, there may be structural changes of the peptide that 
result in a changed spectrum. The shift of the CD spectra between organic solvent and lipid 
membrane is more intensive in case of the 14-helix, compared with the 12-helix. 
Moreover, the blue shift and slight change in shape shown here is in accordance with a 
study of POMERANTZ et al.
[76]
 POMERANTZ et al. was able to show that the aggregation of 
14-helix peptides leads to a change in the CD spectra by self-assembled 14-helix 
-peptides.
[76]
 The amount of aggregated peptides increases with a higher content of buffer 





in a MeOH/buffer solvent. The received CD spectrum from POMERANTZ et al. showed 
matches with the presented CD spectrums of Pep 1 – Pep 4 and Pep 9 - Pep 10 (see Figure 
3.5).  
 
 Peptide dissolved in MeOH  Peptide dissolved in buffer  
Figure 3.5 The influence of aggregation on the CD spectrum of -peptides in studies of POMERANTZ et al. 
depending on the solvent composition. The aggregation causes a shift in the maximum from 214 nm to 205 nm and 
a sharpening of the signal. The signals are inverted unlike the ones used here, because of the use of L-amino 
acids.[76] Reprinted with permission from W. C. Pomerantz et al., Org. Lett. 2008, 10, 1799–1802. Copyright (2008) 
American Chemical Society. 
Based on these results, another reason for the shift in the CD spectra could be an 
aggregation in the lipid membrane because of lipid-peptide interaction. These results are 
attributable to the high concentration of the peptides (P/L-ratio 5:100). FÖRSTER resonance 
energy transfer (FRET) studies of ROST et al. have shown that on a similar model system 
no unwanted aggregation at low peptide concentrations take place.
[94]
 The CD spectra 
intensity change and the shift of the maxima/minima of the 12-helix formed peptides 
Pep 5 – Pep 8 might be others beside the reasons mentioned above (see Figure 3.4). 







with cyclic amino acids (ACPC, ACP) shows a change in the CD spectra from MeOH to 
water.
[75,149]
 In MeOH the peptides delivered stronger CD signals than in water and the 
spectra showed a blue shift from methanol to water (see Figure 3.6). 
 
Figure 3.6 CD spectrum of 12-helix formed -peptide with cyclic amino acids in MeOH and water.[75] Reprinted 
with permission from P. R. LePlae et al., J. Am. Chem. Soc. 2002, 124, 6820–6821. Copyright (2002) American 
Chemical Society. 





Therefore, LEPLAE et al. and PARK et al. supposed a destabilising effect of water on the 
secondary structure of the used peptides.
[75,149]
 There are similarities by comparing these 
spectra with the peptide spectra of Pep 5 – Pep 8. However, the observed spectra of 
peptide Pep 5 – Pep 8 showed no blue shift like the spectra in Figure 3.6, but a slight red 
shift. This red shift could be explained by a destabilisation of the secondary structure in the 
lipid system, but further investigations are needed to determine the exact structure in the 
membrane.  
Based on the properties of ACHC it was possible to force the transmembrane structure 
formation from a 12-helix (Pep 5 – Pep 6) into a 14-helix with 19 amino acids (Pep 9 –
 Pep 10). HAMURO et al. described that the intensity of the CD spectra depends on the 
length of the β-peptide in micelles of dodecylphosphocholine (DPC). With increased 
length of the β-peptides the CD intensity increases, which is in good agreement with the 
here presented results.
[156]
 These results clearly demonstrate that the synthesised β-peptides 
form stable secondary structures in solution and in lipid environment (see Appendix C). 
Membrane location studies  
In order to analyse the position of β-peptides in lipid membranes, the fluorescence property 
of tryptophan was used. This characteristic is known to be sensitive to the polarity of its 
local environment. The fluorescence maximum λmax is shifted as soon as the surrounding of 
the peptide becomes more hydrophobic or hydrophilic.
[16–19]
 Previous studies have shown 
that in a hydrophobic surrounding such as the inner membrane part, tryptophan has a 
fluorescence maximum at λmax < 330 nm. In a more polar environment, the fluorescence 
maximum shows a red-shift (λmax > 330 nm).
[16–19]
 This behaviour is based on a different 
dielectric constant of the nonpolar acyl chains and the polar headgroup. Polar groups 
induce an electron density shift in the indole-ring, which results in a red-shift of the 
fluorescence maximum.
[18,157]
 Figure 3.7 presents the fluorescence emission spectra of four 
β-peptides with D-β
3
-hTrp located in different position and helix conformation 
(14-helix = Pep 1, Pep 2 Figure 3.7 a), 12-helix = Pep 7, Pep 8 Figure 3.7 b). The peptides 
with a bilayer midplane located D-β
3
-hTrp (Pep 1, Pep 7), reveal a maximum at 
λmax, Pep 1 = 318 nm in DOPC (LUVs, P/L-ratio 6:100, T = 25 °C) and at λmax, Pep 7 = 318 nm 
in DMPC (LUVs, P/L-ratio 5:100, T = 30 °C). The fluorescence emission spectra of 
peptides with D-β
3
-tryptophan near the apolar/polar interface (Pep 2, Pep 8) show a 
λmax, Pep 2 = 334 nm in DOPC (LUVs, P/L-ratio 6:100, T = 25 °C) and λmax,Pep 8 = 330 nm in 
DMPC (LUVs, P/L-ratio 5:100, T = 30 °C) (see Figure 3.7 and Appendix C).  
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Figure 3.7 Fluorescence spectra of a) the 14-helix formed Pep 1 (black) and Pep 2 (red) incorporated in DOPC 
(LUVs, P/L-ratio 6:100, T = 25 °C) and of b) the 12-helix formed Pep 7 (black) and Pep 8 (red) incorporated in 
DMPC (LUVs, P/L-ratio 5:100, T = 30 °C).  
However, due to the results of the fluorescence emission spectra of the β-peptides Pep 2 
and Pep 8 it could be assumed that the D-β
3
-hTrp is located at the apolar/polar interface, as 
it was expected. The fluorescence spectra of the β-peptides in Figure 3.7 with the central 
tryptophan (black line) show a blue-shift compared to the spectra of the β-peptides with the 
peripheral D-β
3
-tryptophan (red line), which leads to the conclusion that these kinds of 
β-peptides penetrate the lipid bilayer and are not localised on the surface of the lipid 
bilayer. The fluorescence emission maxima of all analysed β-peptides in different 
membrane environments are given in Appendix C. Except for the not acetylated 12-helix 
formed peptides, Pep 5 and Pep 6, the fluorescence maxima show a blue-shift of the 
maxima from a hydrophobic to a more hydrophilic environment. Pep 5 and Pep 6 show 
artefacts in the fluorescence spectra, which disappear by the comparable acetylated 
peptides. In Figure 3.8 the fluorescence spectra of Pep 5 and Pep 7 are given. Pep 5 shows 
a narrow peak with a shoulder in organic solvent (TFE) and a broad peak in lipid 
surrounding (see Figure 3.8 a). Compared to Pep 5 the spectrum of Pep 7 in organic and 
lipid surrounding displays an expected spectrum with a broad curve and a clear maximum 
(see Figure 3.8 b). The CD spectra of both peptide types (non-acetylated and acetylated) 
provide signals of approximately equal magnitude for organic solvents (~5 × 10-5 –






) and lipid systems (~0.5 × 10-5 – 2.0 × 10-5 deg cm2 dmol-1). 
In general, PETERSEN assumed an effect of N-terminal acetylation on the peptide structure 
and properties of transmembrane β-peptides.
[12]
 In comparison with their work, the 
acetylation of the N-terminus has apparently a stronger effect on the 12-helix than on the 
14-helix. In order to be able to assess these results more precisely, further investigations 
are needed. One approach could be to determine the structural change from organic solvent 





to the lipid model system. Known methods for this would be for example, NMR-based 
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Figure 3.8 Fluorescence spectra of a) Pep 5 and b) Pep 7 in TFE(black line) as well as incorporated in DPPC (red 
line) (LUVs, P/L-ratio 5:100, T = 50 °C). 
In addition to the structural information of the individual peptides, intermolecular 
interactions can also be investigated by the mentioned methods.
[161,162]
 This can help to 
improve the understanding of the measurement data. 
Conclusion 
The synthesis and characterisation of β-peptides constitute a wide and substantial topic in 
biochemistry.
[9,44]
 In the present study, new model systems for transmembrane β-peptides 
were designed, synthesised, purified and analysed. CD and fluorescent spectroscopic 
measurements were used to characterise the synthesised β-peptides Pep 1 – 10. The results 
prove that the secondary structures of β-peptides (12- or 14-helix) in organic solvent 
(MeOH, TFE) as well as in LUVs (DMPC, DPPC, DOPC) depend on the choice of side 
chains and can be controlled by ACHC. Most of the used -peptides showed the presumed 
behaviour in LUVs. This behaviour was analysed by fluorescence spectroscopy of 
peripheral and central positioned tryptophan residues in the β-peptide sequences. These 
and previous findings on similar β-peptides described by ROST et al. indicate that the 
designed -peptides are incorporated in lipid membranes in a transmembrane manner.
[38]
 
The presented results demonstrate that the synthesised transmembrane -peptides can be 
used in a wide research field. Other studies have shown that these kind of β-peptides are 
suitable for transmembrane β-peptide aggregation using D-β
3
-homoglutamine as a 
recognition unit.
[94]
 Hence, the introduced -peptides are an appropriate model system for 
further experiments on transmembrane β-peptides. 





3.2.2 Distance measurements by fluorescence quenching 
The results of the fluorescence measurements (see Appendix C) confirmed the 
incorporation of the synthesised β-peptides in the model membranes. To receive more 
detailed information, further methods have to be performed. Based on the tryptophan 




The basis for the penetration depth of tryptophan is the fluorescence interference by 
quenchers. Quencher molecules do not influence the absorption behaviour of a 
fluorophore, though the quantum yield will be affected.
[114,115]
 The modified fluorescence 
behaviour is induced by a spin-orbit interaction what results in a (S1→T1)-crossing 
(intersystem crossing, ISC, see Figure 3.1). This transition is reflected by a nonradiative 
transfer of energy from the fluorophore to a quencher molecule.
[24,114,115,163]
 For this 
transfer it is necessary that the molecules are located close to each other. Depending on the 
type of quenching mechanism it can be distinguished between static and dynamic 
fluorescence quenching.
[24,114,115,163]
 In the following, a static fluorescence quenching for 
the transmembrane peptide-bounded tryptophan mechanism is postulated.
[20]
 In the static 
fluorescence quenching mechanism the fluorophore and the quencher form a complex [FQ] 
which absorbs the light radiation (h) like a quencher free fluorophore. The excited state 
[FQ]
*
 relaxes in contrast to the quencher free fluorophore without fluorescence but through 
the emission of heat (). Based on this concept by increasing the amount of quencher, the 
number of available fluorophore will be decreased. In Equation 3.1, the processes for a 
quencher free process is given, whereas in Equation 3.2 the process for the static 
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Due to the peptide-bound position of the tryptophan, the imposed requirements on the 
quencher are versatile. Requirements of the quencher molecules are membrane-
permeability, a definite distance to the centre of the membrane and no change of the 
membrane properties. Here, especially lipid-bound quencher molecules have proven to be 
useful. As quencher unit, bromine
[23]
 atoms or DOXYL
[20]
 groups are incorporated into the 
acyl chains. 





In the following, the radical DOXYL was used as static quencher molecule for tryptophan. 
DOXYL can be covalently bound at defined positions of steric acid or 1-palmitoyl-2-





Figure 3.9 1-Palmitoyl-2-stearoyl-(5-doxyl)-sn-glycero-3-phosphocholine (16:0-5 DOXYL PC). 
Because of the quencher’s specific localisation in the lipid membrane, it is possible to 
establish a distance correlation between the quencher and fluorophore. This method is 
called the parallax method. By the variation of the quencher mole fraction DOXYL and the 
resulting change in florescence intensity, the position of tryptophan can be calculated using 
the two-dimensional Perrin equation (see Equation 3.3).
[24,114,115,163]
 
The critical quenching radius R0 and lateral distance between fluorophore and quencher X 
is presumed as a constant for the parallax calculation. The distance of the fluorophore and 
quencher is described by Z (see Figure 3.10). For the graphic analysis, the natural 
logarithm of tryptophan fluorescence in the present of quencher (I) divided by tryptophan 
fluorescence in the absence of quencher (I0) was plotted against DOXYL. The resulting 
slope of the straight line is in direct proportion to    
        . The comparison of 
different graphic analysis with various DOXYL-labelled lipids has a known distance to the 
lipid bilayer centre (Q) and allows the calculation of the distance of tryptophan to the lipid 
bilayer centre (P). 
  
Figure 3.10 Graphical visualisation of the geometric parameters which are necessary for the calculation of the 
distance Trp/lipid bilayer centre (P): lateral distance between fluorophore and quencher (X), distance of the 
fluorophore and quencher (Z), distance of the quencher and lipid bilayer centre (Q).[20] Adapted with permission 
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For the parallax measurements different LUV compositions were prepared. The used films 
were perpetrated with a constant lipid concentration (n = 0.3 · 10
-6
 mol) of DOPC or a 
combination of DOPC and the corresponding DOXYL-labelled lipid. As DOXYL-labelled 
lipid 16:0-10 DOXYL PC and 16:0-16 DOXYL PC were used. The peptide/lipid 
concentration was 1:200 and the vesicles were rehydrated with ultrapure water.  
In Figure 3.11 a section of the results from the parallax measurement of Pep 1 with 16:0-
16 DOXYL PC (full results in Appendix C) is illustrated. The normalised fluorescents 
spectra show a strong dependence of the fluorescence intensity to the mole fraction of the 
quencher molecule DOXYL. Due to the spatial proximity, this behaviour was expected. The 
graphic display of ln(I/I0) against DOXYL creates a balance line with a negative slope. In a 
comparative manner to Figure 3.11, Figure 3.12 shows the correlation of Pep 1 and 
16:0-10 DOXYL PC (full results in Appendix C). Here, the fluorescence intensity 
increased in small mole fraction of the 16:0-10 DOXYL PC. This behaviour was also 
observed during several measurements under the same conditions. Therefore, it is not 
possible to draw a balance line with a negative slope, which would be necessary for a 
meaningful evaluation of the distance measurements.  
a) b) 

































































Figure 3.11 a) Normalised fluorescence spectra of Pep 1 in DOPC/16:0-16 DOXYL PC with changing 
lipid/quencher ratio. b) Fluorescence depth quenching curves derived from the corresponding fluorescence 
spectra (LUVs, P/L-ratio 1:200, T = 25 °C). 
The measured peptides Pep 1 and Pep 2 display in general an expected course for the 
different DOXYL-labelled lipids (see Appendix C). Peptide Pep 1 with the central 
tryptophan tends to show a stronger quenching effect at 16:0-10 DOXYL PC and 16:0-16 
DOXYL PC than peptide Pep 2, with the peripheral tryptophan. Furthermore, the 
quenching effect from Pep 1 at higher molar fractions DOXYL of 16:0-16 DOXYL PC is 
greater than at 16:0-10 DOXYL PC. However, the measurements indicated fluorescence 





properties of peptides as described, which were unexpected. Based on these results, various 
lipid-peptide interactions might be responsible. An influence of the fluorophore or the 
fluorophore quencher complexes [FQ] is possible, which would result in changed 
fluorescence behaviour. It is known that fluorescence parameters, like wavelength 
maximum, fluorescence intensity, fluorescence lifetimes and band shape are influenced by 
the fluorophore’s environment.
[16–19,165]
 The modified lipid composition might lead to a 
modification of the lipid-peptide interaction, what in return leads to a change in the 
tryptophan environment. 
a) b) 
































































 [%]  
Figure 3.12 a) Normalised fluorescence spectra of Pep 1 in DOPC/16:0-10 DOXYL PC with changing 
lipid/quencher ratio. b) Fluorescence depth quenching curves derived from the corresponding fluorescence 
spectra (LUVs, P/L-ratio 1:200, T = 25 °C). 
Possible reasons for this could be peptide aggregations or other lipid-peptide interactions 
(see Figure 2.6). A further source of error in this measurement might be the vesicle 
preparation. Although the vesicles were made several times, it could be that the 
incorporation of 16:0-10 DOXYL PC has led to a modified peptide insertion.  
Based on results of ROST et al. with comparable peptides, where a heavy atom labelled 
peptide was incorporated into the bilayer and the exact position could been proven by 
X-ray measurements,
[38]
 it is known that the synthesised peptides are transmembrane 
peptides. However, in this measurement the labelling with non-commercially available 
heavy atoms is necessary. The parallax method can be carried out with natural amino acids 
or with commercially available fluorophores. In further parallax measurements, a change 
in the experimental setup, such as a subsequent insertion of the peptides in the membrane, 
should be done.  





3.3 Cyanide-labelled β3-amino acid as molecular sensor for surface-enhanced 
infrared absorption (SEIRA)  
The measurement of transmembrane peptides in the natural environment is a demanding 
assignment. Though, important information can be obtained about the orientation, 
aggregation and localisation of transmembrane peptides in biological membranes. Hence, a 
lot of measurement techniques were developed and are still further improved. The lipid 
mesophase crystallisation, for example provides an opportunity to obtain information about 
the secondary structure of transmembrane peptides in a lipid like crystal 
surrounding.
[158,159]
 In contrast, for the measurement of dynamic systems infrared 
spectroscopy in the attenuated total reflection mode (ART-IR) was established. This is an 
enhanced IR technique, where the sample is in contact with an internal reflection element 
(IRE). Since this is a surface-technique, information about the peptide orientation or 
secondary structure in lipid bilayers can be analysed.
[166–168]
 A further development of the 
ATR-IR technique is the surface-enhanced infrared absorption (SEIRA) spectroscopy. 
Here, the IRE is covered by an metal-island film.
[169–171]
 In comparison to the ATR-IR 
technique SEIRA spectroscopy results in a higher enhancement and the molecules can 





3.3.1 Surface-enhanced infrared absorption (SEIRA) 
The biologically, chemically and physically crucial methods, ATR-IR and SEIRA have a 
very similar setup to each other. The probe will be examined by IR and is placed on a 
IRE.
[27,167]
 Total reflection is achieved at the interface and the electromagnetic field of the 
photon leads to a propagation of an evanescent wave through the interface. When a 
molecule is absorbed on the IRE, it can couple with the electric field of the wave, absorb 
energy and therefore attenuate the total reflection beam. SEIRA differs from ATR-IR by a 
thin nanostructured metal layer that separates the internal reflection element and the 
probe.
[26–28]
 This nanostructured layer increases the intensity of the IR spectrum up to three 
orders of magnitude, which results in a better resolution.
[27]
 The enhancement is due to an 
electromagnetic and chemical mechanism. The electromagnetic mechanism is based on 
plasmon resonance and a perturbation of the optical properties. Responsible for this is the 
chemical donor-aceptor interactions and charge-transfer effects.
[169,171]
 The enhancement 
decays from the surface to the solution. For this reason it is possible to enhance structures 
resolution up to 10 nm above the gold surface while signals over the 10 nm area, like the 
bulk solution are not enhanced.
[27]
  





The IR based methods and the required variables for the following calculation are well 
known for the natural -peptides.
[170]
 For the more particular -peptides some of the 
measurements needed new adjustments. To establish the usable measurement of 
-peptides, some model peptides were crucial to be developed. The focus of this study was 
measuring the influence of an electrical stimulated membrane, as well as the influence on 
incorporated transmembrane -peptides by SEIRA. The objective is to investigate peptide 
properties which can be used as a basis for further investigation methods.  
The vibrational STARK effect is a promising tool to study electric fields in and at 
biomimetic interfaces.
[172,173]
 STARK reporter groups such as the nitrile group, react very 
sensitive to changes of the electric field around them and a frequency shift in the 
vibrational spectrum is observable.
[174–178]
 On this basis, SCHKOLNIK et al. was able to 
correlate the nitrile stretch vibration of 4-mercaptobenzonitrile in a locale field.
[172]
 The 
4-mercaptobenzonitrile formed on the nanostructured gold surface self-assembled 
monolayer, thus builds the simplest biomimetic interface.
[172]
 The gold-coated surface in 
the SEIRA measurements makes it possible, among other things, to generate an electric 
field in direct proximity of the sample. In order to use this measurement for the 
investigation of -peptide, it is necessary to synthesise an electrochemical sensitive amino 
acid with a STARK reporter group. Based on literature known -amino acids, a nitrile 
including -amino acid was developed and incorporated in a model -peptide.
[179,180]
 Due 
to this the following Fmoc-D-β
3
-Ala(CN)-OH amino acid was developed and the peptide 
Pep 11 was synthesised.  
3.3.2 Synthesis and measurements 
Synthesis of cyanide-labelled amino acid and peptide 
Based on the structure of the desired molecule some different methods for the synthesis of 
the Fmoc-D-β
3
-Ala(CN)-OH 1 would be possible (see Figure 3.13). A retrosynthetic 
analysis suggested as possible reaction routes a nucleophilic substitution or a dehydration 
reaction.  
 
Figure 3.13 Retrosynthetic analysis of the N-protected target -amino acid by a nucleophilic substitution or a 
dehydration reaction. X illustrates a leaving group that can be exchanged by nitrile and PG represents an 
arbitrary protection group. 





Based on the work of ORTGIES et al. the nucleophilic substitution route was performed 
using Fmoc-D-β
3
-Ser-OH (1.00 eq), which was activated at the free alcohol group by 
trimethylsilyl chloride (TMS-Cl, 2.40 eq) and potassium iodide (2.40 eq) in ACN.
[181]
 The 
activated alcohol should be attacked in a nucleophilic substitution reaction by potassium 
cyanide (KCN, 3.00 eq), but mass spectrometric analysis did not show a successful 
conversion to the product. Allylic alcohol missing might be the reason for the unsuccessful 
conversion. Based on these results, another synthesis strategy was performed. A 
retrosynthetic analysis offered the possibility to receive the product by dehydration of 
asparagine. On the basis of these considerations two different dehydration reagents were 
tested with the analogue -amino acid Fmoc-Asn-OH. Firstly, a suspension of cyanuric 
chloride (1.00 eq) and Fmoc-Asn-OH (2.00 eq) in dry DMF was mixed, though no 
conversion to the desired product could be detected by mass spectrometry. Secondly, the 
dehydration reagent propylphosphonic anhydride (T3P
®
) (1.00 eq) in ACN/EE (1:2) was 
added to Fmoc-Asn-OH (1.00 eq) and the desired -amino acid target product was 
confirmed in mass spectrometric analysis. T3P
®
 is a versatile molecule that can be used in 
many reactions, e.g. the transfer of aldehyde groups to nitrile groups or as a condensation 
reagents for peptide coupling.
[182,183]
 First of all, for the synthesis of the -amino acid target 
product, the used -amino acid has to be transformed in a -amino acid (see Scheme 3.1). 
Therefore, the established procedure of the ARNDT-EISTERT homologation (see Chapter 
2.4) was performed using Fmoc--D-Asn(Trt)-OH 2. Afterwards the trityl side chain 
protection group was cleaved under acid conditions (TFA/H2O/EDT 90:5:5) followed by a 
dehydration with T3P
®
. The product Fmoc-D-β
3
-Ala(CN)-OH 1 was obtained over three 
steps with an overall yield of 26 %. With this component the following peptide Pep 11 (see 
Figure 3.14) was synthesised by manual microwave-supported SPPS without changing the 
coupling method for Fmoc-D-β
3
-Ala(CN)-OH (see Chapter 2.5.1). 
 
 Pep 11  
Figure 3.14 Sequence of peptide Pep 11. 
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Scheme 3.1 Generation of the Fmoc-protected amino acid 1 with an overall yield of 26 %. 
After cleavage from the resin (without any purification), the mass spectrometric analysis of 
the peptide showed two signals with a similar intensity. The target peptide Pep 11 was 
identified with a mass of 3531.4 g/mol. Additionally, a water adduct [M+H2O] was 
identified with a mass of 3549.4 g/mol. There are two explanations for this result. Firstly, 
the used amino acid was not fully purified and remaining Fmoc--D-Asn-OH was 
incorporated during the SPPS. However, a contamination of the used amino acid can be 





spectra show no characteristic signal of the amide group. An amide group (150 – 190 ppm) 
shows in a 
13
C-NMR spectrum a stronger downfield shift relative to a cyanide group 
(105 – 130 ppm).
[184]
 In Figure 3.15 the 
13
C-NMR spectrum of the purified building block 
is shown. In the region of 150 – 190 ppm only the carbon acid signal is displayed.  



















Chemmical shift  [ppm]  
Figure 3.15 13C-NMR spectrum (126 MHz, [D6] DMSO) of 1. 





Secondly, an addition of water happened during the cleavage of the peptide from the resin. 
This side reaction during the cleavage can be counteracting by lower temperature and less 
time during the cleavage step or the omitting of water in the cleavage cocktail. 
Nevertheless, the main product Pep 11 of this synthesis could be separated from [M+H2O] 
by HPLC. 
Conformation and fluorescence studies 
The peptide Pep 11 was measured by CD spectroscopy in organic solvents (MeOH, TFE) 
and in phospholipids (DMPC, DPPC, DOPC). It was suspected that Pep 11 will form a 
14-helix like Pep 1 – Pep 4 and Pep 9 – Pep 10. The CD spectra of Pep 11 in organic 
solvent (TFE, MeOH ~50 µM, T = 25 °C) and in model lipid vesicle DMPC, DOPC, DPPC 
(LUVs, P/L-ratio = 5:100, TDMPC = 30 °C, TDOPC = 25 °C, TDPPC = 50 °C) shows a 
minimum between 185 nm and 195 nm and a maximum between 200 nm and 220 nm (see 
Appendix C).  
The fluorescence emission maxima λmax of Pep 11 in the organic solvents and membrane 
environments showed a maximum at λmax, Pep 11 = 342 nm in MeOH respectively at 
λmax, Pep 11 = 346 nm in TFE and at λmax, Pep 11 = 338 nm in lipid environment (DMPC, 
DOPC, DPPC). This agrees with the previously presented results (see Chapter 3.2). The 
observed D-β
3
-hTrp emission could be explained by their position within the peptide. This 
may not be as meaningful as in Pep 1 – Pep 10, but previous studies showed an 
incorporation of a comparable peptide in DOPC bilayer by ROST et al.
[38]
 On the basis of 
the comparable florescence spectra, an incorporation of the peptide is assumed. Even 
though the peptides show similar results like comparable peptides, further investigations 
are still required. Studies have shown that nitrile derivatives of amino acids are dependent 
on the environment.
[179,180]
 In contrast to tryptophan, which shows a changed fluorescence 
behaviour, the nitrile derivatives show a shift in the CN stretching vibration. Based on the 
CD spectroscopic, it can be assumed that the incorporation of Fmoc-D-β
3
-Ala(CN)-OH has 
no influence on the secondary structure or the fluorescence behaviour of the -peptide.  
IR- measurements 
In the IR spectroscopy asymmetrical vibrations are detected, which have a change in their 
transition dipole moment during the vibration. For the examination of proteins and 
peptides, the vibrations of the amide group are used. Hence, the most important vibrations 
are the amides A, B, I, II and III. The amide A (3310 – 3270 cm
-1
) and B (3010 –
 3030 cm
-1
) are the result of the NH stretching. The amide I (1700 – 1600 cm
-1
) shows the 





CO stretching with a small amount of NH bending.
[185]
 The amide II (1580 – 1480 cm
-1
) 
and the amide III (1300 – 1230 cm
-1
) vibrations are a combination of the NH bending and 
CN stretching together with different proportions of the respective vibrations (see Figure 
3.16).
[185]
 The amid I vibration is often affected by the vibrations of water (~1645 cm
-1
). 





Figure 3.16 Vibration types of the amide bond in the peptide backbone.[185] Reprinted from J. A. Kozuch, 
Structure-Function Relationships of Membrane Proteins - Spectroelectrochemical Investigation of Artificial 
Membranes, 2013. 
The peptide Pep 11 was examined by STAFFA from the HILDEBRANDT group (unpublished 
results). The properties of Pep 11 in the membrane were investigated by the amid I and the 
amid II vibrations. For this purpose it was tested to incorporate Pep 11 into a membrane 
with two different procedures. The two methods differ in the previous or subsequent 
incorporation of the peptides into the membrane. As the first method, the peptide was 
incorporated into LUVs and then spread to a self-assembled monolayer (SAM) consisting 
of dihydrocholesteryl (2-(2-(2-ethoxy)ethoxy)ethanethiol (WK3SH) and 6-
mercaptohexanol (6MH). Following this method it was possible to recognise the amide I 



















A = 0.05 mOD





























A = 0.2 mOD







Figure 3.17 a) IR difference spectra of the incubation of LUV for 150 min. Spectra were shown for every 9 min. 
The black spectrum is for t = 0 min and the violet for t = 150 min. The high negative band at 1644 cm-1 belongs to a 
water vibration and the band at 1741 cm-1 belongs to the CO vibration of the lipids. The band at 1644 cm-1 and 
1550 cm-1 represent the Amid I and II vibrations. b) Potentials were applied for 9 min and spectra was detected 
from 0.4 V to -0.4 V. Small changes in the intensity can be observed, due to a decrease in the water vibration band. 
Measurements and graphics performed by STAFFA. 





After washing with buffer to get rid of the unbound vesicles, voltage was applied to the 
gold surface and showed no change in the ratio or intensity of the observed vibrations 
(Figure 3.17 b). Such a change, would have to be observed during a movement or 
restructuring of the peptide in the membrane. In the second method, the membrane was 
first built up on the SAM and subsequently the peptide was added. For this, the peptide 
was dissolved in MeOH/buffer and added to the spreaded membrane. The concentration of 
organic solvent did not exceed 5 %, as this would destroy the membrane. Earlier studies by 
STAFFA showed that this type of preparation leads to a decrease in the water vibration in 
the spectrum. No amid vibration was observed, which indicates that there was no insertion 
of the peptide into the membrane or dissolving in the MeOH/buffer mixture. Summarising, 
it can be said that the synthesis of the cyanide amino acid building block was successfully 
accomplished and the incorporation into a transmembrane peptide by 
microwave-supported SPPS is possible. The measurements with SEIRA did not show 
successful results so far and have to be optimised. 
4 Transmembrane β-peptides as anchor for near-membrane ion-sensors to study the concentration 





4 Transmembrane β-peptides as anchor for 
near-membrane ion-sensors to study the concentration of 
H⁺ and Ca²⁺ 
Biomolecular membranes represent a complex system that fulfil various tasks in cells.
[1]
 
The polar and charged surface act as a focal point for cations.
[186–188]
 In particular, the 
interaction of protons (H
+
, see Chapter 4.1) and calcium ions (Ca
2+
, see Chapter 4.2) play 
an important role in research.
[186–188]
 As a new approach to measure the ion concentration 




-sensors were synthesised, 
providing the advantages of a stable and easily predictable system. 
4.1 Near-membrane H+-sensor anchored by transmembrane β-peptides 
4.1.1 Introduction and objectives  
Lipids, as the basic unit of the membrane, consist of a non-polar tail and a polar 
headgroup. Due to the amphipathic character the lipids form lipid bilayers. The headgroups 
can be subdivided into polar-neutral, zwitterionic or ionic groups.
[1,189]
 Lipid bilayers in 
aqueous systems direct their polar headgroups to the aqueous phase, which allows polar 
interaction and partially charged headgroups with ions in the aqueous phase.
[1,186–189]
 In 
addition to biologically important metal ions, the interactions of H
+
 with the membrane 
surface are of interest. 
The near-membrane pH value is an important indicator of cellular processes and an 
important driving force for processes located near biological membranes. On the one hand, 
the extracellular acidity for instance can be an indication for pathological states like 
tumours and infections or wounds.
[190–193]
 On the other hand, cellular energy production in 
the form of ATP is based on the generation of a H
+
 gradient (see chapter 4.1.2).
[1,194]
 For 
the near-membrane pH value, it is necessary to understand the interaction of the ubiquitous 
H
+
 with the membrane surface and therefore, it is still the subject of current studies with 
various experiential setups.
[33,186,195]
 The determination of the pH value was carried out 
with microelectrodes,
[196–200]
 pH sensitive peptides
[201]
 or pH sensitive fluoro-
phores.
[29,186,190,195,202,203]
 The measurement by microelectrodes requires a fixed system to 
provide a consistent distance to the membrane and has a high equipment requirement. As 
an alternative, measurements with modified peptides were developed. For example, a 
modified gramicidin peptide was developed as a label free pH-sensor.
[201]
 Here, the 
C-terminal pH insensitive ethanolamine is modified with a pH sensitive ethylenediamine 
or histamine. This leads to a protonation/deprotonation of the C-terminal group and 
4 Transmembrane β-peptides as anchor for near-membrane ion-sensors to study the concentration 





therefore a cis/trans isomerisation is possible.
[201]
 This isomerisation controls the ion flow 
through the ion channel and thereby the single-channel currents. A low pH increases the 
permeability and a high pH decreases the permeability of the ion channel.
[201]
 Nevertheless, 
the larger percentage of near-membranes pH measurement is performed by 
fluorescence-based methods. The use of labelled molecules offers the possibility to observe 
a free moving system. Figure 4.1 depicts some fluorophores, which are used to measure the 
near-membrane pH value in model systems or cells.
[29,34,190,203]
 The required fluorophores 
can be attached to peptides as well as to lipids, which allows a wide range of applications. 
Especially for membrane studies, lipid coupled pH sensitive fluorophores are an important 
tool and for this purpose, the fluorophore is often bound to a phosphoethanolamine (PE) 
headgroup.
[31,34,203,204]
 Attaching fluorophores to the membrane via lipids prevents an 
influence by lipid-peptide interactions. Furthermore, the anchoring by lipids enables a 
simplified variation of the alkyl chain. This allows for example a better adaptation in 
different membrane thickness.
[205]
 The natural range of lipids offers only a small variation 
of the headgroups, which can be used for this purpose.  
a) b) c) 
  
 
Figure 4.1 Examples of pH sensitive molecules that are used to detect near-membrane pH changes. a) Fluorescein 
and in brackets its derivate carboxyfluorescein, b) seminaphtharhodafluor (SNARF), c) 7-hydroxychromen-2-
one.[29,34,190,203] 
However, due to their special properties, peptides can facilitate certain methods of 
measurement. ANDERSON et al. labelled a pH low insertion peptide, which inserts itself in a 
cell membrane depending on the pH value.
[190]
 This system with seminaphtharhodafluor 
(SNARF, Figure 4.1) as the fluorophore was able to detect a pH difference of 0.2 – 0.3 
units.  
As an unexplored possibility of membrane anchoring, the usage of β-peptides is presented 
in this work. For this purpose, already known -peptide transmembrane structures were 
expanded with hydrophilic elongation and modified with carboxyfluorescein (see 
Chapter 4.1.4). These -peptides allow the development of a modifiable and predictable 
structure (see Chapter 2.1).  
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4.1.2 H+ Behaviour at the membrane interface 




, the basic properties are part of many 
studies.
[186]
 In particular, the behaviour of H
+
 on biological membranes differs from the 
behaviour in aqueous solutions. In buffered aqueous systems, the transport of pH relevant 
ions takes place by the buffer molecules.
[186]
 This transport is a rather slow process in 
relation to other biological relevant H
+
 transports. Especially for biological ATP synthesis 
or the active transport of molecules across the membrane driven by a H
+
 gradient, a slow 
buffer mediated diffusion would be disadvantageous.
[206]
 Biological processes driven by a 
H
+
 gradient are generally performed in a two-step process.
[1]
 As a first step the conversion 
of energy (chemical or physical) by specialised transmembrane proteins leads to an active 
H
+
 transport across the membrane, which results in the formation of a H
+
 gradient. As a 
second step, this gradient can be used for synthesising ATP or as driving force for the 
active transport of molecules through the membrane.
[1]
 The peptides that are necessary for 
the generation of the H
+
 gradient are also localised in the membrane.
[1]
 The exact H
+
 
pathway between the gradient creating and the gradient exploited peptides, is still 
unclear.
[186,207]
 After the transport of the H
+
 through the membrane in general, two options 
are possible. Firstly, a rapid equilibration with the bulk solution occurs, which results in 
the loss of the H
+
 to the bulk solution (see Figure 4.2 a) or secondly, a membrane located 
H
+
























Figure 4.2 After the transport trough a H+ transporter two different pathways are possible. a) The H+ can be 
equilibrate with the bulk solution or b) the H+ can be localised at the membrane water interface. 
Studies have shown that the affinity of H
+
 to a membrane/water interface is larger than to 
an air/water interface.
[186]
 These differences in affinity are due to the polar or charged 
headgroups, and to the great hydration of the lipids. XU et al. from the WIDENGREN group 
determined using fluorescence correlation spectroscopy (FCS), a critical surface area for a 
H
+
-collecting antenna effect of membranes.
[33,208]
 Previous studies from the BRZEZINSKI 
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and WIDENGREN group have shown that labelled lipid headgroups incorporated in 
membranes show a similar koff value (see Figure 4.3). 
[31,32,34,208]
 In contrast, the value of 
the kon is critically determinative by the environment of the fluorophore. Compared with 
fluorescein dissolved in water, lipid-bound fluorescein shows a 100-fold higher kon 
value.
[208]
 XU et al. investigated so-called lipid nanodisc with different diameter sizes in 
their study (Figure 4.3).  
kon koff
 
Figure 4.3 Schematic depiction of a lipid nanodisc generated by membrane scaffold proteins.[209] Adapted with 
permission from I. G. Denisov et al, Chem. Rev. 2017, 117, 4669–4713. Copyright (2017) American Chemical 
Society. 
These nanodiscs showed with a surface size less than 60 nm
2
 a kon that corresponds to 
water-soluble fluorescein. Above 60 nm
2
 the kon shows a large increase, which is more 
independent than the surface size.
[33]
 Among other studies, this provides a hint of the 
H
+
-capturing effect of the membrane.  
However, the precise motion of a H
+
 transported over the membrane, like from a 
transporter to an ATP synthase is still being discussed.
[186,206–208]
 For a better understanding 
of H
+ 
dynamics at the membrane/water interface, studies have been conducted on lipid 
monolayers, bacterial membrane fragments, lipid nanodiscs and lipid bilayers.
[186]
 These 
experimental studies were partly supported by theoretical considerations.
[186]
 In particular 
by experiments on lipid monolayers and on membrane fragments of purple bacteria, two 
different hypotheses emerged for the H
+ 
movement over the membrane.
[186]
 In the first 
hypothesis it is assumed that the H
+ 
spread through a hop between titratable membrane 
parts. The titratable membrane parts are primary lipids, which can take up and release H
+
, 
what result in an lateral H
+
 movement (see Figure 4.4 a). The second hypothesis assumes 
that the near-membrane water phase acts as a hydrogen bridge network. The transport takes 
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Figure 4.4 Schematic representation of a) irreversible and b) quasi equilibrium H+ distribution over the 
membrane.[186] Adapted with permission from N. Agmon et al, Chem. Rev. 2016, 116, 7642–7672. Copyright (2016) 
American Chemical Society. 
However, there is still no clear evidence for either mechanism. Taking the above-
mentioned studies partly into account, GENNIS provided a few simplified conclusions for 
the H
+
 dynamics at membrane surfaces.
[208]
 He described that biological membranes have a 
narrow area at the membrane/water interface with increased H
+
 concentration in relation to 
the bulk solution. These hydrated H
+
 are stabilised by headgroup phosphate groups as well 
as carbonyl groups and H
+
 stabilisation results in an increased near-membrane pH. This 
behaviour was observed in zwitterionic and negative charged lipids.
[186,208]
 The transport of 
H
+
 takes place through a deep interface zone by the lateral diffusion of lipids and the 




Figure 4.5 Schematic H+ movement in deep interface zone and adjacent bulk zone by GENNIS.[208] Reprinted from 
Biophys. J., 110 (9), R. B. Gennis, Proton Dynamics at the Membrane Surface, 1909-1911, Copyright (2016), with 
permission from Elsevier. 












round 2 – 3-fold faster than the diffusion coefficient of phospholipids in the lipid 
bilayer.
[208]
 In addition to effects not described above, the following statements about the 
buffer concentration and the H
+
 flux are provided by GENNIS.
[208]
  
1. The transport of H+ across the membrane is comparatively faster in relation to the 
exchange with the bulk solution. 
[208]
 
2. At a low concentration of buffer (< 10 mM), the distribution of H+ in the bulk 
solution after leaving the deep interface zone is slow.
[208]
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4. At a higher buffer concentration (> 10 mM), a faster distribution of the H+ with the 




There are several equilibriums for the movement of H
+
 along unilamellar vesicles, which 
should be taken into account when using a membrane-bound pH active fluorophore. The 
unilamellar vesicles represent a common model system for biomembranes. SANDÉN et al. 
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These equations describe the protonation of the fluorophore (F) with the bulk solution 
(Equation 4.1), the exchange of H
+
 between the lipids (L) and the fluorophore (Equation 
4.2), as well as the exchange between lipids and the bulk solution (Equation 4.3, see Figure 
4.6).
[31]
 In the same study, SANDÉN et al. examines the influence of ion concentration on 
the properties of lipid-bound fluorophores. Measurements with different ion concentrations 
make it possible to deduce the chemical potential  and the distance x between the 
fluorophore and the membrane surface (see Figure 4.6).
[31]
 KRAAYENHOF et al. developed 
various fluorophores anchored in the membrane by alkyl chains.
[29]
 With these 
coumarin-based fluorophores it is possible to measure the H
+
 concentration at different 
distances from the membrane by pH titration. The difference in distance is achieved by 
using various linkages (see Figure 4.7).
[29]
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Figure 4.6 Illustration of the different equilibrium reactions at the membrane surface, when measured with a 
fluorophore labelled lipid. Graphic in the showcase: Ion distribution at the membrane and chemical potential  
with distance x from the membrane surface.[31] 
Four fluorophores were used, which have an average distance to the membrane of 0.2 nm 
(U-2), 0.6 nm (U-6), 1.0 nm (U-10) and 1.3 nm (U-13). Despite repulsion forces, based on 
the positive charge of the coumarin based fluorophores and the positive charged linkers, 
there are several degrees of freedom in the structure.
[29]
 According to SANDÉN et al., the 
distance between the fluorophore and the membrane can be strongly influenced by the ion 





 U-2  U-6  U-10  U-13  
Figure 4.7 Chemical structure of membrane-bound pH-sensors synthesised by KRAAYENHOF with different 
distances to the membrane surface (distance to the surface from left to right 0.2 nm, 0.6 nm, 1.0 nm and 
1.3 nm).[29] 
However, the results of KRAAYENHOF et al. confirm a change in the titration behaviour of 




4.1.3 Carboxyfluorescein as pH-sensor 
A large number of indicators for measuring the pH are available. However, for measuring 
the intracellular pH only a small number of dyes are available because certain requirements 
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have to be fulfilled.
[210]
 The dyes must be non-toxic to the cell, not interfere with any 





Figure 4.8 Examples of the pH range of typical pH sensitive dyes.[210] Reprinted with permission from J. Han et al, 
Chem. Rev. 2010, 110, 2709–2728. Copyright (2010) American Chemical Society. 
Furthermore, pH active fluorophores should not interact with the hydrophobic part of the 
membrane when they have to be used near the membrane. Depending on the way of 
anchoring in the membrane, an undesired interaction can lead to membrane deformation or 
an incorporation of the molecule into the membrane. HUGHES et al. examined some of the 
most common water-soluble fluorophores and their interaction with model lipid 
bilayers.
[211]
 Here, the pH sensitive molecule carboxyfluorescein was investigated among 
other fluorophores. It was found that carboxyfluorescein has a membrane interaction factor 
(mif) less than 0.1, which stands for almost no interaction with the membrane. The low 
interaction with the membrane is confirmed by studies, in which carboxy-
fluorescein-labelled lipids were used as lipid headgroup fluorescent label.
[33,212–214]
 Based 
on these results and the good commercial availability, carboxyfluorescein is a promising 
pH-sensor for near-membrane pH measurements.  
Carboxyfluorescein differs from the basic structure fluorescein, by the addition of a 
carboxyl group at the (5) or (6) position (see Figure 4.1). Commercially available are the 
pure conformers as well as a mixture of both (61:39 isomer ratio).
[215]
 The additional 
carboxylic acid at position (5) or (6) allows a connection to a molecule without major 
changes in the fluorophore system. Due to multiple ionic forms, carboxyfluorescein 
possesses several pKa values and different UV/Vis spectra (see Figure 4.9).
[216]
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Figure 4.9 The change in chemical structure of (6)-carboxyfluorescein dependence on the pH. With change in the 
protonation state the UV/Vis spectrum change of the molecule.[216] Adapted with permission from M. Aschi et al, J. 
Org. Chem. 2008, 73, 3411–3417. Copyright (2008) American Chemical Society. 
The fluorescence properties of fluorescein and its derivatives are well studied and show 
also a pH dependency in the spectroscopic properties, such as the fluorescence spectrum, 
the quantum yield and the molar attenuation coefficient.
[217–219]
 In Figure 4.10 a pH 




Figure 4.10 Emission spectra of carboxyfluorescein excited at 480 nm with different pH values.[220] Adapted with 
permission from A. L. F. Baptista et al., J. Liposome Res. 2003, 13, 123–130. Copyright (2003) Taylor & Francis. 
For free carboxyfluorescein the pKa is 6.36.
[221] 
In the laboratory practice when carboxyfluorescein is used as a dye, a ratio of two 
excitation wavelengths at one emission wavelength is used, instead of the total 
fluorescence intensity.
[222–224]
 This prevents effects such as photobleaching or variations in 
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the excitation light intensity.
[222]
 It is possible to quench the fluorescence of fluorescein and 
its derivates by self-quenching with increased concentration
[225]
 or by quenching partners 
such as oxygen and iodine ions.
[219,226]
 For the above reasons, carboxyfluorescein and some 
of the derivates are ideal sensors for cell and near-membrane pH measurements. 
4.1.4 Considerations, synthesis and measurements 
Considerations 
The work of KRAAYENHOF et al. showed a connection between the distance to a membrane 




 For this study, systems 
with some degree of freedom between the alkyl chain anchoring and the fluorophore were 
used. The intention of the following work was to use a system, which is stable in the 
structure, easy to modify and that shows a defined distance to the membrane surface. Due 
to their rigid structure compared with -peptides (see Chapter 2.1), the -peptides were 
tested as a potential lead structure. -Peptides allow a predictable design, which is a 
prerequisite for the use and the establishment as a peptide based molecular ruler (see 
Figure 4.11). Additionally, the peptide structure enables a variety of modifications ranging 




The -peptide unit developed by ROST et al. was used as a starting point for the 
transmembrane anchoring of molecular sensors.
[11,38]














-hLys) (see Figure 





with the membrane headgroup region, measurements like NMR or crystal structure are 
important, but such measurements are not yet available, whereby the position of an 
attached fluorophore relative to the membrane surface is not possible. Therefore, the first 
design was focused on two peptides, which differ in the number of amino acids in the 
hydrophilic peptide part. To detect clear differences in the following measurements, a 
mismatch in the hydrophilic region of the synthesised β-peptides of six amino acids was 
chosen. For an appropriate extension of the peptide for measurements at different distances 
to the membrane surface, some criteria have to be fulfilled. This extension should not 
exhibit adverse effects on the secondary structure of the transmembrane region and should 
have a high amount of water soluble groups. Furthermore, the fluorophore should be easily 
applied to the extension. On the basis of these assumptions, a system of an alternating 
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-hLys was tested. Due to the branching, β
3
-hVal stabilises 
the helix and the β
3
-hLys increases the water solubility.
[83,88,89]
 The extension by six amino 
acids of the existing transmembrane -peptide motif, in consideration of a tilt angle of 16° 
(in DOPC), a residue per turn of 3.0 and a rise per residue of 1.56 Å, lead to a height 
difference of ~9 Å (see Figure 4.11).
[10,38]
 Unpublished results of WEGNER and HALBMAIR 





Figure 4.11 Simplified peptide model systems for near-membrane pH measurements.  
The calculated ~9 Å difference is comparable with the height difference of U-2 and U-10 
from the study of KRAAYENHOF et al. (8 Å).
[29]
 In contrast to KRAAYENHOF et al. 
carboxyfluorescein was used as a pH active functionalisation of the described -peptides. 
Carboxyfluorescein is able to be attached by the carboxylic acid in position (5) or (6) 
during the SPPS.
[229]
 Thus, two artificial model systems for near-membrane pH 
measurements are designed and investigated in this study. 
Synthesis and structure results 





-hLys were tested with the synthesis of Pep 12. This β-peptide consists of 4 × D-β
3
-
hVal and 5 × D-β
3
-hLys and should show, assuming a stable 14-helix, a 2 2/3 twist. 
 
 Pep 12  
Figure 4.12 Chemical structure of Pep 12, with an alternating sequence of D-β3-hVal and D-β3-hLys. 
The peptide Pep 12 was analysed by CD spectroscopy in ultrapure water (0.6 M, T = 25 °C, 
d = 0.01 mm). Pep 12 shows a minimum at 196 nm and a maximum at 216 nm in the CD 
spectrum (see Appendix C). These values and the course of the curve correspond to a 
14-helix.
[62,70,76]
 Compared with the transmembrane peptides, the CD spectrum shows a red 
9 Å 
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shift. This is probably due to the peptide environment, despite the high concentration 
probable no aggregation of the helix bundles is observed (see Chapter 3.2).
[76]
 
On this basis, the two peptides Pep 13 and Pep 14 were developed. These two peptides 
consist of a transmembrane unit, a linker and a fluorophore. Pep 14 has in contrast to 
Pep 13 an extension of six amino acids, which is based on Pep 12. The linker β-alanine is 
incorporated in the peptide structures to prevent an interaction of the fluorophore with the 
adjacent side chains, which could lead to a change in the secondary structure. Furthermore, 
β-alanine was used to obtain the smallest possible number of degrees of freedom by the 
N-terminal attachment of the carboxyfluorescein. For example, if the fluorophore is bound 
to a lysine side chain, the distance between the membrane surface and the fluorophore is 
less determinable.  
 
 Pep 13  
 
 Pep 14  
Figure 4.13 Chemical structure of Pep 13 and Pep 14. 
The pH sensitive fluorophore carboxyfluorescein was bound to the peptide via an amide 
bond. At first, the pH active 5(6)-Carboxyfluorescein (5.00 eq) as well as PyBOP (4.70 eq) 
was solved in DMF (0.37 M) and DIPEA (10.00 eq) was added to the solution. The dry 
resin was mixed with the solution and shaken overnight. Due to the poor reproducibility of 
the same resin type, though with different swelling properties, other labelling methods 
were tested. Additionally, successful labelling was performed by three 
microwave-supported methods:  
a) DIC (10.00 eq)/Oxyma (5.00 eq)/carboxyfluorescein (5.00 eq) double coupling 
(25 W, 5 min, 90 °C),  
b) HATU (4.90 eq)/HOAt (5.00 eq)/DIPEA (10.00 eq)/carboxyfluorescein (5.00 eq), 
double coupling (25 W, 15 min, 75 °C),  
c) PyAOP (5.00 eq)/HOAt (5.00 eq)/DIPEA (10.00 eq)/carboxyfluorescein (5.00 eq), 
double coupling (25 W, 60 min, 75 °C). 
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After the successful labelling the washed resin was treated with a solution of 
NMP/piperidine (v/v; 80:20) for 15 min at RT to remove the phenolic ester.
[230]
  
In addition to carboxyfluorescein-labelled peptides, a derivative of Pep 14 was synthesised 
with the fluorophore 7-nitrobenz-2-oxa-1,3-diazol-4-yl (NBD) (Pep 15, see Figure 4.14). 
This peptide enables the distribution of incorporated β-peptides with a hydrophilic 




 Pep 15  
Figure 4.14 Chemical structure of Pep 15. 
Therefore, the fluorophore was reduced by the non-permeating sodium dithionite 
(Na2S2O4), what results in the loss of fluorescence depending on the accessibility to the 
added Na2S2O4.
[231]
 The peptide labelling was performed with NBD-F (5.00 eq) and 
DIPEA (20.00 eq) in DMF. This solution was given to the dry resin for gentle agitation 
overnight. 
Measurements of Pep 13 – Pep 15 
To determine the properties of the peptides described above, different methods were used. 
First, the distribution of the peptide Pep 15 in the membrane was investigated by NBD 
reduction in DOPC vesicles. In this method, Na2S2O4 was added to a vesicle solution 
containing a NBD-labelled peptide. The decomposition of S2O4
2−
 into radical SO2
·−
 in an 
aqueous solution leads to a reduction of NBD to 7-amine-2,1,3-benzoxadiazol-4-yl 
(ABD).
[231]
 The impermeability of the membranes for these ions results in a selective 
reduction of the peptides, orientated with NBD on the outside of the vesicle. The degree of 
reduction can be observed by fluorescence spectroscopy, as ABD shows no fluorescence in 
contrast to NBD. Consequently, LUV were produced with a P/L ratio of 1:100. The 
rehydration of the prepared lipid films and the extrusion took place in a phosphate buffer 
(10 mM Na2HPO4, 150 mM NaCl, pH 7.6). 40 µL of the vesicle suspension was diluted in 
1960 µL buffer (0.20 mM lipid in cuvette). After the stabilisation of the fluorescence, 
20 μL of a freshly prepared 50 mM sodium dithionite solution in ultrapure water were 
added to the lipid solution. When no major changes in fluorescence could be observed, a 
10 % solution of Triton X-100 in ultrapure water was added, which leads to the destruction 
of the vesicle. From this measurement, an approximate distribution of Pep 15 was 
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observed with 50 % in the outer leaflet and 50 % in the inner leaflet of the vesicle (see 
Figure 4.15).  






















Time t [min]  
Figure 4.15 Detection of the peptide distribution in DOPC vesicles by NBD emission 
(Ex = 436 nmEm = 535 nm). Therefore, Pep 15 was incorporated in DOPC LUVs (~100 nm, P/L ratio = 1:100, 
T = 25 °C, rpm = 500). A = addition of Na2S2O4; B = addition of Triton X-100. 
This distribution was obtained under the premise of an equal bleaching effect of the inside 
and outside fluorophores by excitation. Such a bleaching effect was observed from the 
beginning of the measurement, over the addition of Na2S2O4 (A in Figure 4.15) and until 
the addition of Triton X-100 (B in Figure 4.15). After the distribution of the used peptides 
in the membrane was known, the properties of the peptide-bound carboxyfluorescein were 
investigated. Therefore, the concentration dependent absorption behaviour of peptide 
Pep 14 in MeOH was examined. It is known from the literature that free 
carboxyfluorescein shows self-quenching effects above a certain concentration.
[225]
 An 
increased carboxyfluorescein concentration lead to a dimerisation. This dimerisation leads 
to the loss of the fluorescence and can be observed by change in the UV/Vis absorption 
spectrum. In order to examine the self-quenching effect of the peptide-bound 
carboxyfluorescein, Pep 14 was dissolved in various concentrations in MeOH (see Figure 
4.16). MeOH was chosen because the high hydrophobic transmembrane moiety shows a 
good solubility in organic solvents (MeOH, TFE). Based on CD measurements
[94]
 in 
organic solvents (additionally unpublished results of WEGNER
[15]
), non or less aggregation 
was presumed (Chapter 3.2.1). It turned out that the carboxyfluorescein-labelled peptides 
also show a concentration-dependent change in their absorption behaviour. At low peptide 
concentrations, the spectra show a maximum at 500 nm. At higher concentrations the 
absorption maxima shift to smaller wavelengths and another maximum appears. These two 
absorption maxima were at 457 nm and 484 nm. Although, the 3-dimensional 
A 
B 
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consideration of Pep 14 solved in MeOH presented here is not directly transferable to a 
2-dimensional peptide behaviour in lipid membranes, yet this measurement indicates a 
reference point and shows a concentration dependency in the absorption of Pep 14, what 
could result in a variation of the fluorescence. 
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Figure 4.16 UV/Vis absorption spectra of Pep 14 in MeOH with variation of the peptide concentration (T = 25 °C). 
In the following experiments, the properties of the carboxyfluorescein-labelled peptides 
Pep 13 and Pep 14 incorporated in model membranes were investigated. It is known from 
KRAAYENHOF et al. that the behaviour of pH sensitive molecules in proximity to 
membranes could be affected by the lipid composition.
[29]
 One of the methods used in this 
study is an acid/base titration. For this titration it is assumed that the membrane surface 
interacts with ions due to the surface charge. A negatively charged membrane surface 
attracts positive ions like H
+
 from the bulk solution.
[232,233]
 This results in a difference in 
the bulk solution pH and the membrane surface pH. In the titration, the varying 
development of both these pH values is measured. Therefore, the pH of the bulk solution is 
measured by a pH meter and the surface pH by a membrane-bound sensor or the amount of 
standard solution is used in conjunction with the point of change of a membrane-bound 
sensor.
[29,31]
 Similar titrations were carried out with proteins, whether membrane-bound or 
water soluble proteins.
[32,221,234]
 Increasing the negative surface charge by charged 
headgroups can lead to an increasing affinity of H
+
 on the surface (see Figure 4.17). In the 
study of SANDÉN et al., a difference was shown between dissolved fluorophore (fluorescein 
and Oregon green) compared to membrane-bound fluorophore. None or marginal 
difference in pKa was observed at DOPC and DOPG vesicles.
[31]
 However, KRAAYENHOF 
et al. observed by titration a change in the pKa for different molecules and lipid 
composition (see Figure 4.7 and Table 4.2). 
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Figure 4.17 Schematic representation of pKa shifts by consideration of the bulk pH and the surface pH 
(determined by Fl ratio) depending on the surface charge of the membrane. 
Due to the influence of the buffer to the membrane-bound fluorophores, the first step was 
to work with an elevated buffer concentration above the limit of 10 mM presumed by 
GENNIS.
[208]
 For this, the peptides were incorporated in 0.38 µmol LUV (P/L ratio of 
1:200) by the extruder method consisting of POPC, DOPC or DOPC/DOPG (50:50) with a 
phosphate-buffered saline (PBS) buffer (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 
1.8 mM KH2PO4, pH 7.4). Subsequently, for the measurement the vesicles were diluted to 
a total concentration of 19.0 nM lipids in buffer (2 mL total volume), partly mixed with 
0.95 µL carbonylcyanid-m-chlorphenylhydrazon (CCCP) of a 0.2 mM solution in DMSO 
and titrated with 2 – 3 M NaOH and HCl solutions. For the measurement, the sample was 
first acidified and then basified, started from a pH of 7.4. Preliminary examinations of pH 
titration with and without CCCP has shown unusual fluorescence behaviour in a pH range 
greater than 8 (Example in Figure 4.18 a). When stimulated with one wavelength (    
   ) 
some probes show a small decrease in the fluorescence. This effect can be eliminated by 
considering the ratio of two extinguish wavelength at one emission wavelength 
(    
   /    
   ; see Figure 4.18 b).
[223]
 In addition, the ratiometric consideration of the 
fluorescence enabled the influence of negative effects such as photobleaching.  
increased negative 
surface charge 
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Figure 4.18 Titration of Pep 14 in DOPC vesicle (P/L ratio = 1:200, T = 25 °C, rpm = 500) in PBS buffer (probe 
without CCCP). a) Measurement of one observed wavelength and b) ratio of two excitation wavelength at one 
emission wavelength     
   /    
   . 
Additionally, a difference in the ratiometric fluorescence     
   /    
    was detected from the 
acidified step to the basified step of peptides which were used after HPLC purification 
(HPLC solvents + 0.1 % TFA) and lyophilisation. Figure 4.19 shows a sample in which the 
peptide was additionally treated with an excess of TFA and subsequently lyophilised to 
increase the effect to better visualise. It appeared for     
   /    
    a maximum ratio of ~10 at 
the beginning of the measurement. The following acidified step leads to a fluorescence 
ratio of ~1 followed by a     
   /    
    maximum in the basified step of ~4. 






























Figure 4.19 Titration of Pep 14 in POPC vesicle (P/L ratio = 1:200, T = 25 °C, rpm = 500) in PBS buffer (probe 
with CCCP). In red the acidification step (performed 1st) and in black the basification step (performed 2nd,) is 
presented. There is a difference in fluorescence ratio at pH 5.5 and higher for the two series of measurements. 
This difference in the fluorescence ratio maximum can be observed due to formation of 
TFA salts with the fluorophore or the lysine side chains and can be prevented by an 
additional lyophilisation of the peptides form H2O or dioxane with a small amount of a 1 M 
HCl solution. 
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The titration of the peptides Pep 13 and Pep 14 was carried out in a PBS buffer (137 mM 
NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4) and in a HEPES buffer (10 mM 
KCl, 2 mM HEPES). These two measurements were performed to show the titration 
behaviour of the peptides above and below a buffer concentration of 10 mM.
[208]
 To break 
down a H
+
 gradient between the vesicle inside and outside, carbonyl cyanide-m-
chlorophenyl hydrazone (CCCP) dissolved in DMSO was added in a CCCP/lipid ration of 
1:2010. The titration in a high concentrated buffer (PBS) was performed with DOPC 
vesicles or DOPC/DOPG (50:50) vesicles and a P/L ratio of 1:200. DOPG was 
incorporated into the vesicle as a negative charged lipid to observe H
+
/membrane effects, 
despite the high buffering concentrations which should prevent such an effect. The vesicles 
were obtained by the extrusion method. Therefore, the rehydrated lipid films (0.38 µmol 
lipid) were extruded through a 100 nm pore (size distribution in the Appendix C). 
Afterwards 1900 µL buffer, 100 µL vesicle suspensions and 0.95 µL of a 0.2 mM CCCP 
solution in DMSO were mixed and titrated with an aqueous 2 M NaOH and 2 M HCl 
solution. The beginning of the titration was at the starting pH of the buffer (~7.4) and was 
performed first towards a low pH (~3) followed by a titration to high pH (~11). Each 
measurement was performed three times with different prepared probes (see Appendix C). 
As a sigmoidal fit curve of the fluorescence excitation ratio     
   /    
    the BOLTZMANN fit 
was used.
[235]
 The pKa value of the measurements were determined as the inflection point 
and present in Table 4.1. 
Table 4.1 pKa Values resulting from fluorescence titration of Pep 13 and Pep 14 in DOPC or DOPC/DOPG vesicles 
(PBS buffer, number of measurements = 3). 
 DOPC DOPC/DOPG (50:50) 
Pep 13 6.33 ± 0.04 6.38 ± 0.04 
Pep 14 6.18 ± 0.05 6.50 ± 0.07 
 
In different lipid composition the values show for Pep 13 no shift in the pKa in the 
magnitude of previous studies performed by KRAAYENHOF et al.
[236]
 They demonstrated 
different titration behaviours for the synthesised molecules (see Figure 4.7) depending on 
the distance to the membrane and lipid composition (Table 4.2).
[236]
 Pep 14 shows a 
slightly different pKa value for the two membrane systems in PBS buffer, the 
meaningfulness of these values is not known and must be confirmed by further studies and 
methods. 
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Table 4.2 Apparent pKa values of fluorophores at various distances from the membrane and different PC and PA 
lipid ratio, determinate by fluorimetric titrations. 
 0 % PA 2.5 % PA 5 % PA 7.5 % PA 10 % PA 20 % PA 
U-2 8.89 9.32 9.61 9.80 10.10 10.35 
U-6 7.08 7.42 7.67 7.79 7.91 8.08 
U-10 8.55 8.85 9.03 9.23 9.28 9.32 
U-13 7.57 7.83 7.95 8.10 8.16 8.27 
 
In order to investigate the repeatability of the process, the pH was changed ten times for 
the probes given in Table 4.1. At high pH values the fluorescence maximum     
    shows 
for Pep 13 a maximum fluorescence intensity reduction of 16 – 35 %. However, this 
reduction has no influence on the     
   /    
    ratio (see Appendix C) and a repeatability for 
all probes exists. 
The titration with a buffer concentration < 10 mM (HEPES) was performed, following 
KRAAYENHOF et al., with vesicles of DOPC or DOPC/DOPA (90:10) and a P/L ratio of 
1:1000.
[236]
 The vesicles were obtained by the extrusion method with a filter pore size of 
400 nm. Therefore 500 µL buffer was given to the dry lipid film and the rehydrated lipid 
films (1.27 µmol lipid) were extruded. Afterwards 1900 µL buffer, 100 µL vesicle 
suspensions and 3.16 µL of a 0.2 mM CCCP solution in DMSO were mixed and titrated 
with 2 M NaOH and 2 M HCl aqueous solution. The titration procedure was analogue to the 
titration in PBS buffer. The pKa values of these measurements are given in Table 4.3. 
These values show no shift in the pKa, which is in the magnitude of the values given in 
Table 4.2. 
Table 4.3 pKa Values resulting from fluorescence titration of Pep 13 and Pep 14 in DOPC or DOPC/DOPA vesicles 
(HEPES buffer, number of measurements = 3). 
 DOPC DOPC/DOPA (90:10) 
Pep 13 6.11 ± 0.11 6.08 ± 0.04 
Pep 14 6.10 ± 0.15 6.43 ± 0.14 
 
Although the vesicle preparation was carried out analogously to the method described by 
KRAAYENHOF et al., the size distribution measurements of the vesicles by DLS, showed no 
homogenous size distribution (see Appendix C). These heterogeneous size distributions are 
independent of vesicle probes with peptides (see Appendix C) or without peptides (results 
not shown). In contrast to these measurements, the PBS buffer vesicle showed one size 
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distribution (see Appendix C). It should also be noted that the measurements of Pep 14 in 
the lipid systems with negative charges DOPC/DOPG (50:50) or DOPC/DOPA (90:10) 
show the largest pKa shift in comparison to the other measured values. The measured 
values are in the range of dissolved carboxyfluorescein (pKa = 6.36)
[221]
 with a pKa value of 
~6.5 (see Figure 4.8). However, the meaningfulness of these values is not known and has 
to be confirmed by further studies. 
4.1.5 Outlook for Pep 13 and Pep 14 
In addition to the titrations, other methods are still in processes to examine the properties 
of the pH functionalised -peptides, whereby a broad understanding of the mechanisms 
should be obtained. Due to the complexity of the measurements, they are not yet finished. 
However, the measurements and preliminary investigations will be discussed briefly.  
Various studies on labelled lipids were carried out in the WIDENGREN group by 
fluorescence correlation spectroscopy (FCS).
[31–34]
 In these studies, inter alia, lipids were 
labelled with pH active fluorophores and vesicles (small unilamellar vesicle, SUV) or lipid 
discs containing the labelled lipids were prepared. Subsequently, various pH values were 
set and the respective autocorrelation functions were recorded (see Figure 4.20).
[34]
 These 
measurements allow the observation of local H
+
 exchange close to the membrane. By this 
method, a H
+
-collecting effect of DOPG could be determined, whereby the cross section of 
fluorescein will be increased by 100 times. Furthermore, it could be shown that the DOPA 
lipid headgroups store H
+
 close to the membrane, which are in a rapid equilibrium with a 
membrane-bound fluorophore.
[34]
 The varying of the surface charge and ion concentration 







Figure 4.20 a) Confocal detection volume of FCS measurement for observation of fluorescence labelled SUV 
movement. b) Example FCS curves of fluorescein labelled vesicles at different pH values.[34] Reprinted with 
permission from M. Brändén et al, Proc. Natl. Acad. Sci. 2006, 103, 19766–19770. Copyright (2006) National 
Academy of Sciences. 
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The following FCS project will be done in cooperation with the ENDERLEIN group. To 
reproduce the results of the WIDENGREN group, vesicles were prepared according to the 
sonicated based method, which resulted in unequal size distribution with multiple size 
maxima (unpublished results). Due to this, vesicle preparation with DOPG lipids, 




 ionophore were 
tested. Therefore, the extrusion method with different filter pore sizes (30 nm, 50 nm, 
100 nm) and different fluorophore/lipid ratios (1:500, 1:1000, 1:3000, 1:5000, 1:7000, 
1:10000, 1:30000) were performed. The vesicles with a ratio of 1:7000 and 1:10000 
prepared with a filter pore size of 30 nm (average vesicle size of ~78 nm) in PBS buffer 
showed constant size distribution and usable FCS measuring properties. A major problem 
in these measurements is the exclusion of CO2, which induced a pH change during the 
measurement because an unbuffered system was used (0.15 M NaCl) for the FCS 
measurements. 
In addition to the FCS measurements, the determination of the distance from the 
fluorophores to the surface will be performed in cooperation with the ENDERLEIN group. 
By the metal-induced energy transfer (MIET) an energy transfer takes place between an 
excited fluorophore and the surface plasmon of a metal structure.
[237–239]
 So far, distances 
in the order of magnitude of the inner and outer leaflet of a membrane were observed with 
this method (yet unpublished results). In this project, MIET would be helpful for pointing 
out the tilt of the peptides in the membrane, without the usual X-ray or ATR-FTIR 
technique and to prove the transmembrane position of the peptides in the membrane. 
These studies will be supported by measurements performed in the POHL 
group.
[186,195,196,204]
 Here, the peptides Pep 13 and Pep 14 will be investigated by a UV 
induced membrane H
+
 gradient. For this purpose, the peptides and (6,7-
dimethoxycoumarin-4-yl)methyl (DMCM) diethyl phosphate are incorporated in a planar 
membrane. DMCM-diethyl phosphate releases a H
+
 by irradiation with UV light. This H
+
 
can move along the surface of the membrane (see Figure 4.21 c).
[196,204]
 At a distance of 
100 µm to the site of the H
+
 release, the fluorescence of the pH active molecule is 
measured (see Figure 4.21 a). In the case of membrane-bound fluorescein, the decreasing 
fluorescence is based on increased H
+
 concentration, which indicates a movement of H
+
 
across the membrane (see Figure 4.21 a). 
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Figure 4.21 a) Measurement setup of the UV induced membrane H+ gradient.[186] The H+ release takes place in the 
red area by UV-flash followed by H+ along the membrane surface to the green/blue area. The horizontal planar 
lipid bilayer is observed by an inverse fluorescent microscope. Reprinted with permission from N. Agmon et al, 
Chem. Rev. 2016, 116, 7642–7672. Copyright (2016) American Chemical Society. b) Fluorescence degreases of 
membrane-bound pH active molecules by H+ arrival in different lipid compositions.[204] Reprinted with permission 
from A. Springer et al, Proc. Natl. Acad. Sci. 2011, 108, 14461–14466. Copyright (2011) Proceedings of the National 
Academy of Sciences. c) UV induced H+ release by DMCM-diethyl phosphate.[186,204] 
In the case of a successful incorporation of the peptides into the membrane, this method 
can show the H
+
 migration across the membrane and the influences at different distances to 
the membrane surface. 
4.1.6 Conclusion and general outlook 
Cellular pH plays an important role in many processes in the cell. Especially for the energy 
production in cells, the near-membrane H
+
 concentration is important.
[1]
 Appropriate 
probes for examining this concentration are the basis for understanding the mechanism of 
the vital pH. 
The described -peptide derivates Pep 13 and Pep 14 showed the successful modification 
of -peptides with carboxyfluorescein as pH active fluorophores.
[33,221]
 For this purpose, 
various coupling conditions were established. Pep 14 was elongated by using an 




-hLys attached to the transmembrane motif 
developed by ROST et al.
[38]
 Due to an increased lysine concentration, the water solubility 
of this elongation was improved.
[88]
 The distribution of the extended peptide was 
determined by Pep 15 and showed ~50 % in the outer leaflet and ~50 % in the inner leaflet 
in LUV (~100 nm). In order to confirm these results the peptides have to be observed in 
4 Transmembrane β-peptides as anchor for near-membrane ion-sensors to study the concentration 





different membrane systems and different vesicle sizes. Measurements have also shown 
that the fluorophore properties, such as self-quenching, are preserved at the peptide-bound 
fluorophore and can be detected by UV/Vis spectroscopy.
[225]
 Titration of Pep 13 and 
Pep 14 was performed with a buffer concentration in a range of < 10 mM (HEPES) and 





 These titrations showed a pH dependence of the fluorescence for all 
performed measurements, which demonstrated the accessibility of the peptide-bound 
fluorophore to the surrounding pH changes. Therefore, the peptides were investigated in 
DOPC vesicles (~100 nm and ~300 nm) and in mixtures of DOPC/DOPG (~100 nm, 
50:50) or DOPC/DOPA (~300 nm, 90:10). These various lipid compositions should 
influence the surface charge of the membrane, whereby the H
+
/membrane interaction can 
be changed.
[29,31,34]
 The evaluation of the titrations shows only a slight change in the pKa 
value in different lipid systems compared to the literature.
[29]
 In order to make an accurate 
statement, further measurements and methods have to be carried out to determine the 
influence of the membrane on the peptide-bound fluorophores.  
For future peptide designs, the presented system can be modified in several ways, which 
allows the change of the peptide properties. One possible modification would be the 
change of the hydrophilic groups at the fluorophore bound side. Increased water solubility 
was achieved by a higher amount of D-β
3
-hLys which can be protonated at the side chain 
amine group. This positive charged peptide could result in a repulsing effect of the H
+
 and 
the peptide. This could be an indication why the measured pKa values of Pep 13 and 
Pep 14 (pKa = 6.10 – 6.50) are in the range of dissolved carboxyfluorescein 
(pKa = 6.36).
[221]
 Because of this it was attempted to synthesise two derivatives of Pep 14. 
Here, the hydrophilic D-β
3









-hGln), which are polar 
neutral amino acids. In previous studies performed by ABELE et al. β-peptides with β
3
-hSer 
showed water solubility with a stabile secondary structure.
[85]
 In contrast, previous studies 




 The feasibility of the 
synthesis of such modified peptides was tested. Therefore, Pep 16 and Pep 17 were 
synthesised by microwave-supported peptide synthesis following Method 2 
(Chapter 2.5.2). For Pep 17 no successful synthesis was verified by mass spectrometry. 
For Pep 16 signals with a higher m/z were observed, instead of the target mass. This 
additional mass of n × 96 m/z was avoided by the treatment of the cleaved peptide with 
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diluted NaOH solution and subsequent lyophilisation. The increased mass can be a result 
of the formation of a TFA ester with the D-β
3
-hSer side chain. 
 
 Pep 16 (R = Ser) 
Pep 17 (R = Gln) 
 
   
Figure 4.22 Chemical structure of Pep 16 and Pep 17. 
However, a more difficult purification was observed because of the reduced polarity, 
compared with Pep 14. Nevertheless, this Pep 16 represents a neutral extension and 
requires further investigation. In addition to polar neutral amino acids, negative charged 
amino acids can be incorporated, which can lead to an attraction effect. Furthermore, as an 
alternative to the carboxyfluorescein used sensor, other pH active fluorophores can be 
investigated
[29,223]
 or nitrile based pH-sensors for IR measurements are possible.
[240]
  
In summary, the synthesis and initial investigations represent a major potential for 
-peptide-bound pH-sensors due to their stability and variability. In this work, the first 
-peptide based pH-sensors Pep 13 and Pep 14 have been developed, which could 
represent a starting point for this application.  
4.2 -Peptide functionalisation with SPPS-compatible Ca2+-sensors 
4.2.1 Intracellular Ca2+  
A variety of metal ions are important for maintaining key processes in life.
[1,241]
 The wide 
range of functions utilising metals, includes the osmotic balance and the electric activity of 
cells, the catalytic activity of enzymes as well as the stability and the activity of the DNA 
and RNA.
[241]
 Calcium, as one of the bulk elements, shows a wide field of application in 
the hard and the soft structures of organic systems. Calcium is with 1.9 % the fifth 
common element in the human body after O, C, H and N.
[242]
 Furthermore, apart from 
strontium, calcium is the only metal that is found in the hard structures like skeleton and 
teeth.
[241]
 In soft structures, calcium mostly exists in its ionic form. Here, the function can 
be distinguished in the following categories: structural, electrical, catalytic cofactor and 
universal intercellular regulator functions.
[241]
 As an inorganic molecule, calcium ions 
(Ca
2+
) are one of the most occurring second messengers besides the organic second 
messengers cyclic adenosine monophosphate (cAMP), inositol triphosphate (IP3) and 
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 Among others, Ca
2+
 regulates the insemination of egg 
cells,
[244,245]
 the synaptic transmission
[246–248]
 as well as the apoptosis.
[249,250]
 Due to the 







 concentration in the extracellular space is up to 2 mM. In 
contrast, the Ca
2+
 concentration in the intercellular space varies from 100 nM in the 
cytoplasmic matrix up to 600 µM in the endoplasmic reticulum.
[188,251,252]
 Especially in the 
transmission of nerve signals, the gradient of Ca
2+
 is an important regulatory element.
[253]
 
During the stimulation of nerve cells, an incoming signal at the axon terminal opens 
voltage-dependent Ca
2+





 The increased Ca
2+
 concentration results in the activation of 




 The basic structure 
of Syt consists of a transmembrane region and two C2 domains. In consequence of a 







 For the SNARE mediated vesicle 
fusion only the Ca
2+
-binding proteins are of interest. Incoming Ca
2+
 bind to the C2 
domains, which leads to a translocation of the Syt in the direction of the membrane due to 
the interaction of the protein-bound Ca
2+
 with the charged acidic lipid headgroups.
[246,255]
 
Especially phosphatidylinositol phosphate (PI) lipids interact strongly with the Syt1/Ca
2+
 
complex. These lipids are mostly found in the cytoplasmic membrane leaflet.
[255,256]
 In 
addition to the interaction with the lipids, an interaction of Syt and SNARE complex 




Figure 4.23 Modulated structure of the SNARE complex formed by synaptobrevin, SNAP-25, syntaxin and 
synaptotagmin. The parts connected with brackets interact with each other during the fusion process.[257] 
Republished with permission of Journal of Neuroscience from “synaptotagmin Mutants Reveal Essential Functions 
for the C2B Domain in Ca2+-Triggered Fusion and Recycling of Synaptic Vesicles In Vivo”, J. T. Littleton et al., 21 
(5), 2001, 1421–1433 permission conveyed through Copyright Clearance Center, Inc. 
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Moreover, studies without Syt have shown that Ca
2+
 also has a positive effect on vesicle 
fusion.
[258]
 Differences between SNARE and SNARE/Ca
2+
 induced fusion were observed 
in experiments with target SNAREs (t-SNAREs) and vesicle SNAREs (v-SNAREs) 
incorporated vesicles.
[258]
 Without prior Ca
2+
 addition a mixture of t- and v-SNARE 
vesicles lead to a strong increase in light scattering signal. In contrast, the same experiment 
with prior Ca
2+
 addition to one sort of vesicle produced a 4-fold weaker light scattering 
signal.
[258]
 The different light scattering signal intensity can be explained by two different 
vesicle processes. The omission of Ca
2+
 leads to the aggregation of both vesicle sorts. This 
aggregation without fusion leads to vesicle clusters with a much bigger diameter then 
vesicles after fusion. As a competitive process, the membrane fusion is triggered by a prior 
addition of Ca
2+
 which leads to ionic interaction of the membrane surfaces and the Ca
2+
. 
This results in smaller particle size compared to the vesicle clusters and shows the 
important function of Ca
2+
 in processes including biological membranes.
[258]
  
4.2.2 Interaction of Ca2+ with the membrane surface 
The interaction of the membrane surface with ions can be influenced by various factors. 
Depending on the composition of the membrane and the kind of cations, different 
interactions can occur. Monovalent alkali cations show only an adsorption effect on the 
membrane when negative charged lipids are incorporated.
[259]
 Divalent ions, like Ca
2+
, are 
adsorbed at the membrane surface even in the absence of negatively charged lipids.
[188]
 In 
general, the extracellular leaflet of membranes consists of neutral or zwitterionc 
components (phosphatidylcholine, sphingomylein, cholesterol). By the coordination of 
cations on the neutral surface a positive surface charge is created.
[260–263]
 This interaction of 
Ca
2+
 with the headgroups has a great influence on the properties of the lipid bilayer like the 
rigidity of lipids and their order.
[188]
 In this context, following effects were reported: 
conformational change of the lipids head region, ordering of acyl chains and lipid 
dehydration.
[188]
 Due to the important influence of Ca
2+
 in the membrane fusion, the 
interaction of the inner leaflet and Ca
2+
 is a major part of research for the transmission of 
signals. To imitate neuronal vesicles, a simple model system of 80 % phosphatidylcholine 
(PC) and 20 % phosphatidylserine (PS) is used.
[188]
 In a mixed membrane consisting of PC 
and PS, three different binding sites are available in the headgroup region.
[188]
 The 
carbonyl and phosphate groups of PC and PS bind Ca
2+
 as well as the carboxyl group of 
the PS headgroup. Using calculations it was tried to clarify the exact percentage of each 
possible binding partner.
[188]
 Figure 4.24 shows the calculated values for two different 
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 and two different lipid compositions. The average number of Ca
2+
 
in the first coordination sphere of the respective functional group is proportional to the 
thickness of the red lines.
[188]
 With increased Ca
2+





 In addition, the binding of a PS carboxyl group to Ca
2+
 leads to a 
reorientation of the PS headgroup from the water interface to the membrane phase. 
 
Figure 4.24 Schematic representation of the Ca2+-binding to the lipid headgroups PC and PC/PS depending on 
Ca2+ concentration. The graphic represents calculated values. Republished under the Creative Commons (CC BY 
4.0) license.[188]  
Alongside the theoretical examinations, the investigations of interactions between Ca
2+
 and 
the membrane surfaces are of interest. Apart from methods such as dynamic light 
scattering (DLS) or X-ray diffraction measurements,
[258]
 other methods are available to 
investigate near-membrane Ca
2+
. The biocompatible and well-established fluorescence 
spectroscopy provides the opportunity to use particular developed sensors, which detect 
Ca
2+
 and allow an attachment close to the membrane surface by membrane anchoring.
[264]
 
4.2.3 Fluorescence-based Ca2+-sensors 
A wide range of fluorescence sensors have been developed to measure the most relevant 













The basic structure of fluorescence-based ion-sensors consists of a ligand and a 
fluorophore. The ligand binds selectively to the respective ion, which affects the 
fluorescence properties of the fluorophore.
[265]
 Derivatives of ethylene glycol-bis(2-
aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA) were designed as selective Ca
2+
 
ligands. Based on this, TSIEN developed 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-




 Structurally, the 
ethylene bridge between the oxygen and the nitrogen of EGTA is replaced in BAPTA by 
benzene rings (see Figure 4.25).
[266]
 The development of BAPTA as a high-affinity ligand 
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and optical indicator for Ca
2+












     
Figure 4.25 Structural formula of ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid (EGTA) and 
1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA). 
The structural modification of the ligand system leads to alterations of properties, like a 
shift in the basicity of the nitrogen atoms.
[264]
 The EGTA nitrogen atom has a pKa value of 
8.5 – 9.5. The aromatic rings of the BAPTA molecule change the pKa value to 6.0 –
 6.3.
[264]
 This basicity shift leads to a decisive change in the complexation of Ca
2+
 at a 
physiological pH.
[264]
 Under these conditions, the nitrogen atoms of the BAPTA molecule 
are deprotonated, in contrast to the nitrogen atoms of the EGTA molecule which are 
protonated. Due to this, no displacement of a H
+
 in the coordination sphere of BAPTA is 
required for the coordination of Ca
2+
, which accelerates the Ca
2+
 absorption of BAPTA in 
two or three orders of magnitude.
[264]
 Crystal structures of 5,5-difluorinated BAPTA with 
complexed Ca
2+
 show BAPTA as an octadentate ligand, where the four carboxyl groups, 
the oxygen atoms of the ethylene glycol bridge and the nitrogen atoms, which act as a 
LEWIS acid are involved.
[267]
 The functionalisation of the aromatic rings with substituents 
makes it possible to adjust the ligand binding properties by controlling the basicity of the 
coordinating nitrogen.
[265]
 Electron donating groups, like alkyl chains (-CnH2n+1) and 
heteroatoms (N, O), increase the basicity of the Ca
2+
-binding nitrogen, which leads to a 
higher affinity (smaller Kd). Electron withdrawing groups, such as halogen atoms (-F, -Cl, -
Br), nitro (-NO2) and nitrile (-CN) groups lead to a decrease in the basicity and to a lower 
binding affinity (larger Kd).
[265]
 This allows the synthesis of a variety of BAPTA-based 
ligands with a broad distribution of Kd values. For additional ligand motifs with modified 
Kd values, one of the aromatic rings can be replaced by other functionalisation (see Figure 
4.26). However, the thereof developed aminophenol triacetic acid (APTRA) does not show 
the desired affinity for Ca
2+





 In contrast, 2-(2′-morpholino-2′-oxoethoxy)-N,N-bis(hydroxycarbonylmethyl)-
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Figure 4.26 Structural formula of 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (BAPTA), 
aminophenol triacetic acid (APTRA), 2-(2′-morpholino-2′-oxoethoxy)-N,N-bis(hydroxycarbonylmethyl)aniline 
(MOBHA). 
BAPTA shows a fluorescence maximum in the range of ~250 nm which is shifting by 
Ca
2+
-binding to two maxima in a range of 200 – 300 nm (see Figure 4.27).
[270]
 These 
fluorescence maxima result in an excitation wavelength < 200 nm, which is highly toxic 
for biological systems. Due to the need of new biological compatible Ca
2+
-sensors, it is 
necessary to shift the fluorescence wavelength to higher wavelengths. 
 
Figure 4.27 Fluorescence spectra of different Ca2+-sensors with and without Ca2+.[270] Reprinted from E. Carafoli, 
C. B. Klee, Calcium as a Cellular Regulator, Copyright (1999) Oxford University Press. Reproduced with 
permission of the Licensor through PLSclear 
Such a fluorescence shift can be obtained by the attachment of a fluorophore to the 
chelating unit.
[264]
 This attachment leads to a change in the electronic system of BAPTA 
and the Ca
2+
-binding effects transfer to the electronic system of the fluorophore.
[264,270]
 In 
Figure 4.28, variations of Ca
2+
-sensors based on BAPTA are shown.
[265]
 The used 
fluorophores of the presented Ca
2+
-sensors are attached via different motifs. 
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Figure 4.28 Selection of Ca2+-sensors.[265] 
Two different working principles of the fluorescent Ca
2+
-sensors were found, the 
photoinduced electron transfer (PET) and the photoinduced charge transfer 
(PCT).
[113,265,271]
 PET based sensors have an electron donating group (D) in their structure 
which is part of the ligand system. In the BAPTA ligand, D is represented by the nitrogen 
atoms. The D is connected by a bridge to the conjugated aromatic system of a fluorophore 
and due to an electron transfer, the fluorescence of the fluorophore is quenched by the D 
(see Figure 4.29).
[113,265,271]
 An example for this type of Ca
2+
-sensors is Rhod-2, shown in 
Figure 4.28. In the Ca
2+
 free case, an electron from the highest occupied molecular orbital 
(HOMO) of the fluorophore is excited to the lowest unoccupied molecular orbital (LUMO) 
of the fluorophore. Subsequently, the D transfers an electron from its HOMO to the 
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Figure 4.29 Schematic functional principle of a PET based Ca2+-sensors. After fluorophore excitation in the Ca2+ 
unbound state, the fluorescence is suppressed by electron transfer of the D to the fluorophore. The binding of Ca2+ 
leads to an increase of the fluorescence, due to the missing electron transfer of the D.[113,265,271] Graphic in 
accordance to YAN and OHEIM et al.[265,271] 
The binding of Ca
2+
 decreases the energy of the HOMO from the nitrogen atoms (D), 
which serves as a LEWIS base in the Ca
2+
-binding and an electron transfer process is no 
longer possible.
[113,265,271]
 This inhibited electron transfer from the D to the fluorophore 





 concentration can be calculated according to the following 





             
                      4.4 
 
The Kd value varies with the ion strength, pH and temperature of the used solution. 
Therefore, a natural fluctuation of the Kd is present in complex biological systems.
[265,271]
 
The PET type sensors are also named non-ratiometric sensors because the evaluation 
considers only one excitation wavelength and one emission wavelength.
[265,271]
 
The PCT based Ca
2+
-sensors show, in contrast to the PET based Ca
2+
-sensors, a different 
fluorophore attachment to the ligand unit. The fluorophore is directly linked to the Ca
2+
 
coordinating unit without a bridge.
[113,265,271]
 Here, the fluorophore can be an electron 
acceptor (A) or an electron donating group (D) and is connected to the electronic 
counterpart, the Ca
2+
-binding unit, via an aromatic system (see Figure 4.30).
[113,265,271]
 
Depending on the distribution of D and A in the sensor, different fluorescence behaviours 
are observed by binding Ca
2+
. As a result of the structure, an outright charge transfer 
process from D to A takes place at an excitation of the aromatic system in an unbound 
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 The binding of Ca
2+
 alters the energy levels and affects the properties of the 
fluorophore. It is distinguished between the role of the chelator and the fluorophore as D or 
A. If the chelator acts as an A, the binding of Ca
2+
 leads to a decrease of the energy levels 
S0 and S1 (see Figure 4.30 a). Here, a greater decrease of the S1 state occurs, which results 
in a red shift in the absorption and the fluorescence spectra. The opposite case shows a 
blue shift of the spectra (see Figure 4.30 b). In addition, the PST principle may result in a 
























































































































Figure 4.30 Schematic functional principle of a PCT based Ca2+-sensors. The binding of Ca2+ induced a energy 
change of the ground state (S0) and the excited state (S1). Depending on the A/D distribution a) a decrease of the 
energy difference between S0 and S1 results from the Ca
2+ binding and leads to a red shift of the fluorescence or b) 
an increase of the energy difference between S0 and S1 results from the binding of Ca
2+ and leads to a blue shift of 
the fluorescence.[113,265,271] Graphic is in accordance to YAN and OHEIM et al.[265,271] 
To determine the Ca
2+
 concentration, two different absorption or emission wavelengths are 
observed and a ratiometric value (R = F(1)/F(2)) is calculated. From the respective ratios 
of Ca
2+
-free (Rmin) and Ca
2+
-saturated (Rmax), the following Formula 4.5 shows the 






                                             4.5 
 
These types of Ca
2+
-sensors are called ratiometric sensors because a ratio of two different 
absorption or emission wavelengths is calculated.
[265,271]
 Compared to the non-ratiometric 
sensors, the ratiometric sensors show less sensitivity to factors that can influence the 
fluorescence measurements. Such factors include the dye concentration, the optical path 
length and the sensitivity of the instrument.
[265]
 A dependency of the sensors of the solvent 
polarity, ionic strength, viscosity and temperature is still existing. However, in the 
literature, the non-ratiometric sensors like Fura-2 are used for most experiments.
[265]
 Based 
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on optimised fluorescence measurements, the ratiometric sensors could be more common 
in the future due to their advantages. 
4.2.4 Design strategies of new near-membrane Ca2+-sensors  
The labelling of biomolecules is a part of many studies and some of these labelling 
techniques are so ubiquitousthat specific kits are commercially available.
[113,223]
 The 
attachment of fluorophores can be performed by various coupling methods which differ in 
the used functionalities, the bioorthogonality and the synthetic effort. A biomolecule is 
often labelled at a functional group with a chemically activated fluorophore.
[117,118,272]
 This 
activation has to be orthogonal to other functional groups and leads to a covalent bond. A 
variety of methods has been developed ranging from nonspecific methods that are labelling 
functional groups to very specialised labelling reactions, which are mediated through a 
particular sequence or an artificial unnatural amino acid.
[117,118,272]
 
Many processes in biological systems depend on varying Ca
2+
 concentrations that interact 
with the membrane surfaces (see Chapter 4.2.2). Although most of the Ca
2+
-sensors are 





 Here, the anchoring in the membrane often takes place 
via a fatty acid chain (see Figure 4.31).
[35–37,264]
 Due to the strong interaction of Ca
2+
 with 
the membrane, higher Ca
2+
 concentrations are observed near the membrane compared to 
the cytosol.
[35,188,264]
 To determine these elevated Ca
2+
 concentrations, the saturation limit 





-sensors with a higher Kd are synthesised.
[35–37,264]
 In addition to 
the increased Ca
2+
 concentration, the membrane itself can lead to interaction with the 
fluorophore of the sensor, wherefore a low flexibility between the sensor and the 




-sensors shown in Figure 4.31 are 
characterised by a relatively high Kd as well as a fatty acid chain modification which takes 
place as far as known in the last reaction of the synthesis.
[37,273]
 The anchoring via a fatty 
acid chain is widespread, though it does not allow a rigid elongation in selectable distances 
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REx = F340/F380 





Ex = 514 nm 
Em = 5540 nm 
Kd = 0.1 µM 
 
 
C12-BIIC (X = NH)
[37]
 
REx = F401/F469 
Kd = 5.5 µM 
C12-BTIC (X = S)
[37]
 
REx = F421/F471 
Kd = 4.5 µM 
 
 
Figure 4.31 Chemical structure and physical properties of membrane-bound Ca2+-sensors. 
GRAF was able to synthesise several Ca
2+







-sensors were modified with an azide group (see Figure 4.32). 
This modification made it possible to bind the Ca
2+
-sensor to a polyethylene glycol (PEG) 
motif by a HUISGEN cycloaddition.
[275,276]
 HANSEN labelled lipid and cholesterol derivatives 
with the Ca
2+
-sensor developed by GRAF, but the attachment to short peptide sequences 
was not successful.
[277]
 The introduction of Ca
2+
-sensors with reactive groups as 
connection point shown by GRAF, represents a promising approach. Since the azide 
functionality is incorporated in the middle of the synthesis, the implementation of 
modifications in the system is difficult based on this synthesis strategy.
[274]
  
The goal of this work is the development of a Ca
2+
-sensor, which can be easily modified, 
primarily for labelling transmembrane -peptides. Therefore, 3-(benzimidazolyl)-
iminocoumarin (BIIC) and 3-(benzothiazolyl)iminocoumarin (BTIC) moieties were used 
as basic structures (see Figure 4.31).
[37,278]
 Here, the incorporation of the fluorophore and 
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the functionalisation with a C12 alkyl chain occurred in the last steps of the synthesis. 
These sensor properties and the -peptide specific properties like the length of the peptide, 
the polarity and the structure enable a new range of Ca
2+






Ex = 493 nm 
Em = 514 nm 





Ex = 493 nm 
Em = 514 nm 
Kd = 0.7  µM 
 
  
Figure 4.32 Chemical structure and physical properties of azide functionalised Ca2+-sensors developed by 
GRAF.[274] 
4.2.5 Synthesis and measurements 
Inspired by the synthesis of C12-BIIC (see Figure 4.31 and Scheme 4.1), different kinds of 
BIIC modifications were tested. The tentative idea was to address different biochemical 
functional groups in peptides, like the -NH2 group of lysine or the -SH group of cysteine 
side chains.
[116–118]
 After the successful modification of the literature known methyl 
protected BIIC, two tert-butyl protected Ca
2+
-sensors based on BTIC were synthesised (6 
and 7). The change of the protection strategy permitted the use in Fmoc-based SPPS. The 
replacement of benzimidazol with benzothiazolyl prevents a side reaction of the activated 
Ca
2+
-sensor in the SPPS with the -NH group of the benzimidazol. Both synthesised 
tert-butyl protected Ca
2+
-sensors differ in the used chelator unit, which were either 
BAPTA (8, 6) or MOBHA (7, see Figure 4.33).
[123] 
 
 8  9  
Scheme 4.1 Functionalisation of the methyl protected BIIC 8 with a C12 alkyl chain lead to the protected 
near-membrane Ca2+-sensor 9.[37] 
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-sensor was synthesised according to the literature as methyl 
protected 8 and as tert-butyl protected 6 and the tert-butyl protected MOBHA Ca
2+
-sensor 
7 was synthesised inspired by the synthesis of Calcium Green FIAsH developed by TOUR 





X = N, R = Me (8) 
X = S; R = tBu (6) 
X = S; R = H (10) 
 
R = tBu (7)  
R = H (11) 
 
     
Figure 4.33 Basic structure of the BAPTA-based Ca2+-sensor 8 and 6 as well as the MOBHA-based Ca2+-sensor 7. 
The starting nitrophenol 12 forms the basis of all following Ca
2+
-sensors. Therefore, in the 
first step, hydroquinone 13 was protected with benzyl bromide 14 in the presence of 
potassium carbonate to 1,4-bis(benzyloxy)benzene 15. The diprotected nitrobenzene 16 
was obtained by the reaction of 15 with acetic acid and nitric acid. 16 was selective 




   13 14 15  16  12   
Scheme 4.2 Synthetic rout for the preparation of 4-benzyloxy-2-nitrophenol 12. 
The monoprotected compound 12 was treated with the commercially available 1-(2-
bromoethoxy)-3-nitrobenzene 17 to obtain the bisnitro compound 18. Thus, the phenolic 
alcohol of 12 was deprotonated with K2CO3 and in a nucleophilic substitution reaction the 
bisnitro compound 18 was yielded. By a BÉCHAMP reduction, the bisnitro compound 18 
was converted into the diamine compound 19 (see Scheme 4.3).
[279,281]
 This diamine 
compound was the starting substance for the subsequently synthesised basic labile (8) and 
acid-labile (6) BAPTA units. 
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     12  17  18    19   
Scheme 4.3 Synthetic rout for the preparation of 2-[2’-(2’’-Aminophenoxy)ethoxy]-5-(benzyloxy)aniline 19 as the 
basic structure for the methyl and tert-butyl protected BAPTA motifs. 
Synthesis and modification of alkaline labile Ca
2+
-sensors based on BAPTA 
The methyl protected BAPTA Ca
2+
sensor was synthesised analogously to the literature. 
Furthermore, the modifiability was tested with four different functional groups.
[37]
 
Therefore, the diamine compound 19 was converted with methyl bromacetate 20 to the 
methyl protected BAPTA unit 21. The selective introduction of an aromatic aldehyde 





 19 20 21  
 
 23  22  
Scheme 4.4 Synthetic rout for the o-hydroxybenzaldehyde 23, which will be the precursor for the attachment of an 
fluorophore by KNOEVENAGEL condensation.[283,284] 
Subsequently the aromatic benzyl protecting group was cleaved by Pd/C. In agreement 
with the original literature, the deprotection was carried out in acetic acid with Pd/C 
(10 % wt). Firstly, a reaction with 0.5 bar H2 overpressure was tested overnight. This 
reaction condition resulted in a deprotection of the aromatic alcohol and also to a reduction 
of the aldehyde group (sees Scheme 4.5).
[285]
 Secondly, a reaction without H2 overpressure 
and a reaction time of less than 3 h was tested. TLC monitoring showed complete 
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conversion of the educt after 3 h. Furthermore, the mass spectrometric analysis indicated a 
partial conversion to the reduced product. Therefore, this reaction was carried out in 




Scheme 4.5 Pd(0)-catalysed hydrogenation of aromatic aldehyde group.[285] 
The deprotected o-hydroxybenzaldehyde 23 and the cyanomethyl compound 24 reacted by 
a KNOEVENAGEL condensation to 8 (see Scheme 4.6).
[283,284]
 This reaction works in a wide 




 23  8  
Scheme 4.6 Synthetic rout for the methyl protected Ca2+-sensor 8 in a KNOEVENAGEL condensation.
[283,284,286–288] 
The protected product 8 was used to test the range of the modifiability based on nitrogen 
substitution (see Scheme 4.1 and Scheme 4.7).
[37]
 This literature known nitrogen 
substitution modification of 8 (BIIC) was performed with the hydrochloride salt of 
dodecylamine.
[37]
 Due to this, for further modifications the hydrochloride salts of the 
reactant were used as well. On the basis of the tentative idea to address the -NH2 group of 
lysine or the -SH group of cysteine side chains, various sensor modifications were tested 
(see Scheme 4.7). The attachment of disulfide bridge forming molecules, like (S)-2-
pyridylthio cysteamine hydrochloride 25 and 2,2'-dithiobis(ethylamine) dihydrochloride 
26, permitted it to equipped the Ca
2+
-sensor 8 -SH selective functionalities.
[116]
 The thiol 
selective maleimide group also provided a motif frequently used in the literature for 
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27 = pyridine 











Scheme 4.7 Different modification of 8 by nitrogen substitution. 
For application of -NH2 groups as target functionality, a modification with -alanine 
hydrochloride 29 was tested. This modification allows among others, the usage of SPPS 
coupling methods.
[289]
 The successful conversion of the products 27, 28 and 32 were 
detected by mass spectrometry and the structures are shown in Scheme 4.7. The poor 
solubility in various solvents of N-(2-aminoethyl)maleimide hydrochloride 31 can lead to 
no reaction with 8. However, these results indicate the broad modification potential of the 
presented Ca
2+
-sensor basic structure. In order to use the sensor in the Fmoc based SPPS, 
the functionalisation with -alanine was investigated in the following. 
Synthesis and modification of acid-labile Ca
2+
-sensors based on BAPTA and 
incorporation by SPPS to a water soluble -peptide 
The functionalisation of 30 with -alanine provides the carboxylic acid, which is required 
in the SPPS. However, the methyl protecting groups are not suitable for the Fmoc based 
SPPS, thus a synthesis route with tert-butyl groups was developed.
[290]
 The conversion of 
19 with tert-butyl bromoacetate 33 enabled this synthesis and an overview of the synthesis 
is given in Scheme 4.8. The acid-labile protecting group tert-butyl was stable to the 
analogous synthesis conditions of the methyl protected derivate. As fluorophore, 
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change was made to prevent interactions of the activated carboxylic acid during the SPPS 
with the NH group of the fluorophore. 
 
 19 33 35  
 
 37  36  
 
 6  38  
Scheme 4.8 Synthetic overview for the tert-butyl protected Ca2+-sensor 38. 
Iminocoumarin is known to show instability in acidic aqueous systems by hydrolysis 
(Scheme 4.9).
[283,288]
 Therefore, the stability of 38 was analysed in HPLC mixture of H2O 
and organic solvent (MeOH or ACN) in a 50:50 ratio with 0.1 % TFA. In addition, a 50:50 
ratio of H2O and ACN together with 1 M TEAA buffer (pH 7.0) was tested. Each mixture 
was shaken for 1 h at RT or 60 °C, respectively. The solvent was subsequently lyophilised 
and the sample was examined by mass spectrometry. In the solvent mixture H2O/MeOH + 
34 
29 
4 Transmembrane β-peptides as anchor for near-membrane ion-sensors to study the concentration 





0.1 % TFA and H2O/ACN + TEAA at 60 °C mass spectrometric analysis have shown a 
conversion of the tert-butyl protected Ca
2+
-sensor 38 to the hydrolysed side product shown 
in Scheme 4.9. 
 
Scheme 4.9 Mechanism of the acid catalysed hydrolysation of the tert-butyl protected Ca2+-sensor 38.[283] 
Regarding the stability in acidified aqueous solution at RT and previous results of 
fluorescein, different SPPS coupling conditions for 38 were tested. The fluorophore 38 
(3.00 eq), PyAOP (6.00 eq) and HOAt (3.00 eq) were dissolved in DMF (15 mL/mmol 
based on resin-bound peptide) and DIPEA (6.00 eq) was added subsequently in three 
fractions to decrease heat development. This reaction mixture was added to the resin and if 
required DMF was added until the resin was completely covered with organic solvent. The 
fluorophore was coupled microwave-supported for 2 h to the resin-bound peptide (20 W, 
2 h, 65 °C (up to 10 °C overshoot)). Because of the longer coupling time and the unknown 
efficiency of the reaction, PyAOP was used instead of HATU. The phosphonium salt 
PyAOP shows in contrast to the uronium salt HATU, no deactivation of a free N-terminus 
by guanidinylation.
[291,292]
 To perform the first characterisations of the peptide-bound 
Ca
2+









-hLys) was used. This sequence allowed the observation of the 
peptide-bound Ca
2+
-sensor Pep 18 in aqueous medium without peptide aggregation or 
lipid-peptide interactions. 
 
 Pep 18  
Figure 4.34 Sequence of peptide Pep 18. 
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The peptide was cleaved from the resin with TFA/TIS (95:5) after the 
microwave-supported SPPS. A water free cleavage solution was used because water 
mediated the conversion of iminocoumarin to coumarin (see Scheme 4.9). The cleaved 
peptide was analysed by HPLC followed by mass spectrometric analysis. For this, the 
dried crude peptide was dissolved in water and examined with a gradient 30→100 % B (A: 
H2O + 0.1 % TFA and B: MeOH + 0.1 % TFA). The HPLC chromatogram (see Figure 
4.35) displays two intense peaks at tR = 15.9 min and 16.8 min, which appear at the peptide 
bond specific wavelength 215 nm and at the fluorophore specific wavelength 480 nm. 





















































Figure 4.35 HPLC chromatogram of the crude peptide Pep 18. Absorption was recorded at 215 nm and 480 nm. 
Analytical HPLC was performed using a gradient 30→100 % B (A: H2O + 0.1 % TFA and B: MeOH + 
0.1 % TFA) in 30 min, flow 1.0 mL/min and 25 °C. The sample was dissolved in 100 % H2O. 
MS analysis of the two signals (see Figure 4.36) revealed that the peak at tR = 15.9 min is 
the desired product with a mass of 1512.8 g/mol and the peak at tR = 16.8 min has a 
decreased mass of 1454.8 g/mol [M-2C2H2O].  
a) b) 


























 = 15.9 min
M = 1512.8 g/mol
 


























 = 16.8 min
M = 1454.8 m/z
 
Figure 4.36 ESI mass spectra of Pep 18 at a) tR = 15.9 min and b) tR = 16.8 min. 
This mass difference can be explained by a defunctionalisation of the chelating carboxylic 
acids due to the cleavage process of the peptide from the resin. Pep 19 does not show this 
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defunctionalisation, why it is assumed that at the non-fluorescent aniline of the sensor (see 
Scheme 4.10 highlighted in blue) the side reaction occurred. This effect could not be 
observed at the peptide-bound MOBHA-based Ca
2+
-sensor Pep 19. 
 
Scheme 4.10 Assumed defunctionalisation of Pep 18 during the cleavage of the resin. 
The HPLC data revealed that besides the target product and a defunctionalised peptide, no 
further side effects can be observed. The conversion of iminocoumarin to coumarin, shown 
below in Scheme 4.9, could not be observed. 
Following the successful synthesis of Pep 18 by SPPS, the different spectroscopic 
properties were investigated. As described in Chapter 4.2.3, the sensor presented here is a 
ratiometric sensor. The UV/Vis absorption spectra show a change in the absorption band 
with increasing Ca
2+
 concentration. In Figure 4.37, the absorption curve of Pep 18 is 
depicted for 0 µM Ca
2+
 and for 1 mM Ca
2+
. Therefore, an approximate consistent amount of 
Pep 18 in Zero Free Ca
2+
 buffer (10 mM K2EGTA, 100 mM KCl, 30 mM MOPS, pH 7.2) 
from INVITROGEN (Carlsbad, USA) and the same amount of Pep 18 in a 1 mM Ca
2+
 buffer 
(1 mM CaCl2, 100 mM KCl, 30 mM MOPS, pH 7.2) was used. At a concentration of 0 µM, 
the absorption maximum is shown at 496 nm and at a Ca
2+
 concentration of 1 mM, two 
maxima are found at 416 nm and 491 nm. These can be clearly assigned to the fluorophore 
and indicates a Ca
2+
 dependency (see Chapter 4.2.3). In addition, the normalised excitation 
spectra of Pep 18 are given in Figure 4.37. Thus, the emission intensities at Em = 544 nm 
were recorded during a Ca
2+ 
titration. Due to variations of the sensor concentration during 
the titration, a normalisation of the data was performed. Therefore, the excitation at 
Ex = 300 nm was used as Fmin and Fmax was taken out of the recorded excitation spectra. 
Although, the excitation spectra are comparable to the absorption spectra, the quality of the 
data hindered a precise determination of the maxima. 
4 Transmembrane β-peptides as anchor for near-membrane ion-sensors to study the concentration 











 Pep 18 in 0 mM  Ca
2+
 buffer


































































Figure 4.37 a) UV/Vis absorption spectra of Pep 18 in Zero Free Ca2+ buffer (10 mM K2EGTA, 100 mM KCl, 
30 mM MOPS, pH 7.2, black curve) from INVITROGEN (Carlsbad, USA) and in a 1 mM Ca2+ buffer (1 mM CaCl2, 
100 mM KCl, 30 mM MOPS, pH 7.2, red curve) (T = RT). b) Excitation spectra of Pep 18 were recorded during a 
Ca2+ titration. The normalised emission intensities at Em = 544 nm were plotted against the excitation 
wavelengths. 
The investigation of the Ca
2+
 dependent fluorescence of Pep 18 was carried out using a 
measuring kit with a range of 0 µM to 39 µM free Ca
2+
 (see Table 6.9 in Chapter 6.3) and 
two buffers were prepared with certain quantities of CaCl2 (100.0 µM or 2000.0 µM CaCl2, 
100 mM KCl, 30 mM MOPS, pH 7.2). For this purpose, the fluorescence was measured at 
an emission of 544 nm and the extinction was carried out at 416 nm and 496 nm. The ratio 
       
              
       with a presumed amount of fluorophore (~2 µM) as a function of the free 
Ca
2+
 concentration results in the graph shown in Figure 4.38. The exact concentration of 
the peptide could not be determined because the extinction coefficient given in the 
literature relate to a derivative of the used Ca
2+
-sensor. Changes due to the modification 
and the attachment to a peptide were excluded, which is, however, negligible because of 
the ratiometric consideration. 
a) b) 
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Figure 4.38 a) Plot of R =        
              
       versus different cfree (Ca
2+) determined by a Ca2+ titration of Pep 18. b) 
Linearisation of the Ca2+ titration of Pep 18. The graph of log(R-Rmin)/(Rmax-R) versus log cfree (Ca
2+) was plotted 
and a linear fit was performed in the range of 1.99 µM to 39.0 µM free Ca2+. As Rmin the ratio of 0 µM Ca
2+ was 
used and as Rmax the ratio at 2000.0 µM free Ca
2+. 
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The dissociation constant (Kd) was determined by the linearisation of the measurements 
which is shown in Figure 4.38. This application resulted in a value of 12.0 µM for the Kd of 
Pep 18. 
The selectivity of the peptide-bound sensor Pep 18 towards Ca
2+










 is of interest because it occurs in increased 
concentrations in the cytoplasm.
[293]
 The following measurements were performed in 
EGTA free buffer (100 mM KCl, 30 mM MOPS, pH 7.2) and the metal ion adjustment was 
performed by adding a certain volume of a 0.5 M aqueous solution of the respective metal 
ion. The individual emission maxima (       
       and        
      ) were measured and the 
resulting fluorescence ratio        
              
       was calculated. As a reference point for the 
ratio        
              
      , a presumed amount (~2 µM) of Pep 18 in EGTA free buffer 
(100 mM KCl, 30 mM MOPS, pH 7.2) was used (       
             




























































































































































Figure 4.39 a) Fluorescence intensity of a constant amount Pep 18 in solutions with different ion concentration of 
Ca2+, Mg2+ and Zn2+ (n = 3). b) Calculated fluorescence ratio        
              
       based on the measured fluorescence 
intensities. The reference point for the ratio        
              
       was determined by Pep 18 in EGTA free buffer 
(100 mM KCl, 30 mM MOPS, pH 7.2). 
The variance of the reference point of Pep 18 in EGTA free buffer (100 mM KCl, 30 mM 
MOPS, pH 7.2) was compared to Pep 18 in a Zero Free Ca
2+
 buffer (10 mM K2EGTA, 
100 mM KCl, 30 mM MOPS, pH 7.2). Here, a decrease in these        
              
       ratios of 
0.62 was observed. This suggests that despite HPLC purification, cations were bound to 






) were tested and an influence on the 
selectivity measurements was not considered. This assumption is supported by a different 
change in the ratio by the addition of 100 µM Ca
2+
 and 100 µM Mg
2+
 to Pep 18. An 
increase of the fluorescence ratio of 0.50 was observed after adding 100 μM Ca
2+
 and a 
decrease of 0.06 after adding 100 μM Mg
2+
. The ratio change after adding 100 µM Mg
2+
 is 
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in the range of the error of the measurements (n = 3). A similar behaviour was observed 
after adding 2000 μM Ca
2+
 and 2000 μM Mg
2+
 to Pep 18 in EGTA free buffer. In contrast, 
the addition of Zn
2+
 (100 µM and 2000 µM) to Pep 18 shows a strong increase in the 
fluorescence wavelength intensity (see Figure 4.39 a) and a strong increase of the ratio 
       
              
       (see Figure 4.39 b). 







quenching influence of ions was investigated. Studies with Fura-2 showed quenching by 








 It is assumed that the paramagnetism of the ions 
induces a intersystem crossing, which lead to a decrease in the fluorescence. However, the 
quenching behaviour of different Ni
2+
concentration towards Pep 18 in EGTA free buffer 
(100 mM KCl, 30 mM MOPS, pH 7.2) is shown in Figure 4.40. Therefore, similar to the 
selectivity measurements the following quenching measurements was performed in EGTA 
free buffer (100 mM KCl, 30 mM MOPS, pH 7.2) and by adding a certain volume of a 
0.5 M aqueous solution of NiCl2. 






























































































Figure 4.40 Exemplary presentation of the quenching effect of Ni2+ on Pep 18. The fluorescence intensity        
       
(black bars) and        
       (red bars) and the fluorescence ratio        
              
       (blue values) is plotted against 
different Ni2+ concentrations. 
The peptide Pep 18 showed a decrease in the fluorescence intensities        
       and        
       
with increasing Ni
2+
concentrations. The        
              
       ratio does not differ after the first 
Ni
2+







 Pep 18 was tested (see Figure 4.41). Therefore, a solution of Pep 18 
in EGTA free buffer (100 mM KCl, 30 mM MOPS, pH 7.2) was mixed with 0.5 M aqueous 
solution of the respective metal ion. For the measurement the fluorescence intensities 
       
       and        
       were recorded each 3 s and after 300 s the metal ion was added (see 
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Figure 4.41 a). Additionally, the fluorescence ratio        
              
       was calculated, which 
is shown in Figure 4.41 b). 
a) b) 
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Figure 4.41 a) Measurement of the fluorescence intensity        
       of Pep 18 in EGTA free buffer (100 mM KCl, 
30 mM MOPS, pH 7.2) and after 300 s 5.0 mM of Co2+, Ni2+ or Mn2+ was added. b) Calculated fluorescence ratio 
       
              
       of the partially in a) shown data.  
It was found that all of the ions show a quenching effect at a concentration of 5.0 mM at 
Pep 18. In Table 4.4 the percentage fluorescence decrease of Pep 18 at        
       and 
       
       after the addition (801 s) is shown and as 100 % the fluorescence intensities before 
the ion addition (294 s) was chosen. Additionally, the fluorescence ratio        
              
       
was calculated. It is noticeable that the quenching effect is not of equal amount for both 
wavelengths. This may be due to the mentioned effect of previous ion binding at Pep 18 
(Figure 4.39). Nevertheless, a clear quenching effect can be seen, for example with a 
residual fluorescence of 5 % after the addition of 5.0 mM Ni
2+





 the fluorescence ratio        
              
       shows no immediate stabilisation after the 
Ni
2+
 addition and only after 200 s such a stabilisation can be observed. 
Table 4.4 Percentage fluorescence decrease of Pep 18 in EGTA free buffer (100 mM KCl, 30 mM MOPS, pH 7.2) at 
       
       and        
       after the addition (801 s) and the calculated fluorescence ratio        
              
       before (294 s) 
and after (801 s) the ion addition. 
        
       [%]        
      [%] 
       
              
       
294 s          801 s 
Ni
2+
 3.28 5.37 0.841 0.515 
Mn
2+
 21.9 43.6 0.941 0.474 
Co
2+
 6.73 14.7 0.771 0.352 
 
In summary, the successful incorporation of a Ca
2+
-sensor into a -peptide could be 
performed by SPPS. This water soluble peptide showed a Kd of 12.0 µM for Ca
2+
 and a 
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 selectivity in the presence of Mg
2+
. Moreover, it is possible to extinguish the 







Synthesis and modification of an acid-labile Ca
2+
-sensor based on MOBHA and 
incorporation by SPPS to a water soluble -peptide 
The sensor developed above shows a high Kd value compared to other known sensors (see 
Figure 4.31). However, the Ca
2+
 concentration close to membrane can be much higher (see 
Chapter 4.2.2). Therefore, the development of less affine sensors is necessary and a 
Ca
2+
-sensor comparable to 38 was synthesised based on the MOBHA chelator. This 
synthesis was inspired by the Ca
2+








Kd = 50 – 100 µM 
 
Figure 4.42 Chemical structure and Kd of Calcium Green FLAsH. 
In order to obtain a Ca
2+
-sensor with a MOBHA-based chelator, the phenolic alcohol of 12 
was deprotonated with K2CO3, followed by a nucleophilic substitution reaction with 
methyl bromoacetate to yield compound 39. Analogous to the BAPTA-based Ca
2+
-sensors, 
the nitro compound 39 was converted to the cycloamide compound 40 by BÉCHAMP 




 12 20  39  40  
Scheme 4.11 Synthetic rout for the preparation of the protected amide 40. 
In contrast to the diamine compound 19 (see Chapter 4.2.5), a ring closing reaction 
occurred in the BÉCHAMP reduction of compound 39.
[279,281,294,295]
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The amide compound 40 was protected with di-tert-butyl dicarbonate to obtain the Boc-
protected product 41. In a ring opening reaction with morpholine 28, isobutly 
chloroformate and triethylamine the Boc-protected aniline 42 was obtained (see Scheme 
4.12). 
 
 40   41 28 42  
Scheme 4.12 Synthetic for the Boc-protected aniline 42. 
The Boc-deprotection of 42 was performed with TFA, H2O and TIS as well as the 
subsequent reaction with tert-butyl bromoacetate gave product 43 and the following 
syntheses were analogous to 35 – 38 (seeScheme 4.13). An aldehyde group was introduced 
to the tert-butyl protected compound 43 with POCl3 and pyridine in DMF to yield the 
product 44. Subsequently, a Pd catalysed debenzylation, of 43 was performed to obtain the 
o-hydroxybenzaldehyde 45. Afterwards, the o-hydroxybenzaldehyde 45 was converted 





 The functionalisation of 7 was carried out 
by a nitrogen substitution with -alanine hydrochloride 29 (see Scheme 4.13). 
 
 42   43  44  
 
 46   7   45  
Scheme 4.13 Synthetic overview for the tert-butyl protected Ca2+-sensor 46 starting from the Boc-protected aniline 
42. 
34 29 
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Analogous to 38, the first characterisation of the peptide-bound Ca
2+
-sensor 46 was 




-hLys (see Figure 4.43). This 
sequence allowed the observation of the peptide-bound Ca
2+
-sensor Pep 19 in aqueous 
medium without peptide aggregation or lipid-peptide interactions. Inspired by coupling 
conditions of the acid-labile Ca
2+
-sensor 38, the fluorophore 46 was coupled 
microwave-supported with PyAOP/HOAt/DIPEA. Therefore, the fluorophore (5.00 eq), 
PyAOP (10.00 eq) and HOAt (5.00 eq) was dissolved in DMF (15 mL/mmol based on 
resin-bound peptide) and subsequently DIPEA (15.00 eq) was added in three fractions to 
decrease heat development. This reaction mixture was added to the resin and if required 
DMF was added until the resin was completely covered with organic solvent. The 
fluorophore was coupled microwave-supported for 2 h to the resin-bound peptide (20 W, 
2 h, 65 °C (up to 10 °C overshoot).  
 
 Pep 19  
Figure 4.43 Sequence of peptide Pep 19. 
Subsequent to the microwave-supported SPPS, the peptide was cleaved off with TFA/TIS 
(95:5) equally to Pep 18. This cleavage mixture was used to prevent a conversion of 
iminocoumarin to coumarin by water (see Scheme 4.9). The cleaved peptide was analysed 
by HPLC followed by mass spectrometric analysis. For this, the dried crude peptide was 
dissolved in water and examined with a gradient 30→100 % B (A: H2O + 0.1 % TFA and 
B: MeOH + 0.1 % TFA). The HPLC chromatogram (see Figure 4.44) displays one peak 
with a retention time tR = 14.2 min with an increasing absorption at 215 nm, which is the 
specific wavelength of the peptide bond, and an increasing absorption at 480 nm, which is 
the specific wavelength of the fluorophore. 
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Figure 4.44 a) HPLC chromatogram of the crude peptide Pep 19. Absorption was recorded at 215 nm and 480 nm. 
Analytical HPLC was performed using a gradient 30→100 % B (A: H2O + 0.1 % TFA and B: MeOH + 
0.1 % TFA) in 30 min, flow 1.0 mL/min and 25 °C. The sample was dissolved in 100 % H2O. b) ESI mass spectra 
of Pep 19 at tR = 14.2 min. 
MS analysis of the signal (see Figure 4.44) revealed in the peak at tR = 14.2 min is the 
desired product with a mass of 1388.8 g/mol. In contrast to Pep 18 no signal with a 
decreased mass by 58 m/z was observed. 
Following the successful synthesis of Pep 19 by SPPS, the different spectroscopic 
properties were investigated. As described in Chapter 4.2.3, the sensor presented here is a 
ratiometric sensor. The UV/Vis spectrum shows a change in the absorption band with 
increasing Ca
2+
 concentration. In Figure 4.45, the absorption curve of Pep 19 is depicted 
for 0 µM Ca and for 1 mM Ca
2+
. Therefore, a consistent amount of Pep 19 in Zero Free 
Ca
2+
 buffer (10 mM EGTA, 100 mM KCl, 30 mM MOPS, pH 7.2) and in a 500 mM Ca
2+
 





0,6  Pep 19 in 0 mM Ca
2+
 buffer


















Figure 4.45 UV/Vis absorption spectra of Pep 19 in Zero Free Ca2+ buffer (10 mM K2EGTA, 100 mM KCl, 30 mM 
MOPS, pH 7.2, black curve) from INVITROGEN (Carlsbad, USA) and in a 500 mM Ca2+ buffer (500 mM CaCl2, 
100 mM KCl, 30 mM MOPS, pH 7.2, red curve) (T = RT). 
At a concentration of 0 µM, the absorption maximum is shown at 489 nm and at a Ca
2+
 
concentration of 500 mM two maxima are found at 404 nm and 490 nm (normalised 
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absorption spectra in Appendix C). The investigation of the Ca
2+
 dependent fluorescence 
of Pep 19 (~15 µM) was carried out with a measuring kit with a range of 0 µM to 39 µM 
free Ca
2+
 (see Table 6.9 in Chapter 6.3) and with prepared buffers with certain quantities of 
CaCl2 (0.0156 – 1000 mM CaCl2, 100 mM KCl, 30 mM MOPS, pH 7.2). For this purpose, 
the fluorescence was measured at an emission of 539 nm and the extinction was carried out 
at 405 nm or 488 nm based on the maxima in the normalised absorption. The ratio 
       
              
       with a presumed amount of fluorophore (~15 µM) as a function of the free 
Ca
2+
 concentration results in the graph shown in Figure 4.46. The exact concentration of 
the peptide could not be determined because the extinction coefficient given in the 
literature relates to a derivative of the used Ca
2+
-sensor. Changes due to the modification 
and attachment to a peptide were excluded, which is, however, negligible because of the 
ratiometric consideration. 




































Figure 4.46 Plot of R =        
              
       versus different cfree (Ca
2+) determined by a Ca2+ titration of Pep 19. 
In contrast to the Pep 18 Ca
2+
 titration, no complete saturation of Pep 19 was observed 
with the prepared buffer. Due to this result, the determination of dissociation constant (Kd) 





) was not tested. Additionally, the exact Ca
2+
 concentration of 
the used buffers were not determined after preparation, for example by a Ca
2+
 electrode. 
Due to this, the concentration showed no comparable accuracy compared to the EGTA 
buffered system. Before further studies will be performed, a suitable method for 
identifying the Ca
2+
 concentration has needs to be found.  






 binding behaviour of the SPPS-compatible Ca
2+
-sensors 38 and 46 leads 
to further usage of 38, although in the analyses of Pep 18 side products were observed. 
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-sensor 38 was coupled to the transmembrane unit developed by ROST 
(see Figure 4.47).
[11,38]
 Analogous to the coupling conditions described in Chapter 4.1.4, 
the fluorophore 38 (3.00 eq), PyAOP (6.00 eq) and HOAt (3.00 eq) were dissolved in 
DMF (15 mL/mmol based on resin-bound peptide) and DIPEA (6.00 eq) was added 
subsequently in three fractions to decrease heat development. This reaction mixture was 
added to the resin and DMF was added if required until the resin was completely covered 
with organic solvent. The fluorophore was coupled microwave-supported for 2 h to the 
resin-bound peptide (20 W, 2 h, 65 °C (up to 10 °C overshoot). 
 
 Pep 20  
Figure 4.47 Sequence of peptide Pep 20. 
The cleaved Pep 20 (TFA/TIS (95:5)) was freshly dissolved for each HPLC run in HFIP 
and examined with a gradient 90→100 % B (A: H2O + 0.1 % TFA + 0.1 % HFIP and B: 
MeOH + 0.1 % TFA+ 0.1 % HFIP). Contrary to other HPLC purification of hydrophobic 
transmembrane units at elevated temperature (Pep 13, Pep 14), the purification of Pep 20 
was performed at RT. Elevated temperatures facilitate the hydrolysis of iminocoumarin to 
coumarin.
[283]
 In Figure 4.48 the HPLC chromatogram of Pep 20 with a high peak at 
tR = 14.4 min is shown.  
a) b) 


































































































Figure 4.48 Absorption was recorded at 215 nm and 480 nm. a) Preparative HPLC was performed using a 
gradient 90→100 % B (A: H2O + 0.1 % TFA + 0.1 % HFIP and B: MeOH + 0.1 % TFA+ 0.1 % HFIP) in 30 min, 
flow 10.0 mL/min and RT. The sample was freshly dissolved in 100 % HFIP. b) Zoom of the HPLC 
chromatogram in a range of 10 min to 20 min. The recorded peak at tR = 14.4 appears as a symmetric peak. 
The main peak was collected in two different fractions from 13.8 min – 14.4 min (fraction 
A) and from 14.4 min – 15.0 min (fraction B). The resulting mass spectrometric analyses 
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are given in Figure 4.49. In the spectrometric data of the collected fraction A, the target 
peptide Pep 20, the defunctionalised peptide-bound Ca
2+
-sensor (see Scheme 4.10) and the 
transmembrane unit with an attached -alanine was found.  
a) b) 
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Figure 4.49 Deconvoluted ESI mass spectra of Pep 20 at tR = 14.4 min. The peak was separately collected in a 
range of a) 13.8 min – 14.4 min and b) 14.4 min – 15.0 min. 
In previous studies of Pep 18 and Pep 19 in this work, the cleavage of the peptide and the 
attached Ca
2+
-sensor was not observed. This side product can be formed by the conversion 
of the iminocoumarin to coumarin (see Scheme 4.14). This mechanism leads to the 
elongation of the transmembrane unit by the -alanine linker of the sensor [M-Ca
2+
-sensor 
10]. Compared with Pep 18, the reason for the side product origin is unclear. In the 
collected fraction B multiple signals which cannot be allocated are seen. 
 
Scheme 4.14 Formation of the transmembrane unit elongated by -alanine seen in mass spectrometric 
analyses.[283] 
Nevertheless, in the fraction A the target product was clearly identified. This allows the 
usage of a transmembrane -peptide functionalised with a Ca
2+
-sensor in further studies, 
whereby the negligibility of the both side products has to be clarified. 
4.2.6 Conclusion and outlook 
Cellular Ca
2+
 concentration plays an important role in many processes in the cell, 
especially for the transmission of nerve signals (see Chapter 4.2.1). Probes for examining 
this Ca
2+
 concentration are the basis for the influence of Ca
2+
 in biological processes. 
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 The functionalisation with -alanine enabled it to apply the 
Ca
2+
-sensors 38 and 46 in microwave-supported SPPS. Comparable with the literature 
known Ca
2+
-sensors BIIC and BTIC, the reaction yields were similar.
[37,278,279]
 As an 
exception, the reduction with Fe and Pd/C did not achieve the expected 
controllability.
[37,278]
 In the Fe mediated reduction, the product was completely 
decomposed several times. Therefore, consideration should be given to other conditions 
such as Se based reductions.
[296]
 To obtain high yields in the Pd/C mediated reduction, it is 
necessary to monitor the reactions conditions and the reaction time. Based on the 
successful synthesis of the unmodified Ca
2+
-sensors 8, it was possible to incorporate 
differed functional groups that can be used as attachment point for peptides (-NH2 and -SH 
groups). The attachment of -alanine to 8 enabled the development and synthesis of the 
BAPTA-based Ca
2+
-sensors 38 and MOBHA-based 46. Therefore, the tert-butyl protected 
Ca
2+
-sensor derivates were used to combine the Ca
2+
-sensor with the Fmoc-based 
SPPS.
[297,298]
 Apart from the literature known fluorophores, no variation was performed. 
However, varying the fluorophore can also provide a wide range of modification.
[37,278]
 In 
Figure 4.50 an overview of the different modification positions is given. 
 
Figure 4.50 Overview of the variation possibility in the used iminocoumarin system.  
The modifications shown in this work were established in known synthesis routes, in 
particular the attachment of the fluorophore and the attachment point for functional groups. 
This modifiability was possible because the fluorophore and the attachment point were 
incorporated in the last synthesis steps with little synthetic effort.  
The Ca
2+
-sensors (38, 46) were coupled to a hydrophilic -peptide motif, which resulted in 
two peptides (Pep 18, Pep 19). Despite the liability of the iminocoumarin basic structure, 
these peptides have shown no formation of coumarin in the cleavage mixture and the 
HPLC solvents at RT. However, Pep 18 showed a partial decomposition, which was 
= Recognition unit 
= Attachment point 
= Fluorophore 
= PG 
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suggested as the release of a chelating carboxylic acid from the BAPTA unit. In contrast to 
the hydrophilic peptide, the coumarin formation was observed in mass spectrometric 
analyses of Pep 20, which is the -peptide transmembrane unit developed by ROST 




 Nevertheless, the results received in ion 
titration showed that the BAPTA-based Ca
2+
-sensor 38 is a good design for upcoming 
Ca
2+
-sensors in peptide chemistry and in biomolecular systems. The MOBHA-based 
Ca
2+
-sensor 46 in Pep 19 showed a higher stability during the peptide cleavage compared 
to Pep 18. Additionally, the Kd of Pep 19 is estimated higher than the measured Kd of 
Pep 18. However, further studies have to be performed with verified Ca
2+
 concentration, 
for example by a Ca
2+





-sensor offers a wide range of applications, but does not show the 
modifiability of the BAPTA motif. Despite, the small number of amino acids and the 
attachment of the Ca
2+
-sensors, the -peptides Pep 18 and Pep 19 show a 14-helix (see 
Appendix C). 
The transmembrane -peptide based Pep 20 can enable the observation of near-membrane 
Ca
2+
 concentration and can help to find out the Ca
2+
 distribution in the electrostatic double 
layer. SINN et al. postulated, based on measurements with ion selective electrodes and 
isothermal titration calorimetry (ITC), that the Ca
2+
 binding is regardless of the lipid 
type.
[299]
 The formal higher Ca
2+
 binding on negative charged membranes depends on the 
electrostatic enrichment in the electrostatic double layer.
[299]
 Therefore, first measurements 
with Pep 20 were performed in DOPC and DOPC/DOPS (90:10) vesicles (100 nm) and a 
P/L ratio of 1:1000 in Ca
2+
 free or Ca
2+
 buffer (162 mM sucrose, 10 mM HEPSE, pH 7.2 
(adjust with free base arginine), optional with 2 mM CaCl2).
[299–301]
 However, unspecific 
changes in the fluorescence were observed, which were not connected to the peptide-bound 
sensor, but the reason is unclear so far. Therefore, experiments with buffered Ca
2+
 
concentration were performed. According to SCHWAMBORN, LUV with Pep 20 was 
prepared with a lipid composition of DOPC/biotin-cap-DOPE (99.6:0.4) and a P/L ratio of 
1:200.
[30,203]
 One probe of LUV was prepared with Zero Free Ca
2+
 buffer (10 mM 
K2EGTA, 100 mM KCl, 30 mM MOPS, pH 7.2) whereas the other one was prepared with 
39 μM Free Ca
2+
 buffer (10 mM CaEGTA, 100 mM KCl, 30 mM MOPS, pH 7.2). Both 
vesicle types were immobilised according to SCHWAMBORN, excited by two lasers (405 nm 
and 488 nm) and detected in a range of 505 nm – 602 nm.
[30,203]
 However, the vesicles 
prepared in Zero Free Ca
2+
 buffer showed compared to the LUV prepared in 39 μM Free 
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 buffer a intensive fluorescence. The LUV prepared with Zero Free Ca
2+
 buffer 
showed aggregation effects on the functionalised surface, but nevertheless, a localisation of 
the peptide to the vesicles is assumed (see Figure 4.51). With the same probes fluorescence 
measurements were performed according to the measurements of Pep 18 and Pep 19. 
These measurements showed a change in the fluorescence ratio        
              
       (0 µM 
Ca
2+
 = 0.84; 39µM = 1.41) and a shift of the fluorescence maxima from ~544 nm (Pep 18) 
to ~530 nm (Pep 20, average maximum values of 0 µM and 39 µM free Ca
2+
). The 
possibilities of -peptide anchored Ca
2+










   0 µM (416 nm)
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 39 µM (416 nm)

















Figure 4.51 a) Fluorecence micrograph of immobilized proteoliposomes (DOPC/biotin-cap-DOPE (99.6:0.4); P/L 
ratio of 1:200).
[30,203]
 LUV was prepared in Zero Free Ca2+ buffer (10 mM K2EGTA, 100 mM KCl, 30 mM MOPS, 
pH 7.2) and the detection was performed in a range of 505 nm – 602 nm (ex. = 405 nm and 488 nm). b) 
Fluorescence spectra of LUV prepared in Zero Free Ca2+ buffer (10 mM K2EGTA, 100 mM KCl, 30 mM MOPS, 
pH 7.2) and in 39 μM Free Ca2+ buffer (10 mM CaEGTA, 100 mM KCl, 30 mM MOPS, pH 7.2). 
In future studies, new applications for the developed system and new design approaches 
for Ca
2+
-sensors should be examined. The developed Ca
2+
-sensors enable the labelling of 
-peptide membrane anchors, as shown in this work, or additionally the usage of lipids as 
membrane anchors. In addition to the above described Ca
2+
/membrane interaction, the Ca
2+
 
movement across the surface can be interesting for cellular processes. Inspired by the 
experimental setup of the POHL group (see Chapter 4.1.5) a caged Ca
2+
 can be incorporated 
into the membrane and released by photoinduced cleavage. This system can also be used to 
imitate the influx of a Ca
2+
 channel. Although no membrane anchored caged Ca
2+
 is known 
NP-EGTA and DMNP-EDTA are known water-soluble structures. The modification with 
alkyl chains can be led to a suitable structure for the experimental setup of the POHL group. 
In addition, a new design approach for the Ca
2+
-sensors can lead to an improvement of the 
sensor properties. Modification of the BAPTA unit enables the adjustment of the 
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-sensor Kd value. GEE et al. were able to manipulate the Kd of Fluo-4 (0.345 µM) by 
exchanging a methyl substituent with fluorine atom (Fluo-5F, 2.3 µM) or nitro group 
(Fluo-5N, 90 µM).
[302]
 In addition to the configuration of the chelating unit, a modification 
of the fluorophore and the iminocoumarin is possible. In the work of ROUSSAKIS et al.
[297]
 
the synthesis of a near-membrane Ca
2+
-sensor is given based on BIIC (see Figure 4.52).  
 
Figure 4.52 Chemical structure of C12-ICPBC developed by ROUSSAKIS et al.[297] 
The modification developed by ROUSSAKIS et al. shows the conversion of the 3-
(benzimidazolyl)-iminocoumarin (BIIC) to a chromeno[3’,2’:3,4]pyrido[1,2a][1,3]-benz-
imidazole chromophore (ICPBC).
[297]
 The received fluorophore can also be modified by 
nitrogen substitution and does not show the instability against aqueous acid solutions of an 
iminocoumarin. However, ROUBINET et al.
[288]
 had converted an iminocoumarin with 
BF3 × Et2O into an boron(III) iminocoumarin, which is a boron-dipyrromethene (BODIPY) 
analogue. Furthermore, there are other Ca
2+
-sensors, which can be useful in the peptide 
modification. TOUR et al. synthesised Calcium Green FLAsH as a Ca
2+
-sensor with a Kd of 
50 – 100 µM and a bis-ARSenic fluorescein.
[269]
 This sensor has shown a self-labelling at a 
tetracysteine tag.
[118,269]
 CALDWELL et al. synthesised also a low affinity ratiometric Ca
2+
 
(NitroAzidoFuraRed) which was modified with an azide group. Based on this 
modification, it was possible to label a N-terminal modified protected amino acid with 
NitroAzidoFuraRed by copper-catalysed azide-alkyne cycloaddition.
[279]
 The synthesised 
o-hydroxybenzaldehyde in the presented work could be used for the synthesis of 
NitroAzidoFuraRed derivates, which lead to an alternative of the iminocoumarin system 
for peptide labelling Ca
2+
-sensors. 
However, the presented Ca
2+
-sensors 38 and 46 show possible structures for the 
establishment of Ca
2+
-sensors in SPPS and a wide range of application in biochemical 







A variety of cellular key processes is performed by peptides or proteins, which are 
localised at the cell membrane.
[1]
 The properties and the functions of such biomolecules are 
very complex, for this reason peptidomimetics were developed.
[6]
 Among other things, 




In the present work -peptides were synthesised as peptidomimetics for transmembrane 
helices.
[1,9]
 In addition to the development of automatic SPPS protocols for -peptides, the 
secondary structure of the synthesised -peptides, which is influenced by the choice of 
different amino acids was examined by CD spectroscopy.
[14]
 It was demonstrated that the 
branching of the side chain groups has an influence on the secondary structure, whereby it 
was possible to change a 12-helix (D-β
3





-homovaline) in organic solvents as well as in lipid model 
systems (Pep 1 – Pep 8).
[14]
 Furthermore, forcing a 12-helix into a 14-helix by ring 
structure amino acids (ACHC) was successfully shown (Pep 9, Pep 10).
[14]
 The 
synthesised -peptides were equipped with certain functionalities, which can be classified 
into sensors in the transmembrane region and in sensors in the intercellular region of the 
peptides (see Figure 5.1). On the one hand, the transmembrane sensors should work as 
tools for the observation of the peptide surrounding and the membrane-peptide interaction. 
On the other hand, the intercellular functionalities are sensors, which use the β-peptides as 
a transmembrane anchor and should help to investigate membrane surface processes (see 





-hTrp) enabled it to characterise the surrounding of the peptides with the help of 
tryptophan fluorescence. These measurements showed that an incorporation of the 
synthesised peptides Pep 1 – Pep 10 in the membrane was successful.
[14]
 To determine the 
exact position of the D-β
3
-hTrp in the membrane, tryptophan fluorescence quenching based 
on DOXYL-labelled lipids was performed. The general tendency of the DOXYL based 
measurements is in line with preliminary considerations, although unknown lipid-peptide 









    
Figure 5.1 Overview of the performed functionalisation in this work and the location in the synthesised peptides. 
In addition to fluorescence measurements, IR based spectroscopic methods are widespread 
in the observation of transmembrane peptides.
[166–168]
 Therefore, a potential IR active 
D-β
3
-amino acid was successfully synthesised. SEIRA measurements performed by the 
HILDEBRANDT group showed the peptide incorporation of Pep 11, though the nitrile typical 
vibration band was not observed. However, the developed IR active D-β
3
-amino acid can 
be used in further studies with other measurement setups or other IR active D-β
3
-amino 
acid can be synthesised on the basis of the presented synthesis route. These IR 
measurements are able to unravel further properties of transmembrane β-peptides.  
The stable membrane position of the β-peptide unit, developed by ROST,
[11,38]
 enables the 
anchoring of sensors near the membrane surface. Also, the properties of the β-peptide 
make it possible to serve as molecular rulers for adjusting a defined membrane distance.
[10]
 
This is possible by the extension of the peptide primary sequence. To test this possible 
application field, β-peptides were functionalised with H
+
 (Pep 13, Pep 14) and Ca
2+
 
sensors (Pep 18 – Pep 20). The β-peptides Pep 13 and Pep 14, were labelled with 
carboxyfluorescein to test the pH dependency in different distances to the membrane. 
Some studies presumed that the lipid membrane surface act as H
+
 collector and, 
furthermore, that the H
+
 moves across the membrane.
[186,208]
 Based on fluorescence 
titration no pKa change through the membrane-bounding of carboxyfluorescein, compared 
with literature known pH sensor titrations, was observed.
[31,32]
 Additionally, no significant 






to variable effects, these results may be unclear at the moment. Nevertheless, a pH 
dependency of the labelled transmembrane peptide was observed. In particular the 
interaction of the membrane surface and the peptide will be of interest. Therefore, 




 is one of the most important second messengers and interacts with the membrane 
surface.
[188,243]
 These ion-membrane interactions increase the near-membrane Ca
2+
 
concentration compared to the cellular concentration.
[299]
 A sensor for the near-membrane 
Ca
2+
 concentration has to fulfil certain requirements. On the one hand the Ca
2+
-sensor has 
to be anchored near the membrane and on the other side the Ca
2+
 affinity has to be lower 




 Among others, two SPPS capable 
Ca
2+
-sensor were developed and attached to water-soluble β-peptides and to the 
transmembrane unit, developed by ROST.
[11,38]
 These iminocoumarin-based Ca
2+
-sensors 
38 and 46 were coupled to water-soluble peptides (Pep 18, Pep 19) to determine the 
binding properties without membrane influences. The Ca
2+
-sensor labelled peptide Pep 18 
showed a side product after the cleavage from the resin, which was not observed in Pep 19. 
Despite the low number of amino acids and the attachment of the Ca
2+
-sensors, Pep 18 and 





. Whereas Pep 19 showed a higher stability against the cleavage 
mixture and a lower affinity against Ca
2+
, which will result in a higher Kd. The 
determination of the Kd from Pep 19 was not possible so far, because no buffered system 
can be used and a Ca
2+
 electrode was unavailable. Therefore, 38 was coupled to the 
literature known transmembrane β-peptide unit (Pep 20).
[11,38]
 Here, the incomplete 
purification showed, beside the known side product, an additional side product, which is a 
result of the conversion of iminocoumarin to coumarin.
[283]
 Nevertheless, the peptide 
synthesis was successful and first measurements showed a Ca
2+
 depending fluorescence of 
the peptide mixture incorporated in DOPC/biotin-cap-DOPE LUV.
[30]
 In further research 
projects the application of the synthesised Ca
2+
-sensors and the attachment to 
transmembrane β-peptides has to be studied.  
To summarise, in this work a wide range of β-peptides has been synthesised. These 
synthesised peptides allowed, on the one hand, investigating properties of transmembrane 
β-peptides and on the other hand, investigating functionalised transmembrane β-peptides 






β-peptides provide a variable helix structure which lead to a wide range of design motifs. 
The anchoring of sensors by transmembrane β-peptides to measure near-membrane 
interactions should be subject of further researches and compared with other anchoring 
methods like lipids.  
 





6 Experimental part 
6.1 General  
Solvents  
Technical solvents were partially distilled before use. All other solvents were at the highest 
grade available. Dry solvents were purchased from ACROS ORGANICS (Geel, Belgium) and 
stored over molecular sieves (4 Å). Solvents of analytical or HPLC grade were obtained 
from FLUKA (Taufkirchen, Germany), VWR INTERNATIONAL (Fontenay-sous-Bois, 
France), ACROS ORGANICS (Geel, Belgium) and SIGMA-ALDRICH (Taufkirchen, Germany). 
Ultrapure water was obtained by using a water purification device SIMPLICITY (MILLIPORE, 
Bredford, UK) or ARIUM MINI lab water system by SARTORIUS (Göttingen, Germany). 
Reagent 
All reagents were of highest grade available and used as supplied. Amino acids, coupling 
reagents and resin for solid peptide synthesis were obtained from BACHEM (Bubendorf, 
Swzitzerland), GL BIOCHEM (Shanghai, China), IRIS BIOTECH (Marktredwitz, Germany), 
NOVABIOCHEM (Darmstadt, Germany) or VWR INTERNATIONAL (Fontenay-sous-Bois, 
France). Lipids were purchased from AVANTI POLAR LIPIDS (Alabama, USA). All other 
chemicals were purchased from ABCR (Karlsruhe, Germany), ACROS ORGANICS (Geel, 
Belgium), ALFAR AESAR (Karlsruhe, Germany), APPLICHEM (Darmstadt, Germany), CARL 
ROTH GMBH (Karlsruhe, Germany), FLUKA (Taufkirchen, Germany), FLUOROCHEM 
(Hadfield, UK), GRÜSSING GMBH (Filsum, Germany), MERCK (Darmstadt, Germany), 
RIEDEL-DE HAËN (Seelze, Germany), SIGMA-ALDRICH (Taufkirchen, Germany), TCI 
(Zwijndrecht, Belgium) and VWR INTERNATIONAL (Fontenay-sous-Bois, France). 
Reaction 
Air and/or water sensitive reactions were carried out under argon atmosphere (> 99.9 %) 
using standard SCHLENK technique. The inert gas was conducted through a drying tube and 
was dried over pumice/NaOH/pumice. If necessary, the glass apparatus was heated with a 
heat gun under reduced pressure and flushed with argon (3 ×). Manuel solid phase peptide 
synthesis was carried out in a syringe from Becton DICKINSON (Heidelberg, Deutschland) 
with inserted PE filter. The manual microwave-assisted reaction was performed in a 
DISCOVER microwave reaction cavity (CEM, Kamp-Lintfort, Germany). Here, the listed 
reaction temperature can be up to 10 °C higher than listed. The automatic 
microwave-supported SPPS was performed in a Liberty Blue from CEM. 






The resins, building blocks, synthesised peptides and lipids were stored at –20 °C. The 
chemicals were thawed at RT before use. 
Freeze-drying  
Lyophilisation from water or dioxane solution was performed by using a CHRIST ALPHA-2-
4 LYOPHILIZER (Osterode am Harz, Germany) equipped with a high vacuum pump. For 
probes with a total volume fewer than 2 mL an evacuable CHRIST RVC 2-18 CD plus 
centrifuge was used, which was connected to the lyophilisation device.  
6.2 Chromatography 
 Thin layer chromatography (TLC) 
Analytic TLC was performed on MERCK (Darmstadt, Germany) coated aluminium sheets 
of silica gel 60 F254 (layer thickness 0.25 mm). The substance on the developed TLC plate 
was visualised under UV fluorescence at 254 nm or 366 nm. Alternatively, the TLC plate 
was immersed into an appropriate reagent (Table 6.1) and subsequently heated. 
Table 6.1 Applied TLC stains. 
TLC stain - Functional group Composition 
Ninhydrin stain 
Free amino group 
0.30 g ninhydrin, 100 mL EtOH 
Cer/Molybdenum stain 
Various groups 
2.50 g ammonium molybdate tetrahydrate, 
1.00 g cerium ammonium sulfate dehydrate, 
10 mL sulfuric acid, 90 mL water 
Dinitrophenylhydrazine (DNP) 
Aldehyde groups 
12.00 g 2,4-dinitrophenylhydrazine, 
60 mL 98 % sulfuric acid, 80 mL water, 
200 mL 95 % ethanol 
 
 Flash column chromatography  
For flash column chromatography silica gel 60 F254 (40 – 63 µm) from MERCK (Darmstadt, 
Germany) was used at 0.3 – 1.0 bar. Columns were packed with wet silica gel (50 –
 100-fold weight excess) and the sample was given on the column absorbed onto silica gel, 
as a concentrated solution or as a solid matter. 
 High performance liquid chromatography (HPLC) 
Reversed phase (RP)-HPLC analyse were performed on a device (Äkta Basic 900, pump 
type P 900, variable wavelength detector UV-900) of AMERSHAM PHARMACIA BIOTECH 





(Freiburg, Germany), if required equipped with a PHARMACIA LKB HPLC column oven 
2155. Alternatively, analytic HPLC runs were performed by a HPLC system from JASCO 
(Tokio, Japan) equipped with an MD-2010 diode array detector, two PU-2085 semi-micro 
pumps, a CO-2060 column thermostat and an AS-2055 autosampler. The peptides were 
detected by UV-absorption at 215 nm, 254 nm, 280 nm and fluorophore specific 
wavelength (see Table 6.2). 
Table 6.2 Used wavelength for detection of NBD, carboxyfluorescein and the synthesised Ca2+-sensors. 
Fluorophore Specific wavelength 
NBD 464 nm 
Carboxyfluorescein 480 – 492 nm 
Ca
2+
-sensor 38/46 480 nm 
 
The substances were analysed and purified with a linear gradient of a two-component 
system (solvent A = water phase, solvent B = organic phase). The following columns from 




100-5-C18, 250 mm × 4.6 mm, 5 µm, 1 mL/min (Analytic), 
MN Nucleodur
® 
100-5-C18, 250 mm × 10 mm, 5 µm, 3 mL/min (Semipreperative), 
MN Nucleodur
® 
100-5-C18, 250 mm × 21 mm, 5 µm, 10 mL/min (Preperative). 
6.3 Characterisation 




C-NMR spectra were recorded with a spectrometer (Unity 300, Mercury-Vx 300, 
VNMRS-300, Inova 500 or Inova 600) by VARIAN (Palo Alto, USA) or an av301 by 
BRUKER (Billerica, USA) spectrometer. The spectra were recorded at RT or 308.1 K. 
Chemical shift (δ) are denoted in parts per million (ppm) downfield of TMS. The 
resonance of the residual protons of the deuterated solvents was used as internal standard. 
Abbreviations for multiplicities are: s (singlet), d (doublet), t (triplet), q (quartet), 
m (multiplet), br (broad). Coupling constants 
n
JX,Y are stated in Hertz (Hz), where n is the 
order of coupling and X and Y the coupling partners.  





Mass spectrometry (MS) 
Electron ionisation (EI) measurements were performed on an AccuTOF obtained from 
JEOL (Akishima, Japan). Electrospray-ionisation (ESI) and high resolution ESI (HR-MS 
(ESI)) spectra were obtained with a BRUKER device (maXis or MicrOTOF). 
UV/Vis spectroscopy 
UV/Vis spectrometry to determinate resin loading, peptide concentration and absorption 
spectra of Ca
2+
-sensor labelled -peptides were measured by using a THERMO SCIENTIFIC 
(Waltham, USA) NanoDrop ND-2000c spectrophotometer. The concentration 
measurements of the peptides in organic solvents (MeOH/TFE) were performed in a 1 cm 
cuvette at 280 nm. The Ca
2+
-sensor labelled -peptides (Pep 18 and Pep 19) UV/Vis 
spectra in aqueous buffer were recorded with the micro-volume pedestal method or with a 
JASCO (Groß-Umstadt, Germany) V-650 UV-Visible Spectrophotometer. Quartz glass 
cuvettes Suprasil
®
 (QS) were used as cuvettes (HELLMA, Müllheim, Germany). The 
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   = Absorption at specific wavelength [nm]   = pathlength [cm] 






























These values were used, although a shift in the maximum compared to the literature was 
observed. The concentration dependent measurements of Pep 14 in MeOH and the 
normalised absorption of Pep 19 were measured by using a JASCO (Groß-Umstadt, 
Germany) V-650 UV-Visible Spectrophotometer. The following settings have been 
selected: 





Table 6.3 UV/Vis settings for measurements of Pep 14 in MeOH with variation peptide concentration and UV/Vis 
settings for measurements of Pep 19 during a Ca2+ titration. 
 Pep 14 Pep 19 
Response Fast Medium 
Scan speed 100 nm/min 200 nm/min 
UV/Vis bandwidth 0.5 nm 2.0 nm 
Change source at 350 nm 330 nm 
Start/end 600 – 250 nm 600 – 300 nm 
Data interval 0.5 nm 0.2 nm 
Accumulation 3 1 
Cell length 1 cm 1 cm 
Temp 25 °C 20 °C 
 
Circular dichroism (CD) measurement 
The CD spectra were recorded on a J-1500 CD spectrometer (JASCO, Groß-Umstadt, 
Germany) equipped with a F250 thermostat (JULABO, Seelbach, Germany). Therefore, the 
measurement chamber was flushed with nitrogen. The temperature has been varied for the 
different solvents and lipids (H2O, MeOH, TFE, DOPC: T = 25 °C; DMPC: T = 30 °C; 
DPPC: T = 50 °C). For the CD measurement normally a cuvette with a length of 0.1 cm 
was used (with the exception of the Pep 12), which was measured in a 0.01 cm cuvette. As 
cuvettes quartz glass cuvettes Suprasil
®
 (QS) were used (HELLMA, Müllheim, Germany). 
Table 6.4 contains the measurement parameters for the CD measurements.  
Table 6.4 Settings for measurements of CD spectra. 
 CD spectra 
Photometric mod CD, Abs 
D.I.T. 1.0 s 
Bandwidth 1.0 nm 
Speed scan 20 – 50 nm/min 
Start/end 250 – 180 nm 
Data pitch 0.1 – 1.0 nm 
Accumulation 5 – 50 
CD scale 200 mdeg /1.0 dOD 
Fl scale 200 mdeg /1.0 dOD 
 
For the CD measurements, the peptides were solved in organic solvent (300 µL, ~50 µM) 
or undiluted vesicle suspension was prepared according to Chapter SOP 7. 





The spectra were corrected with a blank spectrum of solvent or LUV without peptides. The 





the Equation 6.2 of GREENFIELD.
[303]
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Θabs [mdeg] = ellipticity    c [mol/L] = peptide concentration 
d [mm] = layer thickness 
Dynamic light scattering (DLS) 
The distribution of the prepared vesicles was obtained with a Zetasizer Nano S light 
scattering system (MALVERN INSTRUMENTS, Malvern, UK). As light source a 4 mW laser 
(633 nm) was used and the light scattering was detected in an angle of 173°. Data 
acquisition was performed at different temperature in a range of 20 – 30 °C. A 1.5 mL or a 
2.5 mL PS disposable cuvette (BRAND, Wertheim, Germany) was used. The measurement 
parameters were optimised by the device automatically.  
Fluorescence measurements 
General 
Fluorescence measurements were performed on a J-1500 CD spectrometer (JASCO, Groß-
Umstadt, Germany) equipped with a monochromator FMO-427S/15 (JASCO, Groß-
Umstadt, Germany), on a FP-6200 (JASCO, Groß-Umstadt, Germany) or on a FP-8500 
(JASCO, Groß-Umstadt, Germany). Each spectrometer was equipped with a F250 
thermostat (JULABO, Seelbach, Germany). For the fluorescence measurements a 1.5 mL 
quartz glass cuvette Suprasil
®
 (QS) (HELLMA, Müllheim, Germany) or a 2.5 mL UV-





 titration measurments), the fluorescence 
measurements were corrected by blank measurements of solvent or lipids without peptides. 
The solution was stirred at 500 r.p.m during the pH fluorescence measurements, NBD 
distribution measurement and Ca
2+
-sensor fluorescence measurements. Furthermore, the 
corrected spectra were partially normalised with the following Equation 6.3: 
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Amin = Minimum fluorescence  Amax = Maximum fluorescence 
Anom = Normalized fluorescence 
 
In the case of multiple fluorescence measurements, the mean value was calculated and 
displayed in the plots or provided as an error of the given values. The error f of the 
measurements was calculated according to the standard deviation according to the 
multiplied measurement with Equation 6.4. The data was plotted as     and the given 
error was rounded up if necessary. 
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n = number of measurements x = data point of the measurement  
    mean value  
 
Tryptophan fluorescence and parallax measurements 
The J-1500 CD spectrometer was used for the probes of peptides solved in MeOH/TFE or 
incorporated in lipid membranes, which was prepared for the respective CD spectra. For 
this purpose, the EM detector was operated with a voltage of 400 – 800 V. Therefore, the 
emission was adjusted at an intensity value of ~0.7. For the tryptophan fluorescence 
measurements a 1.5 mL quartz glass cuvette Suprasil
®
 (QS) (HELLMA, Müllheim, 
Germany) was used. For the parallax measurements the FP-6200 was used. Table 6.5 
contains the measurement parameters for the measurements performed at the J-1500 CD 
and the FP-6200. 
 










Meas. mode: emission 
D.I.T. 1.0 s 
Em. bandwidth 10.0 nm 
Ex. bandwidth 2.0 nm 
Ex. Wavelength 280 nm 
Start/end 290 – 400 nm 
Data pitch 1.0 nm 
Accumulation 2 – 5 






Meas. mode: Emission 
Response Fast 
Em. bandwidth 5.0 nm 
Ex. bandwidth 5.0 nm 
Ex. Wavelength 280 nm 
Start/end 290 – 400 nm 
Data pitch 1.0 nm 
Accumulation 1 
Sensitivity Medium 
Scan speed 60 nm/min 
 
 
For the tryptophan fluorescence and the parallax measurements, the peptides were solved 
in organic solvent (300 µL, ~50 µM) or undiluted vesicle suspension was prepared 
according to SOP 7.  
 
pH Fluorescence measurements and NBD distribution measurement 
For the pH dependent measurements, a FiveEasy
®
 pH meter from METTLER TOLEDO 
(Gießen, Germany) with a XS SENSOR (Carpi, Italy) Micro electrode and the FP-8500 were 
used. For the pH titration the device was calibrated with calibration solution from HANNA 
INSTRUMENTS (Woonsocket, USA) and a two-step calibration at a pH of 4 and 10 at 25 °C. 
The device specific calibration slope was from 89 % to 91 %. For the pH fluorescence 
measurements, the programme FixedWaveLentgh and for the determination of the 
NBD-labelled peptide Pep 15 distribution, the programme TimeCourse Measurement was 
used. Table 6.5 contains the measurement parameters for both measurements performed at 
the FP-8500. 
 









Response 1.0 s 
Em. bandwidth 5.0 nm 
Ex. bandwidth 5.0 nm 
Wavelength 1 490/520 nm 
Wavelength 2 450/520 nm 
Number of cycles 5 
Cycle interval 30 s 
Sensitivity High 





Response 1.0 s 
Em. bandwidth 5.0 nm 
Ex. bandwidth 5.0 nm 
Ex. wavelength 436 nm 
Ex. wavelength 535 nm 
Data interval 1 s 
Cycle interval 30 s 
Sensitivity medium 
Temperature 25 °C 
Measurement range 0 – 1800 s 
 
 
For the pH fluorescence measurements, a vesicle suspension was prepared according to 
Chapter SOP 7. Subsequently, 100 µL of the vesicle suspension was diluted in 1900 µL 
buffer (PBS = 137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4, 1.8 mM KH2PO4, pH 7.4; 
HEPES = 10 mM KCl, 2 mM HEPES) and 0.95 µL of a 0.2 mM CCCP solution in DMSO 
was added. The titration was performed with 2 – 3 M NaOH and HCl starting from a pH of 
~7 to a pH of 3 following a pH of ~10. For each pH value an individual measurement was 
performed following the conditions in Table 6.6. For the NBD distribution measurements a 
vesicle suspension was prepared according to Chapter SOP 7 and 40 µL vesicle suspension 
was diluted in 1960 µL buffer (10 mM Na2HPO4, 150 mM NaCl, pH 7.6). After the 
stabilisation of the fluorescence, 20 μL of a freshly prepared 50 mM sodium dithionite 
solution in ultrapure water were added to the lipid solution. When no dramatic change in 




 fluorescence measurement 
The Ca
2+
 dependent measurements were performed at 20 °C by using a Ca
2+
 calibration 
buffer kit from INVITROGEN (Carlsbad, USA). This calibration buffer kit consists of two 
solutions, the Zero Free Ca
2+
 buffer (10 mM K2EGTA, 100 mM KCl, 30 mM MOPS, 
pH 7.2) and the 39 μM Free Ca
2+
 buffer (10 mM CaEGTA, 100 mM KCl, 30 mM MOPS, 
pH 7.2). The combination of the two buffers in different ratio allows a free Ca
2+
 
concentration from 0 µM to 39 μM. In addition, different Ca
2+
 concentrations were prepared 
by dilution of a 1.0 M or a 1.5 M CaCl2 solution in buffer (100 mM KCl, 30 mM MOPS, 
pH 7.2). The initial CaCl2 × 6H2O mass was determined by weight. In Table 6.7 and Table 





6.8 the measurement parameters for the Ca
2+
 emission measurements and the Ca
2+
 titration 
measurements are given. 







Response 0.1 s 
Em. bandwidth 5.0 nm 
Ex. bandwidth 5.0 nm 
Start/end 300 – 510 nm 
Em. wavelength  544 nm 
Data interval 0.5 nm 
Scan speed 1000 nm/min 
No. of accumulation 3 
Sensitivity Medium 
Temperature 20 °C 








Response 0.1 s 
Em. bandwidth 5.0 nm 
Ex. bandwidth 5.0 nm 
Start/end 510 – 700 nm 
Ex. wavelength See Table 6.8 
Data interval 0.5 nm 
Scan speed 1000 nm/min 
No. of accumulation 3 
Sensitivity Medium 
Temperature 20 °C 





 titration measurements of Pep 18 and Pep 19 different excitation and 
emission wavelength were observed.  






Pep 18 416/496 nm 544 nm 




-sensor labelled peptides (Pep 18 and Pep 19) were dissolved in ultrapure water 
and equal volumes of the stock solution were distributed to the individual measurements 
(~2 µM Pep 18 and ~15 µM Pep 19). Several Ca
2+
 concentration dependent fluorescence 
dates were recorded per Ca
2+




 emission and Ca
2+
 titration measurements of Pep 18, the following steps, 
based on the INVITROGEN protocol, were carried out:  
1. A small amount of a Pep 18 stock solution in water was added to 1 mL Zero 
Free Ca
2+
 buffer (10 mM K2EGTA, 100 mM KCl, 30 mM MOPS, pH 7.2) 
and four times the amount was added to 4 mL of 39 μM Free Ca
2+
 buffer 
(10 mM CaEGTA, 100 mM KCl, 30 mM MOPS, pH 7.2). 





2. The fluorescence spectrum of Pep 18 in Zero Free Ca2+ buffer was 
recorded by using a total volume of 1 mL. 
3. In the following, the fluorescence intensity was measured at different Ca2+ 
concentrations. For this, the solution from the previous measurement was 
replaced by a certain volume of 39 μM Free Ca
2+
 buffer containing the same 
concentration of Ca
2+
-sensor (see Table 6.9 a). The concentration of the 
sensor (~2 µM) and EGTA (10 mM) remained constant. 
Additionally, two solutions were prepared with a Ca
2+
 concentration of 100 μM and 
2000 μM. Therefore, CaCl2 was dissolved in buffer (100 mM KCl, 30 mM MOPS, pH 7.2) 
to obtain a 1 mM solution and this solution was diluted as required.  
For the Ca
2+
 titration measurements of Pep 19, a 1 M CaCl2 solution in buffer (100 mM 
KCl, 30 mM MOPS, pH 7.2) was prepared and diluted to obtain the Ca
2+
 concentrations 
(seen in Table 6.9 b) given. Subsequently, in 1 mL of each Ca
2+
 containing solution was 
given a constant amount of Pep 19 (~15 µM). 
Table 6.9 a) Serial dilution for the Ca2+ dependent fluorescence measurements of Pep 18 and b) Ca2+ concentration 
of aqueous buffer for Ca2+ dependent fluorescence measurements of Pep 19. 
a) [CaEGTA] [Ca
2+
]free Replaced volume 
0.0 mM 0 µM 900 µL 
9.0 mM 1.35 µM 100 µL 
9.1 mM 1.52 µM 111 µL 
9.2 mM 1.73 µM 125 µL 
9.3 mM 1.99 µM 143 µL 
9.4 mM 2.35 µM 167 µL 
9.5 mM 2.82 µM 200 µL 
9.6 mM 3.60 µM 250 µL 
9.7 mM 4.86 µM 333 µL 
9.8 mM 7.37 µM 500 µL 
9.9 mM 14.9 µM 500 µL 
9.95 mM 29.9 µM - 
10.0 mM 39.0 µM - 
- 100 µM - 




























]) against log {(R-Rmin)/(Rmax-R)}. R is the ratio of the fluorescence 
emission by two different excitation wavelengths at a certain Ca
2+
 concentration. Rmin is the 





ratio at 0 μM free Ca
2+
 and Rmax is the ratio for a fully saturated sensor. The intersection of 
the straight line at y = 0 corresponds to the logarithmic Kd value. 
For the study of fluorescence dependence versus other divalent metal ions, the salts ZnCl2, 
MgCl2 × 6H2O and CaCl2 × 2H2O were used. The salts were dissolved in an EGTA-free 
buffer (100 mM KCl, 30 mM MOPS, pH 7.2) to a concentration of 0.5 M. Subsequently, a 
certain amount of salt solution was added to a solution of Ca
2+
-sensor in buffer (100 mM 
KCl, 30 mM MOPS, pH 7.2) to obtain a final concentration of 100 μM or 2000 μM. The 
sensor concentration was kept constant in all measurements. 
The salts NiCl × 6H2O, MnCl × 4 H2O and CoCl were used to measure the fluorescence 
quenching by ions. Therefore, the salts were dissolved in an EGTA-free buffer (100 mM 
KCl, 30 mM MOPS, pH 7.2) to a concentration of 0.5 M. Subsequently, a certain amount of 
salt solution was added to a solution of Ca
2+
-sensor in buffer (100 mM KCl, 30 mM MOPS, 
pH 7.2) to obtain the given concentration. The sensor concentration was kept constant in 
all measurements. 
6.4 Standard operating procedures (SOPs) 
SOP 1 General synthesis of N-protected D-β3-amino acids 
 
Scheme 6.1 General reaction scheme for β3-amino acids starting from -amino acids (PG = protection group). 
The respective N-protected -amino acid (1.00 eq) was dissolved in dry THF 
(4.7 mL/mmol) and cooled down to 0 °C. Isobutyl chloroformate (1.10 eq) and 
triethylamine (1.10 eq) were added at 0 °C, followed by stirring at 0 °C for 30 min. Under 
light exclusion diazomethane solution in diethyl ether (0.6 M, 2.00 eq) was added to the 
reaction mixture and stirred at RT for 5 h. The reaction was quenched with acetic acid 
(0.1 mL/mmol) followed by the addition of an aqueous solution of sodium bicarbonate 
(6 %, 9.4 mL/mmol). The aqueous phase was extracted with ethyl acetate (3 × 100 mL). 
The combined organic phases were washed with saturated aqueous solution of ammonium 
chloride (3 × 60 mL) and saturated aqueous solution of sodium chloride (60 mL), followed 
by drying over magnesium sulphate. The solvent was removed under reduced pressure and 
the crude product was received as a yellow oil or solid. When the crude product was brown 
or red, side products were removed by flash column chromatography (Pentane/EtOAc 1:1). 





For the following WOLFF rearrangement two reaction conditions could be used: 
1. The diazo ketone (1.00 eq) of the protected amino acid was dissolved in THF/H2O 
(9:1) and silver benzoate (0.10 eq) was added. The reaction mixture was sonicated 
at RT for 2 h and a small amount of water was added.  
2. The diazo ketone (1.00 eq) of the protected amino acid was dissolved in 
dioxane/H2O (2:1) and silver benzoate (0.10 eq) was added. The reaction mixture 
was placed in a domestic microwave (460 W, 1 min) and the organic solvent was 
removed under reduced pressure. 
Afterwards, the respective WOLFF rearrangement mixture was adjusted to a pH 2 – 3 by 
adding 2 M hydrochloric acid. Then, the aqueous phase was extracted with ethyl acetate 
(3 × 100 mL). The combined organic phases were dried over magnesium sulphate. The 
solvent was removed under reduced pressure and the obtained crude product was dissolved 
in DCM and precipitate in cold pentane to get the product which was manageable and pure 
enough for the peptide synthesis (impurities were still contained). For a pure product the 
crude product was purified by flash column chromatography (Pentane/EE or 
DCM/MeOH).  
SOP 2 Manual loading of the resin with the first amino acid 
The loading of the rink amide MBHA resin (1.00 eq) was performed in a BECTON-
DICKINSON (BD; Heidelberg, Germany) discardit II syringe equipped with a PE-frit. The 
resin was swollen in DMF for 2 h. The resin-bound Fmoc protection group was cleaved 
two times using a solution of NMP/piperidine/DBU (v/v/v; 79:20:1) under microwave 
irradiation: (a) 30 s, 25 W, 50 °C (b) 3 min, 35 W, 65 °C. The resin was washed with DMF 
(3×), DCM (3×) and DMF (3×). The amino acid building block (5.00 eq) and HOBt 
(5.00 eq) were dissolved in DMF (2 mL/mmol) and DIC (5.00 eq) was added. The 
coupling solution was given to the resin and coupled microwave-assisted (35 W, 65 °C, 
15 min). The resin was washed with DMF (3×), MeOH (3×) and DCM (3×) and dried 
under reduced pressure. The resign loading was checked by SOP3 and has to be between 
0.3 mmol/g and 0.4 mmol/g. After a successful resign loading free amino groups were 
capped with acetic anhydride/NMP (v/v; 20:80, 3 min, 35 W, 65 °C). Afterwards the resign 
was washed again with DMF (3×), MeOH (3×) and DCM (3×) and dried under reduced 
pressure. 





The NovaPeg rink amide resin LL (0.19 mmol/g) was loaded with the first amino acids 
followed by the normal coupling protocol for the respective peptide.  
SOP 3 KAISER test 
The KAISER test was performed for checking the presence of free amino groups during the 
SPPS. A small amount of dry or MeOH-wet resin was placed in a glass tube. 2 – 3 drops of 
each solution were added to the tube and heated to 100 °C for 2 – 5 min. A negative test 
was performed when the solution and resin were still yellow, which indicated none free 
amino groups. A positive test was performed when the resin or the solution turned to blue, 
which showed the presence of free amino group. The following solutions were prepared for 
the KAISER test: 
 Reagent 1: 1.0 g ninhydrin in 20 mL ethanol, 
 Reagent 2: 16 mg phenol in 4 mL ethanol, 
 Reagent 3: 0.50 mL solution of KCN (1 mM) diluted to 25 mL with pyridine. 
SOP 4 Determination of resin loading[11] 
The determination of resin loading of the rink amide MBHA resin was performed by SOP 
2. A small amount of resin (5 – 10 g) was given in a 10 mL volumetric flask. 40 µL 1,8-
diazabicyclo[5.4.0]undec-7-en (DBU) and 2 mL DMF were added and the solution was 
mixed mechanical or sonicated at RT for 2 h. This solution was filled up to 10 mL, 2 mL 
of these were given to a 25 mL volumetric flask and diluted to 25 mL with ACN. The 
absorption measurement was performed at 304 nm and corrected by a blank probe without 
resin. The resin loading was calculated by following Equation 6.5.  
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A304 = absorption at 304 nm corrected by blank probe 
mresin = mass of resin [mg] 
SOP 5 Manual microwave-supported SPPS 
The synthesis of the β-peptides was performed with manual microwave-assisted solid 
phase peptide synthesis (SPPS) in a BD-syringe equipped with a PE-filter. All peptides 
were synthesised on a NovaPeg resin (0.18 mmol/g), with the exception of Pep 1 – Pep 4 
and Pep 9 – Pep 10, which were synthesised on a rink amide MBHA resin (0.3 –
 0.5 mmol/g). The first amino acid on the rink amide MBHA resin was loaded according to 





SOP 2. The resin was swelled in DMF for at least 1 h and it was washed between the 
reaction steps for at least 3 times with NMP, DMF, DCM or a mixture of DMF/MeOH 
(1:1). 
1. The resin-bound Fmoc-group was deprotected twice by using a solution of 
NMP/piperidine/DBU (v/v/v; 79:20:1) under microwave irradiation. The two 
deprotection steps differ in the reaction time and temperature (1. 30 s, 25 W, 50 °C; 
2. 3 min, 35 W, 65 °C).  
2. After washing, the respective amino acid (5.00 eq) was dissolved in a solution of 
0.5 M HOAt/HATU (5.00 eq/4.90 eq) in DMF and 2.0 M DIPEA (10.00 eq) in 
NMP. The activated amino acid was added to the resin and microwave-assisted 
coupling (15 min, 35 W, 65 °C) was performed. This coupling step was performed 
for the hydrophobic amino acids once (Pep 1 – Pep 4, Pep 9, Pep 10, Pep 12), 
twice (Pep 11, Pep 15) or thrice (Pep 5 – Pep 8). D-
3
-hTrp and ACHC was 
always coupled twice. 
3. Free amino groups were capped with acetic anhydride/NMP (v/v; 20:80) 
microwave-supported (3 min, 35 W, 65 °C).  
After completion of the β-peptide sequence, the final wash was performed at the MBHA 
resin with DCM and at the NovaPeg resin with MeOH followed by diethyl ether. Finally, 
the resin was dried under reduced pressure. Cleavage from the resin and removal of the 
protecting groups was done with TFA/H2O/TIS (v/v/v; 95:2.5:2.5) for 2 h. The solvent was 
removed in a nitrogen stream and the final crude β-peptides were precipitated with diethyl 
ether and purified by using HPLC. 
SOP 6 Automatic microwave-supported SPPS 
The automatic microwave-supported SPPS was performed on a peptide synthesizer 
equipped with a DISCOVER microwave reaction cavity (CEM, Kamp-Lintfort, Germany). 
The resin was not preswelled and two coupling protocols were established. The exact 
reaction cycles for the performed synthesis scales as well as the used coupling solutions are 
listed in Appendix A. Method 1 was used for Pep Met 1 and Method 2 was used for 
Pep Met 2, Pep 13, Pep 14, Pep 16, Pep 18 – Pep 20. 





SOP 7 Preparation of large unilamellar vesicles (LUV) 
General 
Large unilamellar vesicles (LUV) were prepared by extradition a rehydrated lipid film. The 
lipid film was produced by taking a certain amount of lipid dissolved in chloroform and by 
adding peptide dissolved in MeOH or TFE. The solvent was dispersed at 50 °C with a 
nitrogen stream and the residual solvent was removed in vacuum at 40 °C overnight. 
Subsequently, the lipid film was rehydrated with ultrapure water or buffer and incubated at 
50 °C for at least 1 h. The suspension was mixed mechanically (4 × 1 min, after each 
mixing step the sample was left for 5 min at 50 °C). Afterwards, the suspension was 
extruded 31 times through a polycarbonate membrane with a defined pore size in a 
LiposoFast mini-extruder. 
CD and Tryptophan fluorescence measurements 
For the CD and tryptophan fluorescence measurements, 0.30 mg of the respective lipid and 
5 mol% or 6 mol% of the β-peptide dissolved in TFE or MeOH were mixed and dried (P/L 
ratio 5:100 or 6:100). The rehydration was performed with 500 µL ultrapure water and the 
suspension was extruded through a membrane with a pore size of 100 nm. 
Parallax measurement 
For the parallax measurements, 0.3 µmol of the respective lipid (varying amount of 
DOXYL-labelled lipid 0 % – 13 %) and 0.5 mol% of the β-peptide dissolved in TFE or 
MeOH were mixed and dried (P/L ratio 1:200). The rehydration was performed with 
500 µL ultrapure water and the suspension was extruded through a membrane with a pore 
size of 100 nm. 
pH Fluorescence measurements and NBD distribution measurement 
For the pH fluorescence measurements, a total lipid amount of substance of 0.38 µmol and 
0.5 mol% of the β-peptide dissolved in TFE or MeOH were mixed and dried (P/L ratio 
1:200). The rehydration was performed with 500 µL buffer and the suspension was 
extruded through a membrane with a pore size of 100 nm or 400 nm. 
SOP 8 Functionalisation of Ca2+-sensors 
The protected Ca
2+
-sensor (1.00 eq) and the respective hydrochlorid salt (1.00 eq) were 
added in a flame dried flask. Dry ethanol (14.6 mL/mmol) was added under argon 
atmosphere. The reaction was heated under reflux for 5 h.
[37]
 As required the product was 
purified by flash chromatography. The hydrochlorid salts of the commercial available 2,2'-





dithiobis(ethylamine) and -alanine as well as the hydrochlorid salts of the synthesised 
(analysis data not given) N-(2-aminoethyl)maleimide
[304,305]
 and (S)-2-pyridylthio 
cysteamine
[306]
 were obtained by lyophilisation with diluted HCl solution. 
SOP 9 Labelling of -peptides with carboxyfluorescein as pH-sensor 
For the labelling of carboxyfluorescein to the resin-bound peptide three 
microwave-supported conditions were developed. Therefore, the fluorophore and the solid 
coupling reagents were diluted in a minimum of DMF and the liquid coupling reagents 
were added in small portion. Subsequently, the coupling mixture was added to the dry 
resin. 
1. DIC (10.00 eq)/Oxyma (5.00 eq)/carboxyfluorescein (5.00 eq) double coupling 
(25 W, 5 min, 90 °C),  
2. HATU (4.90 eq)/HOAt (5.00 eq)/DIPEA (10.00 eq)/carboxyfluorescein (5.00 eq), 
double coupling (25 W, 15 min, 75 °C),  
3. PyAOP (5.00 eq)/HOAt (5.00 eq)/DIPEA (10.00 eq)/carboxyfluorescein (5.00 eq), 
double coupling (25 W, 60 min, 75 °C). 
After the successful labelling the washed resin was treated with a solution of 
NMP/piperidine (v/v; 80:20) at RT for 15 min to remove the phenolic ester.
[230]
  






-sensor 38 (3.00 eq), PyAOP (6.00 eq) and HOAt (3.00 eq) were dissolved in 
DMF (15 mL/mmol based on resin-bound peptide) and DIPEA (6.00 eq) was added 
subsequently in three fractions. This reaction mixture was added to the resin and if 
required DMF was added until the resin was completely covered. The fluorophore was 
coupled microwave-supported to the resin-bound peptide (20 W, 2 h, 65 °C (up to 10 °C 






-sensor (5.00 eq), PyAOP (10.00 eq) and HOAt (5.00 eq) were dissolved in DMF 
(15 mL/mmol based on resin-bound peptide) and subsequently DIPEA (15.00 eq) was 
added in three fractions. This reaction mixture was added to the resin and if required DMF 
was added until the resin was completely covered. The fluorophore was coupled 
microwave-supported to the resin-bound peptide (20 W, 2 h, 65 °C (up to 10 °C 
overshoot)) for 2 h. 





6.5 Synthesis  









Following SOP 1 the synthesis was achieved starting with Fmoc-D-Lys(Boc)-OH (5.00 g, 
10.10 mmol, 1.00 eq) to yield the product 47 (4.57 g, 9.48 mmol, 89 %) as a yellow solid. 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 1.11 – 1.45 (m, 15H, CH3, CH2), 2.24 – 2.43 
(m, 2H, CH2), 2.81 – 2.94 (m, 2H, CH2), 3.67 – 3.83 (m, 1H, β-CH), 4.17 – 4.33 (m, 3H, 
Fmoc-CH), 6.69 (s, 1H, Boc-NH), 7.14 (d, 
3
JH,H = 8.6 Hz, 1H, Fmoc-NH), 7.26 – 7.47 (m, 
4H, Fmoc-CH), 7.68 (d, 
3
JH,H = 7.7 Hz, 2H, Fmoc-CH), 7.88 (d, 
3
JH,H = 7.7 Hz, 2H, Fmoc-
CH), 12.11 (sbr, 1H, COOH). 
 
MS (ESI, MeOH): m/z = 505.2 [M+ Na]
+




HR-MS (ESI, MeOH):  
 C27H34N2O6Na [M+ Na]
+
 calc.: 505.2309  mesur.: 505.2311. 
 













Following SOP 1 the synthesis was achieved starting with Fmoc-D-Leu-OH (10.00 g, 




H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 0.86 (d, 
3
JH,H = 6.5 Hz, 6H, CH3), 1.11 –
 1.27 (m, 1H, CH2), 1.32 – 1.51 (m, 1H, CH2), 1.49 – 1.62 (m, 1H, CH), 2.23 – 2.45 (m, 
2H, α-CH2), 3.82 – 3.97 (m, 1H, β-CH), 4.15 – 4.26 (m, 1H, Fmoc-CH), 4.26 – 4.37 (m, 
2H, Fmoc-CH2), 7.08 – 7.17 (d,
 3
JH,H = 8.8 Hz, 1H, Fmoc-NH), 7.28 – 7.36 (m, 2H, Fmoc-
CH), 7.36 – 7.44 (m, 2H, Fmoc-CH), 7.63 – 7.73 (m, 2H, Fmoc-CH), 7.87 (d, 
3
JH,H = 7.9 Hz, 2H, Fmoc-CH), 12.12 (sbr, 1H, COOH). 
. 
MS (ESI, MeOH): m/z = 390.2 [M+ Na]
+




HR-MS (ESI, MeOH):  
 C22H25NO4Na [M+ Na]
+











Following SOP 1 the synthesis was achieved starting with Fmoc-D-Val-OH (10.00 g, 
29.50 mmol, 1.00 eq) to yield the product 49 (8.65 g, 24.50 mmol, 83 %) as a colourless or 
yellow solid. 
 






H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 0.67 – 0.94 (m, 6H, CH3), 1.65 – 1.82 (m, 
1H, CH2), 2.24 – 2.48 (m, 2H, α-CH2), 3.69 – 3.84 (m, 1H, β-CH), 4.16 – 4.39 (m, 3H, 
Fmoc-CH, Fmoc-CH2), 7.20 (d, 
3
JH,H = 9.0 Hz, 1H, Fmoc-NH), 7.25 – 7.47 (m, 4H, Fmoc-
CH), 7.66 – 7.75 (m, 2H, Fmoc-CH), 7.87 (d, 
3
JH,H = 7.4 Hz, 2H, Fmoc-CH), 12.07 (sbr, 
1H, COOH). 
 
MS (ESI, MeOH): m/z = 376.2 [M + Na]
+
; 729.3 [2M + Na]
+




HR-MS (ESI, MeOH):  
 C21H24NO4 [M+ H]
+
  calc.: 354.1700  mesur.: 354.1700; 
 C21H23NO4Na [M+ Na]
+










Following SOP 1 the synthesis was achieved starting with Fmoc-D-Ile-OH (5.00 g, 




H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 0.63 – 0.90 (m, 6H, CH3), 0.96 – 1.18 (m, 
1H, CH2), 1.29 – 1.60 (m, 2H, CH2, CH) 2.21 – 2.45 (m, 2H, α-CH2), 3.73 – 3.89 (m, 1H, 
β-CH), 4.15 – 4.40 (m, 3H, Fmoc-CH, Fmoc-CH2), 7.22 (d, 
3
JH,H = 8.9 Hz, 2H, Fmoc-
NH), 7.27 – 7.37 (m, 2H, Fmoc-CH), 7.37 – 7.47 (m, 2H, Fmoc-CH), 7.64 – 7.74 (m, 2H, 
Fmoc-CH), 7.87 (d, 
3
JH,H = 7.4 Hz, 2H, Fmoc-CH), 11.86 (sbr, 1H, COOH). 
 
MS (ESI, MeOH): m/z = 368.2 [M + H]
+
 390.2 [M + Na]
+




HR-MS (ESI, MeOH):  
 C22H26N3O4 [M+ H]
+
  calc.: 368.1856  mesur.: 368.1850; 
 C22H25N3O4Na [M+ Na]
+
 calc.: 390.1676  mesur.: 390.1676. 













Following SOP 1 the synthesis was achieved starting with Fmoc-D-Trp(Boc)-OH (10.00 g, 
19.00 mmol, 1.00 eq) to yield the product 51 (8.09 g, 15.00 mmol, 79 %) as a yellow solid. 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 1.55 (s, 9H, CH3), 2.45 – 2.57 (m, 2H, CH2, 
overlaid by solvent), 2.88 (d, 
3
JH,H = 6.8 Hz, 2H, α-CH2), 4.05 – 4.32 (m, 4H, Fmoc-CH, 
Fmoc-CH2, β-CH), 7.20 – 7.54 (m, 8H, Fmoc-CH, Trp-H, Fmoc-NH), 7.56 – 7.64 (m, 2H, 
Fmoc-CH), 7.71 (d, 
3
JH,H = 7.9 Hz, 1H, Trp-H), 7.86 (d, 
3
JH,H = 7.6 Hz, 2H, Fmoc-CH), 
8.04 (d, 
3
JH,H = 7.9 Hz, 1H, Trp-H). 
 
MS (ESI, MeOH): m/z = 563.2 [M + Na]
+




HR-MS (ESI, MeOH):  
 C32H32N2O6Na [M+ Na]
+









Following SOP 1 the synthesis was achieved starting with Fmoc-D-Ser(tBu)-OH (5.00 g, 
13.00 mmol, 1.00 eq) to yield the product 52 (1.10 g, 2.77 mmol, 21 %) as a white solid. 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 1.10 (s, 9H, OtBu), 2.25 - 2.39 (m, 1H; α-
CH2), 2.43 - 2.57 (m, 1H; α-CH2, partially overlaid by solvent), 3.09 - 3.21 (m, 1H, -
CH2), 3.25 - 3.35 (m, 1H, -CH2), 3.79 - 3.93 (m, 1H, β-CH), 4.15 - 4.37 (m, 3H, Fmoc-





CH2, Fmoc-CH), 7.22 (d,
 3
JH,H = 8.4 Hz, 1H, Fmoc-NH), 7.28 - 7.36 (m, 2H, Fmoc-CH), 
7.37 - 7.45 (m, 2H, Fmoc-CH), 7.69 (d,
 3
JH,H = 7.4 Hz, 2H, Fmoc-CH), 7.88 (d,
 
3
JH,H = 7.5 Hz, 2H, Fmoc-CH), 12.21 (sbr, 1 H, COOH). 
 
13
C-NMR (126 MHz, [D6]DMSO): δ (ppm) = 27.24, 36.25, 46.71, 48.39, 62.83, 65.22, 
72.40, 119.93, 125.04, 126.87, 127.42, 140.54, 143.63, 143.75, 155.30, 172.33. 
 








HR-MS (ESI, MeOH):  
 C23H27NO5 [M+H]
+
  calc.: 398.1962  mesur.: 398.1966; 
C23H27NO5Na [M+Na]
+










Following SOP 1 the synthesis was achieved starting with Fmoc-D-Asn(Trt)-OH (5.00 g, 
8.37 mmol, 1.00 eq) to yield the product 4 (2.87 g, 4.71 mmol, 56 %) as a yellow solid. 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 2.31 – 2.66 (m, 4H, CH2, α-CH2, overlaid by 
solvent), 4.04 – 4.16 (m, 1H, β-CH), 4.17 – 4.28 (m, 2H, Fmoc-CH2), 4.29 – 4.41 (m, 1H, 
Fmoc-CH), 7.08 – 7.36 (m, 18H, Trt-CH, Fmoc-CH, Fmoc-NH), 7.36 – 7.45 (m, 2H, 
Fmoc-CH), 7.69 (d, 
3
JH,H = 7.5 Hz, 2H, Fmoc-CH), 7.88 (d, 
3
JH,H = 7.5 Hz, 2H, Fmoc-
CH), 8.54 (s, 1H, Trt-NH). 
 
13
C-NMR (125 MHz, [D6]DMSO): δ (ppm) = 40.85, 46.71, 65.34, 69.31, 119.87, 124.94, 
125.04, 125.08, 126.10, 126.85, 126.88, 127.18, 127.39, 127.96, 128.07, 128.34, 128.66, 
129.00, 140.47, 143.60, 143.63, 144.59, 154.91, 169.38, 172.12. 
 













HR-MS (ESI, MeOH):  
 C39H35N2O5 [M+H]
+
  calc.: 611.2540  mesur.: 611.2529; 
C39H34N2O5Na [M+Na]
+












-Asn(Trt)-OH (2.87 g, 4.71 mmol, 1.00 eq) was stirred in 30 mL of 
TFA/EDT/H2O (v/v/v 90:5:5) and the reaction was controlled by TLC. TFA was removed 
by a nitrogen stream and the crude product was precipitated, centrifuged and washed 3 
times with diethyl ether. The dried intermediate product was suspended in ethyl 
acetate/acetonitrile (dry) (2:1) under an argon atmosphere. Propylphosphonic anhydride 
(50 % in DMF, T3P
®
) (2.75 mL, 9.42 mmol, 2.00 eq) was added and the reaction mixture 
was stirred at 60 °C for 3 h. The reaction mixture was poured in distilled water and 
extracted with ethyl acetate (3×100 mL) to yield the product (780 mg, 2.23 mmol, 47 %) as 
a colourless solid.  
 
1
H-NMR (500 MHz, [D6]DMSO): δ (ppm) = 2.43 - 2.57 (m, 2H, α-CH2, partially overlaid 
by solvent), 2.64 - 2.83 (m, 2H, CH2), 3.98 - 4.08 (m, 1H, β-CH), 4.19 - 4.26 (m, 1H, 
Fmoc-CH), 4.26 - 4.36 (m, 2H, Fmoc-CH2), 7.28 - 7.36 (m, 2H, Fmoc-CH), 7.37 - 7.44 (m, 
2H, Fmoc-CH), 7.65 - 7.73 (m, 3H, Fmoc-CH, Fmoc-NH), 7.84 - 7.90 (m, 2H, Fmoc-CH). 
 
13
C-NMR (126 MHz, [D6]DMSO): δ (ppm) = 22.54, 38.09, 44.93, 46.62, 65.51, 66.29, 
118.22, 120.03, 125.11, 127.01, 127.56, 140.66, 143.69, 143.74, 155.32, 171.51. 
 











HR-MS (ESI, MeOH):  
 C20H19N2O4 [M+H]
+
  calc.: 351.1339  mesur.: 351.1338; 
C20H18N2O4Na [M+Na]
+
 calc.: 373.1159  mesur.: 373.1158; 
C20H17N2O4 [M-H]
-









DMT/NMM/TOS 53 was synthesised by following modified literature protocol.
[307]
 2-
chloro-4,6-dimethoxy-1,3,5-triazine (CDMT) (2.00 g, 11.40 mmol, 1.00 eq) were added to 
a cooled (5 °C) and stirred solution of N-methylmorpholine (1.25 mL, 11.40 mmol, 
1.00 eq), p-toluenesulfonic acid (2.17 g, 11.40 mmol, 1.00 eq) and sodium hydrogen 
carbonate (2.87 g, 34.20 mmol, 3.00 eq) in ACN (34 mL). The solution was stirred for 24 h 
at 5 °C. After filtration and solvent removal by reduced pressure (N2-rotary evaporator, 
T ≤ 20 °C) the precipitation was washed with THF, recrystallised from boiled diethyl ether 
with small amounts of ACN and crystallised at -18 °C. After filtration and drying 53 was 
obtained as a colourless solid (2.44 g, 59.10 mmol, 52 %). 
 
1
H-NMR (300 MHz, [D3]ACN): δ (ppm) = 2.32 (s, 3H, CH3-C6H4-), 3.43 (s, 3H, CH3-N), 
3.65 – 3.77 (m, 2H, -N-CH2-CH2-O-), 3.78 – 3.89 (m, 2H, -N-CH2-CH2-O-), 3.92 – 4.03 
(m, 2H, -N-CH2-CH2-O-), 4.09 (s, 6H, CH3-O), 4.35 – 4.46 (m, 2H, -N-CH2-CH2-O-), 
7.09 – 7.23 (m, 2H, -C6H4-), 7.52 – 7.63 (m, 2H, -C6H4-). 
 








HR-MS (ESI, MeOH):  
 C10H17N4O3 [M-C7H7O3S]
+
 calc.: 241.1295  mesur.: 241.1298; 
C7H7O3S [M- C10H17N4O3]
-
 calc.: 171.0121  mesur.: 171.0122. 
 













Under argon atmosphere 1,4-hydroquinol (10.00 g, 90.90 mmol, 1.00 eq) and NaI (14.30 g, 
95.00 mmol, 1.05 eq) were suspended in dry acetone (50 mL) at 0 °C. Benzyl bromide 
(42.60 mL, 364 mmol, 4.00 eq) was added slowly to the reaction mixture followed by 
K2CO3 (50.30 g, 364 mmol, 4.00 eq). The reaction mixture was heated under reflux for 
24 h. The hot solution was poured in water (500 mL), the precipitation was filtered off and 
washed with water. The crude product was purified by recrystallization from boiling EtOH 
(if necessary with small portions of water). After filtration and drying under vacuum the 
product was given as colourless needles (25.90 g, 89.20 mmol, 98 %). 
 
1
H-NMR (300 MHz, CDCl3): δ (ppm) = 5.05 (s, 4H, -O-CH2-Ph), 6.96 (s, 4H, Ph-(OBn)), 
7.32 - 7.53 (m, 10H, O-CH2-Ph, solvent in signal). 
 
13
C-NMR (126 MHz, CDCl3): δ (ppm) = 70.60, 115.71, 127.31, 127.72, 128.39, 137.14, 
153.01.  
 












HR-MS (ESI, MeOH):  
C20H19O2 [M+H]
+
  calc.: 291.1380  mesur.: 291.1382; 
C20H18O2Na [M+Na]
+
 calc.: 313.1199  mesur.: 313.1197. 
 












1,4-Bis(benzyloxy)benzene (25.90 g, 89.10 mmol, 1.00 eq) was suspended in glacial acetic 
acid (163 mL) and cooled to 0 °C. Nitric acid (65 %, 8.55 mL, 178.00 mmol, 2.00 eq) was 
added slowly and the solution was stirred rapidly at 0 °C for 3 h. When the solution was 
frozen it was melted in a sonication bath. Afterwards the reaction was poured in water, 
filtered off and washed with water. The product was filtered off with DCM on Silical gel 
and dried by lyophilisation to yield the product (29.20 g, 86.90 mmol, 98 %) as a yellow 
solid. 
 
TLC (pentane/DCM, 3:1): Rf = 0.63. 
 
1
H-NMR (300 MHz, CDCl3): δ (ppm) = 5.03 (s, 2H, -O-CH2-Ph). 5.16 (s, 2H, -O-CH2-
Ph), 7.03 (d,
 3
JH,H = 9.2 Hz, 1H, Ph-(OBn)), 7.11 (dd,
 3
JH,H = 9.2, 3.0 Hz, 1H, Ph-(OBn)), 
7.21 - 7.53 (m, 11H, O-CH2-Ph, Ph-(OBn)). 
 
13
C-NMR (75 MHz, CDCl3): δ (ppm) = 70.83, 71.98, 111.12, 117.14, 121.39, 127.04, 
127.40, 127.47, 128.10, 128.25, 128.58, 128.63, 135.80, 135.91, 140.19, 146.27, 152.20. 
 






HR-MS (ESI, MeOH):  
C20H21N2O4 [M+NH4]
+
 calc.: 353.1496  mesur.: 353.1489; 
C20H17NO4Na [M+Na]
+
 calc.: 358.1050  mesur.: 358.1043. 
 












1,4-Bis(benzyloxy)benzene (25.00 g, 74.60 mmol, 1.00 eq) was suspended in dry 
chloroform (700 mL, 4 Å molecular sieve) and cooled to 0 °C. Aluminium chloride 
(10.40 g, 78.30 mmol, 1.05 eq) was added and the solution was stirred for 10 – 20 min. 
The reaction process was monitored by TLC. The reaction was quenched with 10 % HCl 
(700 mL), extracted with DCM (3 × 300 mL) and filtered. The solvent of the combined 
organic phases was removed under reduced pressure. The desired product was obtained 
after purification by flash-column chromatography (pentane/DCM, 7:1; alternatively 
100 % toluene) as a yellow solid (13.70 g, 56.00 mmol, 75 %). 
 
TLC (pentane/DCM, 3:1): Rf = 0.83. 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 5.10 (s, 2H, -O-CH2-Ph), 7.09 (d,
 
3
JH,H = 9.1 Hz, 1H, Ph-(OBn)), 7.25 – 7.48 (m, 6H, O-CH2-Ph, Ph-(OBn)), 7.51 (d,
 
3
JH,H = 3.1 Hz, 1H, Ph-(OBn)), 10.47 (s, 1H, ArOH). 
 
13
C-NMR (75 MHz, [D6]DMSO): δ (ppm) = 70.57, 109.60, 120.68, 124.54, 128.22, 
128.40, 128.89, 136.47, 137.04, 147.10, 150.93. 
 




HR-MS (ESI, MeOH):  
C13H10NO4 [M-H]
-
  calc.: 244.0615  mesur.: 244.0618. 
 


















4-Benzyloxy-2-nitrophenol (6.00 g, 24.50 mmol, 1.00 eq) and dry potassium carbonate 
(3.38 g, 24.50 mmol, 1.00 eq) were dissolved in dry DMF (14 mL) and heated to 120 °C 
under argon atmosphere. 1-(2-Bromoethoxy)-2-nitrobenzene (8.85 g, 36.00 mmol, 1.47 eq) 
was added and the mixture was stirred for 5 – 10 min. The reaction process was monitored 
by TLC. Afterwards, the mixture was diluted with saturated sodium bicarbonate solution, 
extracted with DCM and dried over MgSO4. The solvent was evaporated under reduced 
pressure and the crude product was purified by flash column chromatography 
(pentane/EE/DCM, 2:1:1). The product was obtained as yellow solid (9.70 g, 23.60 mmol, 
97 %). 
 
TLC (pentane/EE 2:1): Rf = 0.63. 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 4.44 – 4.54 (m, 4H, -O-CH2CH2-O-), 5.14 (s, 
2H, -O-CH2-Ph), 7.07 – 7.18 (m, 1H, Ph-NO2), 7.26 – 7.50 (m, 8H, O-CH2-Ph, Ph-NO2, 
Ph-(OBn)), 7.53 (d,
 3
JH,H = 2.9 Hz, 1H, Ph-NO2), 7.60 – 7.69 (m, 1H, -Ph-NO2), 7.85 (dd,
 
3
JH,H = 8.1 Hz, 1.7 Hz, 1H, -Ph-NO2). 
 
13
C-NMR (75 MHz, [D6]DMSO): δ (ppm) = 68.64, 69.26, 70.64, 110.96, 115.99, 117.99, 
121.40, 121.59, 125.34, 128.25, 128.45, 128.92, 134.77, 136.91, 140.20, 140.50, 145.57, 
151.42, 152.38. 
 






HR-MS (ESI, MeOH):  
C21H18N2O7Na [M+Na]
+
 calc.: 433.1006  mesur.: 433.1000. 
 












Ammonium chloride (9.65 g, 180.40 mmol, 6.20 eq) and 2-nitro-1-[2’-(4’’-benzyloxy-2’’-
nitrophenoxy)ethoxy]benzene (12.00 g, 29.20 mmol, 1.00 eq) were dissolved in 
acetone/H2O (3:1) under argon atmosphere in a miniclave (BÜCHI, Uster, Switzerland). 
Iron powder (12.60 g, 225.20 mmol, 7.70 eq) was added. The mixture was stirred for 1 –
 4 h at 70 °C. The solvent was evaporated under reduced pressure and the crude product 
purified by flash column chromatography (pentane/EE, 10:1→0:1). The product was 
obtained as brown solid (4.30 g, 16.70 mmol, 98 %). 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 4.15 – 4.29 (m, 4H, -O-CH2CH2-O-), 4.75 (s, 
4H, -O-CH2-Ph, Ph-NH2), 4.96 (s, 2H, Ph-NH2), 6.16 (dd,
 3
JH,H = 8.6 Hz, 3.0 Hz, 1H, 
Ph-NH2), 6.37 (d,
 3
JH,H = 3.0 Hz, 1H, Ph-NH2), 6.46 – 6.59 (m, 1H, Ph-NH2), 6.64 – 6.81 
(m, 3H, Ph-NH2), 6.85 (dd,
 3




C-NMR (75 MHz, [D6]DMSO): δ (ppm) = 67.72, 68.68, 69.70, 101.68, 102.08, 113.15, 
114.63, 114.81, 116.68, 121.91, 127.91, 128.04, 128.79, 138.11, 138.62, 140.02, 140.39, 
145.85, 154.13. 
 






HR-MS (ESI, MeOH):  
C21H23N2O3 [M+H]
+
  calc.: 351.1703  mesur.: 351.1702; 
C21H22N2O3Na [M+Na]
+
 calc.: 373.1523  mesur.: 373.1512. 
 












2-[2’-(2’’-Aminophenoxy)ethoxy]-5-(benzyloxy)aniline (3.80 g, 10.84 mmol, 1.00 eq), 
sodium iodide (4.47 g, 29.82 mmol, 2.75 eq) and 1,8-bis(dimethylamino)naphthalene 
(15.83 g, 73.85 mmol, 6.81 eq) were dissolved in dry ACN (21 mL) under argon 
atmosphere. Methyl bromoacetate (9.25 mL, 97.71 mmol, 9.01 eq) was added slowly and 
the solution was stirred at 80 °C for 24 h. The solvent was evaporated under reduced 
pressure and the residue was dissolved in toluene and filtered. The organic solvent was 
washed with diluted HCl and brine solution until no 1,8-bis(dimethylamino)naphthalene 
remain in the organic phase (TLC). The solvent was evaporated under reduced pressure, 
the crude product was purified by recrystallisation (Petroleum ether (60 – 80)/EE) and 
obtained as white solid (5.47 g, 8.56 mmol, 79 %). 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 3.47 – 3.53 (m, 12H, -COOMe), 4.08 – 4.16 
(m, 12H, -N-CH2-COOMe, -O-CH2CH2-O-), 4.99 (s, 2H, -O-CH2-Ph), 6.34 (d,
 
3
JH,H = 2.9 Hz, 1H, Ph-N-(CH2)2-), 6.50 (dd,
 3
JH,H = 8.8 Hz, 2.9 Hz, 1H, Ph-N-(CH2)2-), 




C-NMR (75 MHz, [D6]DMSO): δ (ppm) = 51.19, 51.23, 53.00, 67.05, 67.73, 69.47, 
105.51, 106.07, 113.32, 114.59, 118.02, 120.98, 121.21, 127.57, 127.64, 128.31, 137.32, 
138.69, 139.85, 143.88, 149.60, 152.89, 171.13, 171.21. 
 









HR-MS (ESI, MeOH):  
C33H39N2O11 [M+H]
+
  calc.: 639.2548  mesur.: 639.2549; 
C33H38N2O11Na [M+Na]
+








ethoxy)phenyl)azanediyl)diacetate (5.47 g, 8.56 mmol, 1.00 eq) was dissolved in dry DMF 
(42 mL) under argon atmosphere. Pyridine (6.91 mL, 85.65 mmol, 10.00 eq) was added 
and the reaction mixture was cooled to 0 °C. Phosphoryl chloride (6.41 mL, 68.52 mmol, 
8.00 eq) was added and stirred at 0 °C for 1.5 h. The reaction was quenched with cold 1 M 
KOH solution, the crude product was extracted with DCM (3 × 100 mL), the organic phase 
was washed with brine and dried over MgSO4. The solvent was evaporated under reduced 
pressure and the crude product was purified by filtration over SiO2 with EE. The product 
was obtained as yellow solid (5.16 g, 7.74 mmol, 90 %). 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 3.47 – 3.54 (m, 12H, -COOMe), 4.11 (m, 
8H, -N-CH2-COOMe), 4.25 (s, 4H, -O-CH2CH2-O-), 5.20 (s, 2H, -O-CH2-Ph), 6.35 (s, 1H, 
Ph-N-(CH2)2-), 6.67 – 6.75 (m, 1H, Ph-N-(CH2)2-), 6.80 – 6.95 (m, 3H, Ph-N-(CH2)2-), 
7.15 (s, 1H, Ph-N-(CH2)2-), 7.30 – 7.47 (m, 5H, O-CH2-Ph), 10.17 (s, 1H, -CHO). 
 
13
C-NMR (75 MHz, [D6]DMSO): δ (ppm) = 51.18 , 51.51, 52.97, 53.54, 66.64, 67.49, 
70.44, 102.10, 109.97, 113.09, 116.32, 117.82, 120.98, 121.12, 127.44, 127.88, 128.47, 
136.64, 138.70, 142.94, 146.05, 149.46, 156.89, 170.51, 171.25, 186.05. 
 









HR-MS (ESI, MeOH):  
C34H39N2O12 [M+H]
+
  calc.: 667.2498  mesur.: 667.2499; 
C34H38N2O12Na [M+Na]
+









ethoxy)-4-formylphenyl)azanediyl)diacetate (4.80 g, 7.20 mmol, 1.00 eq) was dissolved in 
acetic acid (14.70 mL/g educt) and 10 % Pd/C (294.10 mg/g educt) was added. The 
solution was stirred for up to 3 h under H2 atmosphere (room pressure). The reaction 
solution was filtered over celite and the solvent was evaporated under reduced pressure. 
The crude product was purified by filtration over SiO2 with EE. The product was obtained 
as white solid (3.16 g, 5.49 mmol, 76 %). 
 
1
H-NMR (300 MHz, [D6]CDCl3): δ (ppm) = 3.48 – 3.59 (m, 12H, -COOMe), 4.07 – 4.20 
(m, 12H, -N-CH2-COOMe, -O-CH2CH2-O-), 6.08 (s, 1H, Ph-N-(CH2)2-), 6.74 – 6.92 (m, 
5H, Ph-N-(CH2)2-), 9.55 (s, 1H, Ph-OH), 11.14 (s, 1H, -CHO). 
 






HR-MS (ESI, MeOH):  
C27H33N2O12 [M+H]
+
  calc.: 577.2028  mesur.: 577.2028; 
C27H32N2O12Na [M+Na]
+
 calc.: 599.1847  mesur.: 599.1852. 
 











Piperidine (1.70 mL, 1.73 mmol, 1.00 eq) was added to a solution of dimethyl 2,2'-((2-(2-
(2-(bis(2-methoxy-2-oxoethyl)amino)-5-formyl-4-
hydroxyphenoxy)ethoxy)phenyl)azanediyl)diacetate (273 mg, 1.74 mmol, 1.00 eq) in dry 
MeOH (10 mL). Then 2-cyanomethylbenzimidazole (1.00 g, 1.73 mmol, 1.00 eq) was 
added and the solution was stirred overnight under argon atmosphere at RT. The solvent 
was removed in vacuo, the product was obtained as yellow solid and used without further 
purifications. 
 






HR-MS (ESI, MeOH):  
C36H38N5O11 [M+H]
+
  calc.: 716.2562  mesur.: 716.2567; 
C36H37N5O11Na [M+Na]
+
 calc.: 738.2382  mesur.: 738.2383. 
 












Following SOP 8 the synthesis was achieved by starting with 8. The product 28 was 
obtained as a yellow solid. 
 






HR-MS (ESI, MeOH):  
C40H48N6O11S2 [M+2H]
2+
 calc.: 426.1406  mesur.: 426.1410; 
C40H47N6O11S2 [M+H]
+








Following SOP 8 the synthesis was achieved by starting with 8. The product 27 was 
obtained as a yellow solid. 
 











HR-MS (ESI, MeOH):  
C43H45N6O11S [M+H]
+
 calc.: 885.2582  mesur.: 885.2572; 
C43H44N6O11SNa [M+Na]
+








Following SOP 8 the synthesis was achieved by starting with 8. The product 30 was 
obtained as a yellow solid. 
 




HR-MS (ESI, MeOH):  
C39H42N5O13 [M+H]
+
  calc.: 788.2774  mesur.: 788.2765; 
C39H41N5O13Na [M+Na]
+
 calc.: 810.2593  mesur.: 810.2584. 












2-[2’-(2’’-Aminophenoxy)ethoxy]-5-(benzyloxy)aniline (5.55 g, 15.84 mmol, 1.00 eq), 
sodium iodide (6.53 g, 43.56 mmol, 2.75 eq) and 1,8-bis(dimethylamino)naphthalene 
(19.35 g, 90.28 mmol, 5.70 eq) were dissolved in dry ACN (32 mL) under argon 
atmosphere. tert-Butyl bromoacetate (21.10 mL, 142.70 mmol, 9.01 eq) was slowly added 
and the solution was stirred at 80 °C for 24 h. The reaction was quenched with saturated 
NaHCO3 solution and the crude product was extracted with DCM (3 × 100 mL). The 
organic phase was washed with acetic acid/brine and dried over MgSO4. The solvent was 
evaporated under reduced pressure, the crude product was purified by flash column 
chromatography (toluene/EE, 9:1) and obtained as brown solid or yellow oil (8.49 g, 
10.52 mmol, 66. %). 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 1.29 – 1.37 (m, 32H, -COOtBu), 3.98 – 4.07 
(m, 8H, -N-CH2-COOtBu), 4.18 – 4.27 (m, 4H, -O-CH2CH2-O-), 4.99 (s, 2H, -O-CH2-Ph), 
6.42 – 6.51 (m, 2H, Ph-N-(CH2)2-), 6.77 – 6.90 (m, 4H, Ph-N-(CH2)2-), 6.92 – 6.98 (m, 
1H, Ph-N-(CH2)2-), 7.26 – 7.42 (m, 5H, O-CH2-Ph). 
 
13
C-NMR (75 MHz, [D6]DMSO): δ (ppm) = 27.64, 54.06, 67.47, 68.47, 69.47, 80.15, 
80.25, 106.05, 106.80, 114.62, 116.67, 119.03, 121.09, 121.36, 127.16, 127.45, 128.13, 
137.19, 138.79, 140.17, 143.96, 149.85, 153.17, 169.33, 169.40. 
 











HR-MS (ESI, MeOH):  
C45H63N2O11 [M+H]
+
  calc.: 807.4426  mesur.: 807.4413; 
C45H62N2O11Na [M+Na]
+








phenoxy)ethoxy)phenyl)azanediyl)diacetate (8.49 g, 10.52 mmol, 1.00 eq) was dissolved 
in dry DMF (52 mL) under an argon atmosphere. Pyridine (8.49 mL, 105.19 mmol, 
10.00 eq) was added and the reaction mixture was cooled to 0 °C. Phosphoryl chloride 
(7.87 mL, 84.15 mmol, 8.00 eq) was added and stirred at 0 °C for 1.5 h. The reaction was 
quenched with cold 1 M KOH solution and the crude product was extracted with DCM 
(3 × 100 mL). Subsequently, the organic phase was washed with brine and dried over 
MgSO4. The solvent was evaporated under reduced pressure and the crude product was 
purified by filtration over SiO2 with EE. The contaminated product was obtained as orange 
solid (8.42 g) and used directly in the next step. 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 1.32 (s, 18H, -COOtBu), 1.36 (s, 
18H, -COOtBu), 4.00 (s, 4H, -N-CH2-COOtBu), 4.20 (s, 4H, -N-CH2-COOtBu), 4.25 (s, 
4H, -O-CH2CH2-O-), 5.16 (s, 2H, -O-CH2-Ph), 6.42 (s, 1H, Ph-N-(CH2)2-), 6.77 – 6.89 (m, 
3H, Ph-N-(CH2)2-), 6.93 – 6.99 (m, 1H, Ph-N-(CH2)2-), 7.20 (s, 1H, Ph-N-(CH2)2-), 7.32 –
 7.48 (m, overlay by pyridine, O-CH2-Ph), 10.15 (s, 1H, -CHO). 
 
13
C-NMR (75 MHz, [D6]DMSO): δ (ppm) = 28.14, 54.48, 55.09, 66.81, 67.65, 68.54, 
70.97, 80.75, 81.29, 102.78, 111.99, 115.19, 116.82, 119.59, 121.86, 121.96, 127.95, 
128.50, 129.02, 136.95, 143.49, 150.34, 169.49, 170.12, 186.44. 
 










HR-MS (ESI, MeOH):  
C46H63N2O12 [M+H]
+
  calc.: 835.4376  mesur.: 835.4364; 
C46H62N2O12Na [M+Na]
+








phenoxy)ethoxy)-4-formylphenyl)azanediyl)diacetate (8.42 g) was dissolved in acetic acid 
(15.00 mL/g educt) and 10 % Pd/C (294.10 mg/g educt) was added. The solution was 
stirred for up to 3 h under H2 atmosphere (room pressure). The reaction solution was 
filtered over celite and the solvent was evaporated under reduced pressure. The crude 
product was purified by flash column chromatography (toluene/EE, 9:1→8:2). The product 
was obtained after lyophilisation as yellow solid (1.61 g, 2.16 mmol, 21 % over 2 steps). 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 1.37 (s, 18H, -COOtBu), 1.42 (s, 
18H, -COOtBu), 4.06 (s, 4H, , -N-CH2-COOtBu), 4.20 (s, 4H, -N-CH2-COOtBu), 4.24 –
 4.33 (m, 4H, -O-CH2CH2-O-), 6.16 (s, 1H, Ph-N-(CH2)2-), 6.83 – 6.95 (m, 3H, 
Ph-N-(CH2)2-), 6.98 – 7.04 (m, 1H, Ph-N-(CH2)2-), 7.23 (s, 1H, Ph-N-(CH2)2-), 9.93 (s, 
1H, -CHO), 10.63 (s, 1H, -OH). 
 
13
C-NMR (75 MHz, [D6]DMSO): δ (ppm) = 27.64, 54.00, 54.68, 67.16, 68.24, 80.25, 
80.78, 103.51, 113.48, 114.00, 114.73, 119.18, 121.34, 121.49, 139.00, 142.06, 147.12, 
149.88, 157.42, 168.89, 169.60, 189.67. 
 











HR-MS (ESI, MeOH):  
C45H63N2O11 [M+H]
+
  calc.: 745.3906  mesur.: 745.3901; 
C45H62N2O11Na [M+Na]
+







Piperidine (4.51 mL, 45.64 mmol, 10.00 eq) was added to a solution of di-tert-butyl 2,2'-
((2-(2-(2-(bis(2-(tert-butoxy)-2-oxoethyl)amino)-5-formyl-4-
hydroxyphenoxy)ethoxy)phenyl)azanediyl)diacetate (3.40 g, 4.56 mmol, 1.00 eq) in dry 
MeOH (10 mL). Then benzothiazole-2-yl-acetonitrile (795 mg, 4.56 mmol, 1.00 eq) was 
added and the solution was stirred overnight under argon atmosphere at room temperature. 
The precipitate was filtered and washed with dry ether and dried under reduced pressure. 
The product was obtained as yellow solid (3.03 g, 3.37 mmol, 74 %) 
 
1
H-NMR (300 MHz, CDCl3): δ (ppm) = 1.42 (s, 18H, -COOtBu), 1.48 (s, 18H, -COO
t
Bu), 
4.09 (s, 4H, -N-CH2-COO
t
Bu), 4.17 (s, 4H, -N-CH2-COO
t
Bu), 4.34 – 4.40 (m, 
4H, -O-CH2CH2-O-), 6.56 (s, 1H, Ph-N-(CH2)2-), 6.90 – 6.95 (m, 4H, Ph-N-(CH2)2-), 7.06 
(s, 1H, Ph-N-(CH2)2-), 7.33 – 7.56 (m, 2H, benzothiazole), 7.93 (d,
 3
JH,H = 7.8 Hz, 1H, 
benzothiazole), 8.05 (d,
 3
JH,H = 8.0 Hz, 1H, benzothiazole), 8.48 (bs, 1H, HAr). 
 
13
C-NMR (75 MHz, CDCl3): δ (ppm) = 28.14, 54.54, 54.85, 67.59, 68.69, 81.14, 81.91, 
104.24, 113.39, 115.59, 119.91, 121.33, 122.16, 122.26, 126.17, 139.89, 146.18, 149.86, 
150.34, 169.52, 170.33. 
 











HR-MS (ESI, MeOH):  
C48H61N4O11S [M+H]
+
 calc.: 901.4052  mesur.: 901.4051, 
C48H60N4O11SNa [M+Na]
+








Following SOP 8 38 was achieved by using di-tert-butyl 2,2'-((3-(benzothiazol-2-yl)-6-(2-
(2-(bis(2-(tert-butoxy)-2-oxoethyl)amino)phenoxy)ethoxy)-2-imino-2H-chromen-7-yl)-
azanediyl)diacetate (2.55 g, 2.83 mmol, 1.00 eq) and 3-aminopropanoic acid hydrochloride 
(250 mg, 2.83 mmol, 1.00 eq). The crude product was purified by flash column 
chromatography (pentane/EE, 1:2→0:1). The product was obtained after lyophilisation as 
orange solid (1.49 g, 1.53 mmol, 54 %). 
 
1
H-NMR (300 MHz, CDCl3): δ (ppm) = 1.38 (s, 18H, -COOtBu), 1.44 (s, 18H, -COO
t
Bu), 
2.79 – 2.86 (m, 2H, N-CH2-CH2-COOH ), 3.82 – 3.89 (m, 2H, N-CH2-CH2-COOH ),4.06 
(s, 4H, -N-CH2-COO
t
Bu), 4.15 (s, 4H, -N-CH2-COO
t
Bu), 4.32 – 4.38 (m, 4H, -O-
CH2CH2-O-), 6.56 (s, 1H, Ph-N-(CH2)2-), 6.88 – 6.91 (m, 4H, Ph-N-(CH2)2-), 7.05 (s, 1H, 
Ph-N-(CH2)2-), 7.25 – 7.44 (m, 2H, benzothiazole), 7.81 – 7.87 (m, 1H, benzothiazole), 
7.94 – 7.99 (m, 1H, benzothiazole), 8.48 (s, 1H, HAr). 
 
13
C-NMR (126 MHz, CDCl3): δ (ppm) = 28.17, 28.19, 35.26, 41.90, 54.57, 54.88, 67.67, 
68.65, 81.11, 81.88, 104.34, 111.77, 113.40, 115.64, 118.83, 119.88, 121.30, 122.10, 
122.19, 122.54, 124.65, 125.92, 134.88, 136.38, 139.80, 143.97, 146.44, 149.26, 150.11, 
150.26, 152.18, 161.23, 169.41, 170.17, 175.52. 
 











HR-MS (ESI, MeOH):  
C51H65N4O13S [M+H]
+
 calc.: 973.4263  mesur.: 973.4265; 
C51H64N4O13SNa [M+Na]
+
 calc.: 995.4083  mesur.: 995.4083. 
6.5.5 Acid-labile MOBHA-based Ca2+-sensor 





4-Benzyloxy-2-nitrophenol (6.00 g, 24.50 mmol, 1.00 eq) and dry potassium carbonate 
(3.38 g, 24.50 mmol, 1.00 eq) were dissolved in dry DMF (14 mL) and heated to 120 °C 
under an argon atmosphere. Methyl bromoacetate (2.55 mL, 26.90 mmol, 1.10 eq) was 
added and the mixture was stirred for 5-10 min. The reaction process was monitored by 
TLC. Afterwards, the mixture was diluted with saturated sodium bicarbonate solution, 
extracted with DCM and dried over MgSO4. The solvent was evaporated under reduced 
pressure and the crude product was purified by flash column chromatography (pentane/EE, 
3:1). The product was obtained as yellow solid (6.40 g, 20.20 mmol, 82 %). 
 
TLC (pentane/EE 2:1): Rf = 0.63. 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 3.69 (s, 3H, -COOMe), 4.95 (s, 2H, -O-CH2-
COOMe), 5.15 (s, 2H, -O-CH2-Ph), 7.22 – 7.49 (m, 7H, O-CH2-Ph, Ph-NO2), 7.52 – 7.60 
(m, 1H, Ph-NO2). 
 
13
C-NMR (75 MHz, [D6]DMSO): δ (ppm) = 52.39, 66.56, 70.63, 111.03, 117.39, 121.35, 
128.27, 128.48, 128.93, 136.89, 140.49, 144.82, 152.55, 169.08. 
 













HR-MS (ESI, MeOH):  
C16H16NO6 [M+H]
+
  calc.: 318.0972  mesur.: 318.0967; 
C16H15NO6Na [M+Na]
+






2-(4-(Benzyloxy)-2-nitrophenoxy)methyl acetate (5.41 g, 17.10 mmol, 1.00 eq) and 
ammonium chloride (5.63 g, 105.20 mmol, 6.20 eq) were dissolved in acetone/H2O (3:1) 
under argon atmosphere in a miniclave (BÜCHI, Uster, Switzerland). Iron powder (7.33 g, 
131.30 mmol, 7.70 eq) was added and the mixture was stirred for 1 h at 80 °C. The crude 
product was purified by filtration over SiO2 in DCM. The solvent was dried over MgSO4, 
evaporated under reduced pressure and the product was obtained as colourless solid 
(4.30 g, 16.70 mmol, 98 %). 
 
TLC (pentane/EE 2:1): Rf = 0.40. 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 4.49 (s, 2H, CO-CH2-O), 5.02 (s, 2H, -O-
CH2-Ph), 6.52 – 6.62 (m, 2H, -Ph-NH-), 6.81 – 6.92 (m, 1H, -Ph-NH-), 7.26 – 7.48 (m, 5H, 
-O-CH2-Ph), 10.64 (s, 1H, NHCO). 
 
13
C-NMR (75 MHz, [D6]DMSO): δ (ppm) = 67.31, 70.11, 103.33, 108.91, 116.97, 128.05, 
128.25, 128.52, 128.86, 137.50, 137.83, 154.09, 165.69. 
 








HR-MS (ESI, MeOH):  
C15H14NO3 [M+H]
+
  calc.: 256.0968  mesur.: 256.0977; 
C15H13NO3Na [M+Na]
+
 calc.: 278.0788  mesur.: 278.0797. 











6-(Benzyloxy)-2H-benzo[b][1,4]oxazin-3(4H)-one (4.26 g, 16.69 mmol, 1.0 eq) was 
dissolved in dry THF (100 mL). Di-tert-butyl dicarbonate (5.11 g, 23.41 mmol, 1.5 eq), 
diisopropylethylamine (5.31 mL, 31.21 mmol, 2 eq) and 4-(dimethylamino)-pyridin 
(catalytic amount) were added and the solution was stirred at RT for 5 h. The reaction 
process was monitored by TLC. Subsequently, the reaction was treated with a 3 M KOH 
solution, the solvent was removed under reduced pressure and the crude product was 
purified by flash column chromatography (pentane/EE, 2:1). The product was obtained as 
yellow oil (4.72 g, 13.28 mmol, 80 %) 
 
TLC (pentane/EE 2:1): Rf = 0.80. 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 1.52 (s, 9H, Boc-NH), 4.63 (s, 2H, CO-CH2-
O), 5.07 (s, 2H, -O-CH2-Ph), 6.69 (d,
 3
JH,H = 2.8 Hz, 1H, -Ph-NH-), 6.75 – 6.82 (m, 1H, -
Ph-NH-), 7.00 – 7.06 (m, 1H, -Ph-NH-), 7.28 – 7.45 (m, 5H, -O-CH2-Ph). 
 
13
C-NMR (75 MHz, [D6]DMSO): δ (ppm) = 27.69, 68.29, 70.32, 86.17, 105.02, 111.61, 
118.21, 127.03, 128.00, 128.34, 128.88, 128.93, 137.29, 139.35, 149.65, 154.16, 164.66. 
 








HR-MS (ESI, MeOH):  
C20H22NO5 [M+H]
+
  calc.: 356.1492  mesur.: 356.1506; 
C20H21NO5Na [M+Na]
+
 calc.: 378.1312  mesur.: 378.1327. 
 











(4.72 g, 13.28 mmol, 1.00 eq) was dissolved in dry THF (30 mL) and cooled down to 0 °C. 
Isobutyl chloroformate (2.07 g, 15.17 mmol, 1.20 eq), triethylamine (2.10 mL, 
15.17 mmol, 1.20 eq) and morpholine (2.86 g, 32.87 mmol, 2.60 eq) were added and the 
solution was stirred at RT for 4 – 6 h. The reaction was quenched with acetic acid followed 
by the addition of a saturated aqueous solution of sodium bicarbonate. The aqueous phase 
was extracted with ethyl acetate (3 × 100 mL), the combined organic phases were washed 
with saturated aqueous solution of ammonium chloride (3 × 60 mL) and saturated aqueous 
solution of sodium chloride (60 mL), followed by drying over magnesium sulphate. The 
solvent was removed under reduced pressure. The crude product was purified by flash 
column chromatography (Pentane/EE 1:2). The product was obtained as white solid 
(3.13 g, 7.07 mmol, 53 %). 
 
TLC (pentane/EE 1:2): Rf = 0.30. 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 1.48 (s, 9H, Boc-NH), 3.34 – 3.48 (m, 
4H, -N-CH2-CH2-O), 3.53 – 3.61 (m, 4H, -N-CH2-CH2-O), 4.87 (s, 2H, CON-CH2-O), 
5.03 (s, 2H, -O-CH2-Ph), 6.62 (dd,
 3
JH,H = 8.9 Hz, 3.0 Hz, 1H, -Ph-NH-), 6.98 (d,
 
3
JH,H = 8.9 Hz, 1H, -Ph-NH-), 7.27 – 7.47 (m, 5H, -O-CH2-Ph), 7.53 (d,
 3
JH,H = 3.0 Hz, 1H, 
-Ph-NH-), 8.59 (s, 1H, Boc-NH). 
 
13
C-NMR (75 MHz, [D6]DMSO): δ (ppm) = 28.50, 42.11, 44.73, 66.29, 66.42, 69.67, 
69.99, 79.92, 107.33, 108.66, 117.18, 127.99, 128.18, 128.83, 130.85, 137.69, 142.93, 
152.83, 153.81, 167.74. 
 













HR-MS (ESI, MeOH):  
C24H31N2O6 [M+H]
+
  calc.: 443.2177  mesur.: 443.2187; 
C24H30N2O6Na [M+Na]
+
 calc.: 465.1996  mesur.: 465.2008; 
C24H34N3O6 [M+NH4]
+







tert-Butyl (5-(benzyloxy)-2-(2-morpholino-2-oxoethoxy)phenyl)carbamate (3.13 g, 
7.07 mmol, 1.00 eq) was suspended in 4 M aq HCl in dioxane (40 mL) and stirred for 2 h. 
The solvent was evaporated under reduced pressure and the crude product was lyophilised 
from dioxane. The intermediate product was obtained as white solid (2.42 g, 7.07 mmol) 
and was dissolved in dry ACN (7.8 mL) under argon atmosphere. Sodium iodide (1.59 g, 
10.60 mmol, 1.50 eq), 1,8-bis(dimethylamino)naphthalene (6.06 g, 28.27 mmol, 4.00 eq) 
and tert-butyl bromoacetate (5.22 mL, 35.34 mmol, 5.00 eq) were added slowly and the 
solution was stirred at 80 °C for 24 h. The reaction was quenched with saturated NaHCO3 
solution, the crude product was extracted with DCM (3 × 100 mL), the organic phase was 
washed with acetic acid/brine and dried over MgSO4. The solvent was evaporated under 
reduced pressure, the crude product was purified by flash column chromatography 
(toluene/EE) and obtained as red oil (2.92 g, 7.07 mmol, 73 %). 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 1.37 (s, 18H, -COOtBu), 3.41 – 3.48 (m, 4H, 
-N-CH2-CH2-O), 3.53 – 3.60 (m, 4H, -N-CH2-CH2-O), 4.01 – 4.07 (m, 4H, -N-CH2-
COOtBu), 4.72 (s, 2H, CON-CH2-O), 4.99 (s, 2H, -O-CH2-Ph), 6.36 – 6.51 (m, 2H, -Ph-
NH-), 6.80 (d,
 3
JH,H = 8.8 Hz, 1H, -Ph-NH-), 7.28 – 7.43 (m, 5H, -O-CH2-Ph). 
 
13
C-NMR (75 MHz, [D6]DMSO): δ (ppm) = 28.21, 54.53, 60.20, 66.51, 67.67, 69.93, 
80.80, 106.24, 107.17, 115.90, 127.87, 128.14, 128.82, 137.87, 140.28, 144.20, 153.62, 
166.74, 170.24. 











HR-MS (ESI, MeOH):  
C31H43N2O8 [M+H]
+
  calc.: 571.3014  mesur.: 571.3015; 
C31H42N2O8Na [M+Na]
+








acetate (2.92 g, 5.12 mmol, 1.00 eq) was dissolved in dry DMF (25.0 mL) under argon 
atmosphere. Pyridine (4.13 mL, 51.17 mmol, 10.00 eq) was added and the reaction mixture 
was cooled to 0 °C. Phosphoryl chloride (3.83 mL, 40.93 mmol, 8.00 eq) was added and 
stirred at 0 °C for 1.5 h. The reaction was quenched with cold 1 M KOH solution, the crude 
product was extracted with DCM (3 × 100 mL), the organic phase was washed with brine 
and dried over MgSO4. The solvent was evaporated under reduced pressure and the crude 
product was purified by filtration over SiO2 with EE. The product was obtained as brown 
solid (2.52 g) and used directly in the next step. 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 1.41 (s, 18H, -COOtBu), 3.43 – 3.50 (m, 4H, 
-N-CH2-CH2-O), 3.54 – 3.63 (m, overlaid by dioxane, -N-CH2-CH2-O), 4.22 (s, 4H, -N-
CH2-COOtBu), 4.82 (s, 2H, CON-CH2-O), 5.16 (s, 2H, -O-CH2-Ph), 6.39 (s, 1H, -Ph-
NH-), 7.12 (s, 1H, -Ph-NH-), 7.32 – 7.49 (m, 5H, -O-CH2-Ph), 10.13 (s, 1H, CHO). 
 
13
C-NMR (75 MHz, [D6]DMSO): δ (ppm) = 28.23, 42.09, 45.09, 55.13, 66.74, 66.81, 
70.96, 81.16, 102.58, 111.31, 116.64, 127.95, 128.50, 129.02, 136.96, 143.15, 146.89, 
157.54, 166.22, 169.72, 186.45. 
 










HR-MS (ESI, MeOH):  
C32H43N2O9 [M+H]
+
  calc.: 599.2963  mesur.: 599.2965; 
C32H42N2O9Na [M+Na]
+








azanediyl)diacetate (2.52 g) was dissolved in acetic acid (15.00 mL/g educt) and 10 % 
Pd/C (294.10 mg/g educt) was added. The solution was stirred for up to 2 h under H2 
atmosphere (room pressure). The reaction solution was filtered over celite and the solvent 
was evaporated under reduced pressure. The crude product was purified by flash column 
chromatography (pentane/EE, 1:2→0:1). The product was obtained after lyophilisation as 
white solid (1.57 g, 3.09 mmol, 60 % over 2 steps). 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 1.41 (s, 18H, -COOtBu), 3.43 – 3.51 (m, 4H, 
-N-CH2-CH2-O), 3.52 – 3.65 (m, overlaid by dioxane, -N-CH2-CH2-O), 4.18 (s, 4H, -N-
CH2-COOtBu), 4.77 (s, 2H, CON-CH2-O), 6.08 (s, 1H, -Ph-NH-), 7.07 (s, 1H, -Ph-NH-), 
9.88 (s, 1H, CHO), 10.50 (s, 1H, OH). 
 
13
C-NMR (75 MHz, [D6]DMSO): δ (ppm) = 28.22, 42.06, 45.07, 55.21, 66.81, 66.94, 
81.15, 103.90, 113.13, 113.90, 142.25, 147.47, 157.89, 166.27, 169.61, 189.61. 
 






HR-MS (ESI, MeOH):  
C25H37N2O9 [M+H]
+
  calc.: 509.2494  mesur.: 509.2492, 
C25H36N2O9Na [M+Na]
+
 calc.: 531.2313  mesur.: 531.2313. 











To a solution of di-tert-butyl 2,2'-((4-formyl-5-hydroxy-2-(2-morpholino-2-
oxoethoxy)phenyl)azanediyl)diacetate (1.57 g, 3.09 mmol, 1.00 eq) in dry MeOH (10 mL), 
piperidine (3.05 mL, 30.87 mmol, 10.00 eq) was added. Then Benzothiazole-2-yl-
acetonitrile (540 mg, 3.09 mmol, 1.0 eq) was added and the solution was stirred overnight 
under argon atmosphere at RT. The precipitate was filtered and washed with dry ether and 
dried under reduced pressure. The product was obtained by flash column chromatography 
(pentane/ethanol, 1:1) as orange solid (1.44 g, 2.17 mmol, 70 %) 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 1.38 – 1.41 (m, 18H, -COOtBu), 3.41 – 3.54 
(m, 4H, -N-CH2-CH2-O), 3.57 – 3.69 (m, 4H, -N-CH2-CH2-O), 4.15 – 4.26 (m, 4H, -N-
CH2-COOtBu), 4.87 (s, 2H, CON-CH2-O), 6.42 (s, 1H, -Ph-NH-), 7.30 – 7.65 (m, 3H, 
benzothiazole, -Ph-NH-), 7.98 (d,
 3
JH,H = 8.1 Hz, 1H, benzothiazole), 8.09 (d,
 
3
JH,H = 7.8 Hz, 1H, benzothiazol), 8.63 (bs, 1H, HAr), 8.72 (bs, 1H, =NH) 
 
13
C-NMR (75 MHz, [D6]DMSO): δ (ppm) = 28.24, 42.03, 44.92, 55.13, 66.54, 81.15, 
103.25, 110.88, 112.64, 117.82, 122.30, 122.42, 125.02, 126.60, 135.93, 137.08, 143.83, 
145.37, 149.72, 152.30, 154.53, 165.97, 169.83. 
 






HR-MS (ESI, MeOH):  
C34H41N4O8S [M+H]
+
  calc.: 665.2640  mesur.: 665.2641. 











Following SOP 8 46 was achieved with di-tert-butyl 2,2'-((3-(benzothiazol-2-yl)-6-(2-(2-
(bis(2-(tert-butoxy)-2-oxoethyl)amino)phenoxy)ethoxy)-2-imino-2H-chromen-7-
yl)azanediyl)diacetate (1.14 g, 1.71 mmol, 1.00 eq) and 3-aminopropanoic acid 
hydrochloride (215 mg, 1.71 mmol, 1.00 eq). The crude product was purified by flash 
column chromatography (pentane/EE, 1:2→0:1). The product was obtained after 
lyophilisation as red solid (745 mg, 1.01 mmol, 59.0 %). 
 
1
H-NMR (300 MHz, [D6]DMSO): δ (ppm) = 1.38 - 1.51 (m, 18H, -COOtBu), 2.67 – 2.81 
(m, 2H, N-CH2-CH2-COOH ), 3.50 – 3.857 (m, 2H, N-CH2-CH2-COOH ), 3.58 – 3-76 (m, 
8H, -N-CH2-CH2-O, -N-CH2-CH2-O), 4.02 – 4.14 (m, 4H, -N-CH2-COOtBu), 4.71 – 4.78 
(m, 2H, CON-CH2-O), 6.39 (s, 1H, -Ph-NH-), 6.92 (s, 1H, -Ph-NH-), 7.10 – 7.36 (m, 3H, 
benzothiazole), 7.79 (dd,
 3
JH,H = 8.0 , 25.1Hz, 2H, benzothiazole), 8.15 (s, 1H, HAr). 
 
13
C-NMR (126 MHz, [D6]DMSO): δ (ppm) = 28.23, 42.17, 42.40, 45.49, 54.75, 66.74, 
66.83, 68.53, 81.84, 104.81, 112.10, 113.93, 121.28, 122.36, 124.57, 125.82, 136.60, 
143.75, 145.75, 149.44, 151.98, 161.31, 166.14, 169.48. 
 




HR-MS (ESI, MeOH):  
C37H45N4O10S [M+H]
+
 calc.: 737.2851  mesur.: 737.2844; 
C37H44N4O10Na [M+Na]
+
 calc.: 759.2670  mesur.: 759.2668.  


















Pep Met 1 
C199H332N38O29 
3718.57 g/mol 
The peptide Pep Met 1 was synthesised following SOP 6 using the amino acids described 
in Chapter 6.5.1. 
 











HR-MS (ESI, MeOH):  
 C199H335N38O29 [M+3H]
3+
 calculated: 1241.1984 measured: 1241.2000; 
 C199H336N38O29 [M+4H]
4+
 calculated: 931.1506  measured: 931.1521; 
 C199H337N38O29 [M+5H]
5+
 calculated: 745.1219  measured: 745.1233; 
C199H33 N38O29 [M+6H]
6+
 calculated: 621.1028  measured: 621.1035. 
 
HPLC (analytic, A (H2O + 0.1 % TFA + 0.1 HFIP), B (MeOH + 0.1 % TFA + 0.1 HFIP), 














Pep Met 2 
C190H316N36O29 
3534.45 g/mol 
The peptide Pep Met 2 was synthesised following SOP 6 using the amino acids described 
in Chapter 6.5.1. 
 















HR-MS (ESI, MeOH):  
C190H318N36O29 [M+2H]
2+
 calculated: 1769.2333 measured: 1769.2345; 
 C190H319N36O29 [M+3H]
3+
 calculated: 1179.8246 measured: 1179.8267; 
 C190H320N36O29 [M+4H]
4+
 calculated: 885.1203  measured: 885.1218; 
 C190H321N36O29 [M+5H]
5+
 calculated: 708.2977  measured: 708.2987; 
C190H322N36O29 [M+6H]
6+
 calculated: 590.4160  measured: 590.4164. 
 
HPLC (analytic, A (H2O + 0.1 % TFA + 0.1 HFIP), B (MeOH + 0.1 % TFA + 0.1 HFIP), 

















The peptide Pep 1 was synthesised following SOP 5 using the amino acids described in 
Chapter 6.5.1. 
 











HR-MS (ESI, MeOH):  
 C148H271N29O23 [M+2H]
2+
 calculated: 1412.0473 measured: 1412.0488; 
 C148H272N29O23 [M+3H]
3+
 calculated: 941.7007  measured: 941.7014; 
 C148H273N29O23 [M+4H]
4+
 calculated: 706.5273  measured: 706.5281; 
 C148H274N29O23 [M+5H]
5+
 calculated: 565.4233  measured: 565.4235. 
 
HPLC (preparative, A (H2O + 0.1 % TFA), B (MeOH + 0.1 % TFA), 90.0→100.0 % B, 
30 min, RT): tR = 8.6 min. 
 




















The peptide Pep 2 was synthesised following SOP 5 using the amino acids described in 
Chapter 6.5.1. 
 











HR-MS (ESI, MeOH):  
 C148H271N29O23 [M+2H]
2+
 calculated: 1412.0473 measured: 1412.0475; 
 C148H272N29O23 [M+3H]
3+
 calculated: 941.7007  measured: 941.7015; 
 C148H273N29O23 [M+4H]
4+
 calculated: 706.5273  measured: 706.5277; 
 C148H274N29O23 [M+5H]
5+
 calculated: 565.4233  measured: 565.4234. 
 
HPLC (preparative, A (H2O + 0.1 % TFA), B (MeOH + 0.1 % TFA), 90.0→100.0 % B, 

















The peptide Pep 3 was synthesised following SOP 5 using the amino acids described in 
Chapter 6.5.1. 
 
















HR-MS (ESI, MeOH):  
 C166H307N29O23 [M+3H]
3+
 calculated: 1025.7946 measured: 1025.7949; 
 C166H308N29O23 [M+4H]
4+
 calculated: 769.5977  measured: 769.5983; 
 C166H309N29O23 [M+5H]
5+
 calculated: 615.8797  measured: 615.8797. 
 
HPLC (preparative, A (H2O + 0.1 % TFA), B (MeOH + 0.1 % TFA), 92.0→100.0 % B, 

















The peptide Pep 4 was synthesised following SOP 5 using the amino acids described in 
Chapter 6.5.1. 
 











HR-MS (ESI, MeOH):  
 C166H307N29O23 [M+2H]
2+
 calculated: 1538.1882 measured: 1538.1895; 
 C166H308N29O23 [M+3H]
3+
 calculated: 1025.7946 measured: 1025.7952; 
 C166H309N29O23 [M+4H]
4+
 calculated: 769.5977  measured: 769.5991; 
 C166H310N29O23 [M+5H]
5+
 calculated: 615.8797  measured: 615.8815. 
 
HPLC (preparative, A (H2O + 0.1 % TFA), B (MeOH + 0.1 % TFA), 92.0→98.0 % B, 
30 min, RT): tR = 16.3 min. 




















The peptide Pep 5 was synthesised following SOP 5 using the amino acids described in 
Chapter 6.5.1. 
 











HR-MS (ESI, MeOH):  
 C138H255N25O19 [M+2H]
2+
 calculated: 1283.9888 measured: 1283.9893; 
 C138H256N25O19 [M+3H]
3+
 calculated: 856.3283  measured: 856.3288; 
 C138H257N25O19 [M+4H]
4+
 calculated: 642.4980  measured: 642.4987; 
 C138H258N25O19 [M+5H]
5+
 calculated: 514.1999  measured: 514.1998. 
 
HPLC (preparative, A (H2O + 0.1 % TFA), B (MeOH + 0.1 % TFA), 87.0→95.0 % B, 

















The peptide Pep 6 was synthesised following SOP 5 using the amino acids described in 
Chapter 6.5.1. 
 
















HR-MS (ESI, MeOH):  
 C138H255N25O19 [M+2H]
2+
 calculated: 1283.9888 measured: 1283.9888; 
 C138H256N25O19 [M+3H]
3+
 calculated: 856.3283  measured: 856.3283; 
 C138H257N25O19 [M+4H]
4+
 calculated: 642.4980  measured: 642.4978; 
 C138H258N25O19 [M+5H]
5+
 calculated: 514.1999  measured: 514.1989. 
 
HPLC (preparative, A (H2O + 0.1 % TFA), B (MeOH + 0.1 % TFA), 85.0→95.0 % B, 

















The peptide Pep 7 was synthesised following SOP 5 using the amino acids described in 
Chapter 6.5.1. 
 








HR-MS (ESI, MeOH):  
 C140H257N25O20 [M+2H]
2+
 calculated: 1304.9941 measured: 1304.9937; 
 C140H258N25O20 [M+3H]
3+
 calculated: 870.3318  measured: 870.3311; 
 C140H259N25O20 [M+4H]
4+
 calculated: 653.0007  measured: 652.9996. 
 
HPLC (preparative, A (H2O + 0.1 % TFA), B (MeOH + 0.1 % TFA), 90.0→100.0 % B, 
90 min, RT): tR = 14.4 min. 
 




















The peptide Pep 8 was synthesised following SOP 5 using the amino acids described in 
Chapter 6.5.1. 
 











HR-MS (ESI, MeOH):  
 C140H257N25O20 [M+2H]
2+
 calculated: 1304.9941 measured: 1304.9950; 
 C140H258N25O20 [M+3H]
3+
 calculated: 870.3318  measured: 870.3326; 
 C140H259N25O20 [M+4H]
4+
 calculated: 653.0007  measured: 653.0013. 
 
HPLC (preparative, A (H2O + 0.1 % TFA), B (MeOH + 0.1 % TFA), 87.0→95.0 % B, 






















The peptide Pep 9 was synthesised following SOP 5 using the amino acids described in 
Chapter 6.5.1. 
 
















HR-MS (ESI, MeOH):  
 C166H295N29O23 [M+2H]
2+
 calculated: 1532.1413 measured: 1532.1408; 
 C166H296N29O23 [M+3H]
3+
 calculated: 1021.7633 measured: 1021.7637; 
 C166H297N29O23 [M+4H]
4+
 calculated: 766.5743  measured: 766.5753; 
 C166H298N29O23 [M+5H]
5+
 calculated: 613.4609  measured: 613.4613. 
 
HPLC (preparative, A (H2O + 0.1 % TFA), B (MeOH + 0.1 % TFA), 92.0→98.0 % B, 
























The peptide Pep 10 was synthesised following SOP 5 using the amino acids described in 
Chapter 6.5.1. 
 











HR-MS (ESI, MeOH):  
 C166H298N29O23 [M+3H]
3+
 calculated: 1022.4352 measured: 1022.4364; 
 C166H299N29O23 [M+4H]
4+
 calculated: 767.0782  measured: 767.0780; 
 C166H300N29O23 [M+5H]
5+
 calculated: 613.8640  measured: 613.8644. 
 
HPLC (preparative, A (H2O + 0.1 % TFA), B (MeOH + 0.1 % TFA), 93.0→97.0 % B, 
30 min, RT): tR = 11.9 min. 
 

























The peptide Pep 11 was synthesised following SOP 5 using the amino acids described in 
Chapter 6.5.1. 
 











HR-MS (ESI, MeOH):  
 C189H313N37O27 [M+2H]
2+
 calculated: 1767.7153 measured: 1767.7143; 
 C189H314N37O27 [M+3H]
3+
 calculated: 1178.8126 measured: 1178.8141; 
 C189H315N37O27 [M+4H]
4+
 calculated: 884.3613  measured: 884.3626; 
 C189H316N37O27 [M+5H]
5+
 calculated: 707.6905  measured: 707.6915. 
 
HPLC (preparative, A (H2O + 0.1 % TFA), B (MeOH + 0.1 % TFA), 91.5→93.0 % B, 













The peptide Pep 12 was synthesised following SOP 5 using the amino acids described in 
Chapter 6.5.1. 
 













HR-MS (ESI, MeOH):  
C59H118N15O9 [M+H]
+
 calculated: 1180:9231 measured: 1180:9225; 
 C59H117N15O9 Na [M+Na]
+ 
calculated: 1202.9051 measured: 1202.9043; 
 C59H119N15O9 [M+2H]
2+
 calculated: 590.9652  measured: 590.9639. 
 
HPLC (preparative, A (H2O + 0.1 % TFA), B (80 % ACN + 20 % H2O + 0.1 % TFA), 


















The peptide Pep 13 was synthesised following SOP 6 using the amino acids described in 
Chapter 6.5.1. The fluorophore labelling was carried out in compliance with SOP 9. 
 













HR-MS (ESI, MeOH):  
C214H333N37O34 [M+2H]
2+
 calculated: 1983.7758 measured: 1983.7778; 
 C214H334N37O34 [M+3H]
3+
 calculated: 1322.8529 measured: 1322.8549; 
 C214H335N37O34 [M+4H]
4+
 calculated: 992.3915  measured: 992.3928; 
 C214H336N37O34 [M+5H]
5+
 calculated: 794.1147  measured: 794.1161; 
 C214H337N37O34 [M+6H]
6+
 calculated: 661.9301  measured: 661.9309. 
 
HPLC (semi-preparative, A (H2O + 0.1 % TFA + 0.1 % HFIP), B (MeOH + 0.1 % 
TFA+ 0.1 % HFIP), probe dissolved in 100 % HFIP, 88.0→100.0 % B, 30 min, 60 °C): 
tR = 12.0 min. 
 

























The peptide Pep 14 was synthesised following SOP 6 using the amino acids described in 
Chapter 6.5.1. The fluorophore labelling was carried out in compliance with SOP 9. 
 















HR-MS (ESI, MeOH):  
 C253H409N46O40 [M+3H]
3+
 calculated: 1578.0476 measured: 1578.0492; 
 C253H410N46O40 [M+4H]
4+
 calculated: 1183.7875 measured: 1183.7887; 
 C253H411N46O40 [M+5H]
5+
 calculated: 947.2315  measured: 947.2325; 
 C253H412N46O40 [M+6H]
6+
 calculated: 789.5274  measured: 789.5277; 
 C253H413N46O40 [M+7H]
7+
 calculated: 677.0251  measured: 677.0253; 
 C253H414N46O40 [M+8H]
8+
 calculated: 592.5229  measured: 592.5230. 
 
HPLC (semi-preparative, A (H2O + 0.1 % TFA + 0.1 % HFIP), B (MeOH + 0.1 % 
TFA+ 0.1 % HFIP), probe dissolved in 100 % HFIP, 80.0→100.0 % B, 30 min, 60 °C): 






















The peptide Pep 15 was synthesised following SOP 5 using the amino acids described in 
Chapter 6.5.1. The fluorophore labelling was performed with NBD-F (5.00 eq) in DMF 





and DIPEA (20.0 eq). This solution was given to the dry resin for gentle agitation 
overnight. 
 













HR-MS (ESI, MeOH):  
 C238H400N49O37 [M+3H]
3+
 calculated: 1513.0323 measured: 1513.0319; 
 C238H401N49O37 [M+4H]
4+
 calculated: 1135.0260 measured: 1135.0261; 
 C238H402N49O37 [M+5H]
5+
 calculated: 908.2223  measured: 908.2227; 
 C238H403N49O37 [M+6H]
6+
 calculated: 757.0198  measured: 757.0199; 
 C238H404N49O37 [M+7H]
7+
 calculated: 649.0180  measured: 649.0176. 
 
HPLC (preparative, A (H2O + 0.1 % TFA), B (MeOH + 0.1 % TFA), 88.0→98.0 % B, 






















The peptide Pep 16 was synthesised following SOP 6 using the amino acids described in 
Chapter 6.5.1. The fluorophore labelling was carried out in compliance with SOP 9. 
 




HR-MS (ESI, MeOH):  
 C217H364N41O39 [M+3H]
3+
 calculated: 1390.2601 measured: 1390.2641; 
 C217H365N41O39 [M+4H]
4+
 calculated: 1042.9469 measured: 1042.9496. 
 














The peptide Pep 18 was synthesised following SOP 6 using the amino acids described in 
Chapter 6.5.1. The fluorophore labelling was carried out in compliance with SOP 10. 
 






HR-MS (ESI, MeOH):  
 C74H110N14O18 S [M+2H]
2+
 calculated: 757.3916  measured: 757.3917; 
 C74H111N14O18 S [M+3H]
3+
 calculated: 505.2635  measured: 505.2639. 
 
HPLC (analytic, A (H2O + 0.1 % TFA), B (MeOH + 0.1 % TFA), 30.0→100.0 % B, 











The peptide Pep 19 was synthesised following SOP 6 using the amino acids described in 
Chapter 6.5.1. The fluorophore labelling was carried out in compliance with SOP 10. 
 











HR-MS (ESI, MeOH):  
 C68H106N14O15S [M+2H]
2+
 calculated: 695.3836  measured: 695.3843; 
 C68H107N14O15S [M+3H]
3+
 calculated: 463.9248  measured: 463.9254. 
 
HPLC (analytic, A (H2O + 0.1 % TFA), B (MeOH + 0.1 % TFA), 30.0→100.0 % B, 


















The peptide Pep 20 was synthesised following SOP 6 using the amino acids described in 
Chapter 6.5.1. The fluorophore labelling was carried out in compliance with SOP 10. 
 











HR-MS (ESI, MeOH):  
 C225H349N40O39S [M+3H]
3+
 calculated: 1423.2106 measured: 1423.2104; 
 C225H350N40O39S [M+4H]
4+
 calculated: 1067.6598 measured: 1067.6598; 
 C225H351N40O39S [M+5H]
5+
 calculated: 854.3293  measured: 854.3290. 
 
HPLC (preparative, A (H2O + 0.1 % TFA + 0.1 % HFIP), B (MeOH + 0.1 % TFA+ 0.1 % 
HFIP), probe freshly dissolved in 100 % HFIP, 90.0→100.0 % B, 30 min, RT): 








Appendix A Automatic microwave-supported SPPS 
Method 1 (synthesis scale 0.15 mmol) 
Reagents 0.15 mmol Reagents 0.15 mmol 
Wash solvent DMF Activator 1 0.5 M DIC in DMF 
Deprotection  
Cocktail 
20 % Piperidine  
in DMF 
Activator Base 1 1.0 M Oxyma in DMF +  
0.1 M DIPEA 
Amino Acids 0.2 M in DMF Activator 2 0.5 M/HATU and 
0.5 M/HOAT in DMF 
Capping 1 1.0 M Ac2O in DMF Activator Base 2 2 M DIPEA in NMP 
Capping 2 0.25 M Oxyma in DMF + 
0.03 M DIPEA 
  
 
Amino acid cycles  
 Parameters Microwave method Bubble time 
Deprotection Deprotection Volume: 8 70 °C, 140 W, 180 s, 
ΔT = 2 °C 
On = 2 s 
Off = 3 s 
4×Wash Volume 6, Drain Time: 20   
Wash Volume 6, Drain Time: 25   
Deprotection Deprotection Volume: 8 70 °C, 140 W, 180 s, 
ΔT = 2 °C 
On = 2 s 
Off = 3 s 
5×Wash Volume 6, Drain Time: 20   
Wash Volume 6, Drain Time: 25   
Coupling Amino Acid Volume: 3.75 
Activator 1 Volume: 1.5 
Activator Base 1 Volume: 0.75 
1. 25 °C, 0 W, 60 s, 
ΔT = 2 °C 
2. 75 °C, 190 W, 15 s, 
ΔT = 2 °C 
3. 90 °C,350 W, 285 s, 
ΔT = 2 °C 
4. 25 °C, 0 W, 60 s, 
ΔT = 2 °C 
On = 2 s 
Off = 3 s 
3×Wash Volume 6, Drain Time: 20   
Wash Volume 6, Drain Time: 25   
Coupling Amino Acid Volume: 3.75 
Activator 2 Volume: 1.5 
Activator Base 2 Volume: 0.75 
1. 25 °C, 0 W, 60 s, 
ΔT = 2 °C 
2. 75 °C, 43 W, 1140 s, 
ΔT = 2 °C 
On = 2 s 
Off = 3 s 
3×Wash Volume 6, Drain Time: 20   
Wash Volume 6, Drain Time: 25   
Capping Capping 1 Volume: 5 
Capping 2 Volume: 5 
1. 65 °C, 65 W, 30 s, 
ΔT = 5 °C 
2. 65 °C, 0 W, 30 s, 
ΔT = 5 °C 
3. 65 °C, 65 W, 30 s, 
ΔT = 5 °C 
4. 65 °C, 0 W, 30 s, 
ΔT = 5 °C 
On = 1 s 
Off = 3 s 
2×Wash Thru 
Mainfold 






Wash Thru  
Mainfold 
Volume 6, Drain Time: 25   
2×Wash Volume 6, Drain Time: 20   
2×Wash Volume 6, Drain Time: 25   
 
Method 2 (synthesis scale 0.1 mmol) 
Reagents 0.1 mmol 
Wash solvent DMF 
Deprotection 
Cocktail 
20 % Piperidine in DMF 
Amino Acids 0.2 M in DMF 
Activator 1 0.5 M DIC in DMF 
Activator Base 1 1.0 M Oxyma in DMF + 
0.1 M DIPEA 
Capping 1 1.0 M Ac2O in DMF 
Capping 2 0.25 M Oxyma in DMF + 
0.03 M DIPEA 
 
Amino acid cycles (additional steps for the first amino acid in italic letters) 
 Parameters Microwave method Bubble time 
Deprotection Deprotection Volume: 5 1. 75 °C, 260 W, 15 s, 
ΔT = 2 °C 
2. 90 °C, 60 W, 50 s, 
ΔT = 1 °C 
On = 2 s 
Off = 3 s 
Wash Volume 6, Drain Time: 10   
Deprotection Deprotection Volume:  1. 75 °C, 260 W, 15 s, 
ΔT = 2 °C 
2. 90 °C, 60 W, 50 s, 
ΔT = 1 °C 
On = 2 s 
Off = 3 s 
Wash Volume 6, Drain Time: 10   
3×Wash Volume 6, Drain Time: 5   
Wash Volume 6, Drain Time: 10   
Coupling Amino Acid Volume: 2.5 
Activator 1 Volume: 2.0 
Activator Base 1 Volume: 0.5 
1. 85 °C, 300 W, 20 s, 
ΔT = 1 °C 
2. 105 °C, 100 W, 135 s, 
ΔT = 1 °C 
On = 5 s 
Off = 2 s 
Wash Volume 6, Drain Time: 10   
3×Wash Volume 6, Drain Time: 5   
Wash Volume 6, Drain Time: 10   
Coupling  Amino Acid Volume: 2.5 
Activator 1 Volume: 2.0 
Activator Base 1 Volume: 0.5 
1. 85 °C, 300 W, 20 s, 
ΔT = 1 °C 
2. 105 °C, 100 W, 135 s, 
ΔT = 1 °C 
On = 5 s 
Off = 2 s 
Wash Volume 6, Drain Time: 5   
Wash Volume 6, Drain Time: 10   
Capping Capping 1 Volume: 2.5 
Capping 2 Volume: 2.5 
1. 65 °C, 65 W, 30 s, 
ΔT = 5 °C 
2. 65 °C, 0 W, 30 s, 
ΔT = 5 °C 
 
On = 5 s 






3. 65 °C, 65 W, 30 s, 
ΔT = 5 °C 
4. 65 °C, 0 W, 30 s, 
ΔT = 5 °C 
Wash Thru  
Mainfold 
Volume 6, Drain Time: 10   
2×Wash Thru  
Mainfold 
Volume 6, Drain Time: 5   
Wash Volume 6, Drain Time: 5   
Wash Volume 6, Drain Time: 10   
 
Appendix B Lipids [https://avantilipids.com 16.10.2018 17:40] 
1,2-Dimyristoyl-sn-glycero-3-phosphocholine (DMPC) 
 
Molecular Weight [g/mol]:  677.933 
Molecular Formula:   C36H72NO8P 
Saturation degree:   14:0/14:0 




Molecular Weight [g/mol]:  733.039 
Molecular Formula:   C40H80NO8P 
Saturation degree:   16:0/16:0 




Molecular Weight [g/mol]:  786.113 
Molecular Formula:   C44H84NO8P 
Saturation degree:   18:1/18:1 







1,2-Dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) (sodium salt) (DOPG) 
 
Molecular Weight [g/mol]:  797.026 
Molecular Formula:   C42H78NO10PNa 
Saturation degree:   18:1/18:1 





Molecular Weight [g/mol]:  862.188 
Molecular Formula:   C46H90N2O10P· 





Molecular Weight [g/mol]:  862.188 
Molecular Formula:   C46H90N2O10P· 
Saturation degree:   16:0/18:0 (16 DOXYL) 
 
1,2-Dioleoyl-sn-glycero-3-phosphate (sodium salt) (DOPA) 
 
Molecular Weight [g/mol]:  722.948 
Molecular Formula:   C39H72NO8PNa 







1,2-Dioleoyl-sn-glycero-3-phospho-L-serine (sodium salt) (DOPS) 
 
Molecular Weight [g/mol]:  810.025 
Molecular Formula:   C42H77NO10PNa 
Saturation degree:   18:1/18:1 
 
Appendix C Spectroscopy of Peptides 
Analytic Data of Pep 1 
a) b) 



































































Wavelength  [nm]  
Figure 6.1 Analytic Data of Pep 1. a) Overlay of CD spectra of Pep 1 in organic solvents (MeOH, TFE) and in 
LUV (DMPC, DOPC, DPPC) show a characteristic right handed 14-helix. b) Fluorescence spectra of Pep 1 in 
organic solvents (FMax,MeOH = 339 nm, FMax,TFE = 349 nm) and in LUV (FMax,DMPC = 322 nm, FMax,DPPC = 317 nm, 
FMax,DOPC = 318 nm). 
Analytic Data of Pep 2 
a) b) 




































































Figure 6.2 Analytic Data of Pep 2. a) Overlay of CD spectra of Pep 2 in organic solvents (MeOH, TFE) and in 
LUV (DMPC, DOPC, DPPC) show a characteristic right handed 14-helix. b) Fluorescence spectra of Pep 2 in 
organic solvents (FMax,MeOH = 340 nm, FMax,TFE = 349 nm) and in LUV (FMax,DMPC = 333 nm, FMax,DPPC = 333 nm, 






Analytic Data of Pep 3 
a) b) 



































































Figure 6.3 Analytic Data of Pep 3. a) Analytic Data of Pep 1. a) Overlay of CD spectra of Pep 3 in organic solvents 
(MeOH, TFE) and in LUV (DMPC, DOPC, DPPC) show a characteristic right handed 14-helix. b) Fluorescence 
spectra of Pep 3 in organic solvents (FMax,MeOH = 337 nm, FMax,TFE = 345 nm) and in LUV (FMax,DMPC = 313 nm, 
FMax,DPPC = 313 nm, FMax,DOPC = 312 nm). 
Analytic Data of Pep 4 
a) b) 




































































Figure 6.4 Analytic Data of Pep 4. a) Overlay of CD spectra of Pep 4 in organic solvents (MeOH, TFE) and in 
LUV (DMPC, DOPC, DPPC) show a characteristic right handed 14-helix. b) Fluorescence spectra of Pep 4 in 
organic solvents (FMax,MeOH = 340 nm, FMax,TFE = 345 nm) and in LUV (FMax,DMPC = 332 nm, FMax,DPPC = 330 nm, 
FMax,DOPC = 332 nm). 
Analytic Data of Pep 5 
a) b) 







































































Figure 6.5 Analytic Data of Pep 5. a) Overlay of CD spectra of Pep 5 in organic solvents (MeOH, TFE) and in 
LUV (DMPC, DOPC, DPPC) show a characteristic left handed 12-helix. b) Fluorescence spectra of Pep 5 in 
organic solvents (FMax,MeOH = 314 nm, FMax,TFE = 305 nm) and in LUV (FMax,DMPC = 308 nm, FMax,DPPC = 314 nm, 






Analytic Data of Pep 6 
a) b) 







































































Figure 6.6 Analytic Data of Pep 6. a) Overlay of CD spectra of Pep 6 in organic solvents (MeOH, TFE) and in 
LUV (DMPC, DOPC, DPPC) show a characteristic left handed 12-helix. b) Fluorescence spectra of Pep 6 in 
organic solvents (FMax,MeOH = 314 nm, FMax,TFE = 306 nm) and in LUV (FMax,DMPC = 317 nm, FMax,DPPC = 3316 nm, 
FMax,DOPC = 314 nm). 
Analytic Data of Pep 7 
a) b) 






































































Figure 6.7 Analytic Data of Pep 7. a) Overlay of CD spectra of Pep 7 in organic solvents (MeOH, TFE) and in 
LUV (DMPC, DOPC, DPPC) show a characteristic left handed 12-helix. b) Fluorescence spectra of Pep 7 in 
organic solvents (FMax,MeOH = 336 nm, FMax,TFE = 343 nm) and in LUV (FMax,DMPC = 318 nm, FMax,DPPC = 318 nm, 
FMax,DOPC = 314 nm). 
Analytic Data of Pep 8 
a) b) 






































































Figure 6.8 Analytic Data of Pep 8. a) Overlay of CD spectra of Pep 8 in organic solvents (MeOH, TFE) and in 
LUV (DMPC, DOPC, DPPC) show a characteristic left handed 12 helix. b) Fluorescence spectra of Pep 8 in 
organic solvents (FMax,MeOH = 335 nm, FMax,TFE = 339 nm) and in LUV (FMax,DMPC = 330 nm, FMax,DPPC = 330 nm, 






Analytic Data of Pep 9 
a) b) 




































































Figure 6.9 Analytic Data of Pep 9. a) Overlay of CD spectra of Pep 9 in organic solvents (MeOH, TFE) and in 
LUV (DMPC, DOPC, DPPC) show a characteristic right handed 14-helix. b) Fluorescence spectra of Pep 9 in 
organic solvents (FMax,MeOH = 340 nm, FMax,TFE = 349 nm) and in LUV (FMax,DMPC = 310 nm, FMax,DPPC = 310 nm, 
FMax,DOPC = 312 nm). 
Analytic Data of Pep 10 
a) b) 





































































Figure 6.10 Analytic Data of Pep 10. a) Overlay of CD spectra of Pep 10 in organic solvents (MeOH, TFE) and in 
LUV (DMPC, DOPC, DPPC) show a characteristic right handed 14-helix. b) Fluorescence spectra of Pep 10 in 
organic solvents (FMax,MeOH = 341 nm, FMax,TFE = 344 nm) and in LUV (FMax,DMPC = 334 nm, FMax,DPPC = 335 nm, 
FMax,DOPC = 337 nm). 
Analytic Data of Pep 11 
a) b) 





































































Figure 6.11 Analytic Data of Pep 11. a) Overlay of CD spectra of Pep 11 in organic solvents (MeOH, TFE) and in 
LUV (DMPC, DOPC, DPPC) show a characteristic right handed 14-helix. b) Fluorescence spectra of Pep 10 in 
organic solvents (FMax,MeOH = 342 nm, FMax,TFE = 346 nm) and in LUV (FMax,DMPC = 338 nm, FMax,DPPC = 338 nm, 






Analytic Data of Pep 12 




























Wavelength  [nm]  
Figure 6.12 CD spectrum of Pep 12 in organic ultrapure water shows a characteristic right handed 14-helix.  
Analytic Data of Pep 18 and Pep 19 
a) b) 



























































Wavelength  [nm]  
Figure 6.13 a) CD spectrum of Pep 12 in organic ultrapure water shows a characteristic right handed 14-helix and 
CD spectrum of Pep 12 in organic ultrapure water shows a characteristic right handed 14-helix. 












































Figure 6.14 Absorbance spectra of Pep 19 were recorded during a Ca2+ titration. The normalised absorbance 












a) Pep 1 in DOPC/10:0-10 DOXYL PC b) Pep 1 in DOPC/16:0-16 DOXYL PC 














































c) Pep 2 in DOPC/10:0-10 DOXYL PC d) Pep 2 in DOPC/16:0-16 DOXYL PC 














































Figure 6.15 Fluorescence depth quenching curves of Pep 1 and Pep 2 with varying percentages of 10:0-10 DOXYL 
PC or 16:0-16 DOXYL PC derived from the corresponding fluorescence spectra. 
Titration curve PBS 
a) Pep 13 in DOPC b) Pep 13 in DOPC/DOPG (50:50) 























































c) Pep 14 in DOPC d) Pep 14 in DOPC/DOPG (50:50) 



















































Figure 6.16 Titration curve of Pep 13 and Pep 14 in DOPC and DOPC/DOPG (50:50) vesicles rehydrated and 
extruded in PBS buffer. 
Titration curve HEPES 
a) Pep 13 in DOPC b) Pep 13 in DOPC/DOPA (90:10) 

















































c) Pep 14 in DOPC d) Pep 14 in DOPC/DOPA (90:10) 



















































Figure 6.17 Titration curve of Pep 13 and Pep 14 in DOPC and DOPC/DOPA (90:10) vesicles rehydrated and 











Size distribution  
100 nm 
a) Pep 13 in DOPC  b) Pep 13 in DOPC/DOPG (50:50) 














































c) Pep 14 in DOPC d) Pep 14 in DOPC/DOPG(50:50) 













































Figure 6.18 DLS measurements of Pep 13 and Pep 14 in DOPC and DOPC/DOPG (50:50) vesicles rehydrated and 
extruded in PBS buffer. 
400 nm 
a) Pep 13 in DOPC b) Pep 13 in DOPC/DOPA (90:10) 


























































c) Pep 14 in DOPC d) Pep 14 in DOPC/DOPA (90:10) 












































Figure 6.19 DLS measurements of Pep 13 and Pep 14 in DOPC and DOPC/DOPA (90:10) vesicles rehydrated and 
extruded in HEPES buffer. 
 
Fluorescence measurements of Pep 13 and Pep 14 with multiplied pH steps 
a) Pep 13 in DOPC b) Pep 13 in DOPC/DOPG (50:50) 





































































































c) Pep 14 in DOPC d) Pep 14 in DOPC/DOPG (50:50) 



















         Pep 14 in DOPC
















































































Figure 6.20 Fluorescence measurements of Pep 13 and Pep 14 in DOPC and DOPC/DOPG (50:50) vesicles 








Å  Ångström 
2Dc hydrophobic region 
6MH 6-mercaptohexanol 
A electron acceptor group 
AA amino acids 
Ac acetyl 
Ac2O acetic anhydride 
ACHC  trans-2-aminocyclohexanecarboxylic acid 
ACHC trans-2-aminocyclohexanecarboxylic acid 
ACN acetonitrile 
Ala alanine 
ART-IR attenuated total reflection  
Asn asparagine 
ATP adenosine triphosphate 
ATR  attenuated total reflection 
BAPTA 1,2-bis(o-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid 
BD Becton Dickinson 
BIIC 3-(benzimidazolyl)-iminocoumarin 





CCCP carbonyl cyanide m-chlorophenyl hydrazone 
CD  circular dichroism 
D electron donating group 
DBU 1,8-diazabicyclo[5.4.0]undec-7-ene 
DCM  dichlormethane 
DHPE 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine 
DIC  N,Nˈ-diisopropylcarbodiimide 
DIPEA N,N-diisopropylethylamine 











DMSO  dimethyl sulfoxide 
DNP dinitrophenylhydrazine 
DOPA 1,2-dioleoyl-sn-glycero-3-phosphate 





DPC dodecyl phosphocholine 
DPPC 1,2-dipalmitoyl-sn-glycero-3-phosphocholine 
Ds diffusion coefficient 
EE ethyl acetate 
EGTA ethylene glycol-bis(2-aminoethylether)-N,N,N′,N′-tetraacetic acid 
EI electron ionisation 
eq equivalents 
ESI  electrospray-ionisation 
ESI electrospray ionization 
EtOAc ethyl acetate 
FCS fluorescence correlation spectroscopy 
Fmoc  fluorenylmethoxycarbonyl 
FRET FÖRSTER resonance energy transfer 





HATU  O-(7-azabenzotriazol-1-yl)-N,N,Nˈ,Nˈ-tetramethyluronium 
hexafluorophosphate 
HBTU  O-(1H-benzotriazol-1-yl)-N,N,Nˈ,Nˈ-tetramethyluronium 
hexafluorophosphate 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HFIP hexafluoro-2-propanol 
HOAt  1-hydroxy-7-azabenzotriazole 
HOBt  1-hydroxybenzotriazole 
HOMO highest occupied molecular orbital 
HPLC  high performance liquid chromatography 







IR infrared spectroscopy 
IRE internal reflection element 
J coupling constant 
Kd  dissociation constant 
Leu leucine 
LUMO lowest unoccupied molecular orbital 
LUV  large unilamellar vesicle 
Lys lysine 
m/z mass-to-charge ratio 
MBHA  4-methylbenzhydrylamine 
MD molecular-dynamics 
MeOH methanol 
MIET metal-induced energy transfer 
mif membrane interaction factor 
MOBHA 2-(2′-morpholino-2′-oxoethoxy)-N,N-bis(hydroxycarbonylmethyl)-
aniline 
MS mass spectrometry 
Mtt 4-methyltrityl 
NBD  7-nitrobenz-2-oxa-1,3-diazol-4-yl 
NMP  N-methyl-pyrrolidone 
NMR  nuclear magnetic resonance 
NP-EGTA o-nitrophenyl EGTA 
Oxyma ethyl cyanohydroxyiminoacetate 
P/L peptide-to-lipid  
PBS phosphate buffered saline 
PCT photoinduced charge transfer 
PE phosphoethanolamine 
PEG polyethylene glycol 
PET photoinduced electron transfer 
pKa acid dissociation constant 










RP reversed phase 
rpm rotations per minute 
RT room temperature 
SAM self assembled monolayer 
SEIRA surface-enhanced infrared absorption 
Ser serine 
SNARE soluble N-ethylmaleimide-sensitive factor attachment protein receptor 
SNARF seminaphtharhodafluor 
SOP  standard operating procedure 
SPPS  solid phase peptide synthesis 
SUV  small unilamellar vesicle 





tBu tert-butyl protection group 
TFA  trifluoroacetic acid 
TFE  trifluoroethanol 
THF  tetrahydrofuran 
TIS  triisopropylsilan 
TLC  thin-layer chromatography 
TMS trimethylsilyl 
tR retention time 
Trp tryptophan 
UV  ultraviolet 





 mole fraction 
 chemical shift (NMR) 
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